Text

Attachment 3: Defueled Offsite Dose Assessment Manual (Dodam)
	ML21104A151
Person / Time
Site:	Duane Arnold
Issue date:	04/14/2021
From:	Tanho D; NextEra Energy Duane Arnold
To:	; Office of Nuclear Reactor Regulation
Shared Package
ML21104A148	List: ML21104A149; ML21104A150; NG-21-0008, Attachment 3: Defueled Offsite Dose Assessment Manual (Dodam);
References
	NG-21-0008
	Download: ML21104A151 (197)
	v • d • e

DUANE ARNOLD ENERGY CENTER 2020 ANNUAL RADIOACTIVE MATERIAL RELEASE REPORT ATTACHMENT 3: DEFUELED OFFSITE DOSE ASSESSMENT MANUAL (DO DAM)

Cover Page Page 38

DEFUELED OFFSITE DOSE ASSESSMENT MANUAL GASEOUS AND LIQUID EFFLUENTS Duane Arnold Energy Center Record the following: Date/Time: ______ / ____ Initials: __

NOTE: User shall perform and document a Temp Issue I Rev. Chee/< to ensure revision is current, in accordance with procedure use and adherence requirements.

Prepared By:

Approved By Approved By Approved By Approved By DAEC DODAM LICENSING MANAGER CROSS DISCIPLINE REVIEW CHEMISTRY MANAGER PROCEDURE APPROVAL ORG REVIEW

VJ.: t¥i II IS Print

~

OR.G.;;>t>J/-4.< Date: 4 /;J Signature Page 1 of 196 Rev. 000

TABLE OF CONTENTS Section Title Page

1.0 INTRODUCTION

5 2.0 LIQUID EFFLUENT 7

2.1 Radioactivity In Liquid Waste 7

2.2 Aqueous Concentration 7

2.3 Basis of Mixing Ratios 8

2.4 Method of Establishing Alarm Setpoints 9

2.4.1 Setpoint for a Batch Release 9

2.4.2 Setpoint for a Continuous Release 10 2.5 Radioactivity Concentration in Water at the Restricted Area Boundary 12 2.6 Accumulated Personal Maximum Dose 12 2.7 Projected Maximum Dose to a Person Offsite 14 2.8 Groundwater Pathway 15 3.0 GASEOUS EFFLUENT 17 3.1 Introduction 17 3.2 Radioactivity in Gaseous Effluent 17 3.3 Not Used 3.4 Effluent Noble Gas Monitor Alarm Setpoint 19 3.5 Dose Equivalent Rate Offsite 22 3.5.1 Noble Gas 22 3.5.1.1 Total Body Dose Rate 22 3.5.1.2 Skin Dose Rate 24 3.5.2 Iodine, Tritium, and Particulates 25 3.5.2.1 Organ Dose Rate 25 3.5.2.2 Rainwater Recapture of Tritium 27 3.6 Noble Gas Gamma Radiation Dose Accumulated in Air 27 3.6.1 Alternate Method of Evaluating Compliance with Gamma Air Dose Limits 29 3.7 Noble Gas Beta Radiation Dose Accumulated in Air 31 3.8 Dose Due to Iodine and Particulates in Gaseous Effluents 32 3.8.1 Alternate Method of Evaluating Doses Due to Iodine and Particulates in Gaseous Effluents 35 3.9 Dose to a Person from Noble Gases 36 3.9.1 Gamma Dose to Total Body 36 3.9.2 Dose to Skin 37 4.0 DOSE COMMITMENT FROM RELEASE OVER EXTENDED TIME 46 4.1 Dose Assessment for 10 CFR Part 50, Appendix I 46 4.2 Dose Assessment for 40 CFR Part 190 and 10 CFR 72.104 47 5.0 ENVIRONMENTAL MONITORING PROGRAMS 49 5.1 Radiological Environmental Monitoring Program 49 5.2 Ground Water Protection Program (GWPP) 49 5.3 Sampling Station Locations 50 continued DAEC DODAM Page 2of196 Rev. 000

TABLE OF CONTENTS Section Title 6.0 6/7.1 6.0.1 6.0.2 6.0.3 7.0.3 6.1.1 6.1.2 6.1.3 6.1.4 6.1.5 RADIOLOGICAL EFFLUENT CONTROLS AND SURVEILLANCE REQUIREMENTS Use and Application 6.0.1.1 Definitions 6.0.1.2 Logical Connectors 6.0.1.3 Completion Times 6.0.1.4 Frequency (Not Used)

Limiting Conditions for Operation (OLCO) Applicability Surveillance Requirement (OSR) Applicability Radioactive Liquid Effluent Controls and Surveillance Requirements Radioactive Liquid Instrumentation Liquid Effluent Concentration Dose Due to Liquid Radioactive Effluents Liquid Waste Treatment Liquid Holdup Tanks 617.2 Radioactive Gaseous Effluent Controls and Surveillance Requirements 6.2.1.1 6.2.2 6.2.3 6.2.4 Radioactive Gaseous Effluent Instrumentation Gaseous Effluent Dose Rate 617.3 6.3.1 6.3.2 Doses Due to Noble Gases Doses Due to Iodine and Particulates in Air Offsite Dose Assessment Controls and Surveillance Requirements Dose Radiological Environmental Monitoring Program (REMP) and Ground Water Protection Program (GWPP)

BASES 6.1.1and7.1.1 BASES 6.1.2 and 7.1.2 BASES 6.1.3 and 7.1.3 BASES 6.1.4 and 7.1.4 BASES 6.1.5 and 7.1.5 BASES 6.2.1 and 7.2.1 BASES 6.2.2 and 7.2.2 BASES 6.2.3 and 7.2.3 BASES 6.2.4 and 7.2.4 BASES 6.3.1 and 7.3.1 BASES 6.3.2 and 7.3.2 BASES continued DAEC DODAM Page 3of196 Page 60 60 60 62 63 64 65 66 67 67 70 76 78 80 82 82 87 91 93 95 95 97 105 106 107 107 109 110 111 111 111 112 112 Rev. 000

TABLE OF CONTENTS Section Title Page 8.0 ADMINISTRATIVE CONTROLS 113 8.1 Programs and Manuals 113 8.1.1 Radioactive Effluent Controls Program 113 8.1.2 Radiological Environmental Monitoring Program 114 8.1.3 lnterlaboratory Comparison Program 114 8.2 Reporting Requirements 115 8.2.1 Annual Radioactive Material Release Report 115 8.2.2 Annual Radiological Environmental Operating Report 118 8.2.3 Special Reports 119 8.3 Changes to the DODAM 120 APPENDIX A: DOSE TRANSFER FACTORS FOR AIRBORNE PATHWAYS 121 APPENDIX B: TECHNICAL BASES FOR EFFECTIVE DOSE FACTORS 143 APPENDIX C: DOSE TRANSFER FACTORS FOR WATERBORNE PATHWAYS 147 DAEC DODAM Page 4of196 Rev. 000

DEFUELED OFFSITE DOSE ASSESSMENT MANUAL FOR GASEOUS AND LIQUID EFFLUENTS

1.0 INTRODUCTION

This manual provides a description of the facility's Defueled Offsite Dose Assessment Program (DODAM), the Radiological Effluents Controls Program and the Radiological Environmental Monitoring Program (REMP).

CESSATION OF POWER OPERATIONS In July of 2018 NextEra Energy Duane Arnold L.L.C announced the cessation of power operations planned for the 4th quarter of 2020, however a severe windstorm on August 10, 2020 damaged the plants cooling towers. There were no abnormal releases as all safety systems functioned as designed. The reactor was permanently defueled on October 8, 2020. The decommissioning process has started with system layup plans for long term dormancy period prior to returning the area to greenfield. The plant is being placed in SAFSTOR.

EFFLUENTS CONTROLS PROGRAM This program, conforming to 10 CFR 50.36a, provides for the control of radioactive effluents and for maintaining the doses to members of the public from radioactive effluents as low as reasonably achievable (ALARA). The program is contained in sections six and seven of the DODAM, is implemented by procedures, and includes remedial actions to be taken whenever the program limits are exceeded.

Section eight of the DO DAM includes the requirement for the Annual Radioactive Material Release Report (ARM RR). The ARMRR covers the operation of the unit during the previous calendar year shall be submitted prior to May 1 of each year in accordance with 10 CFR 50.36a.

The report includes a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the unit. The material provided in the report is consistent with the objectives outlined in the DO DAM and Process Control Program and in conformance with 1 O CFR 50.36a and 10 CFR Part 50, Appendix I, Section IV.B.1.

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM The REMP provides for representative measurements of radioactivity in the highest potential exposure pathways, verification of the accuracy of the effluent monitoring program and modeling of environmental exposure pathways. Additionally, the REMP is designed to demonstrate that radioactive effluents from DAEC are ALARA.

GROUNDWATER PROTECTION PROGRAM The Groundwater Protection Program (GWPP) provides representative measurements of radioactivity in the highest potentially exposed aquifer, verification of the accuracy of the GWPP monitoring efforts and modeling of the subsurface. Additionally, the GWPP is designed to protect and mitigate radiological contaminates to groundwater. The GWPP is incorporated within REMP and includes standards set forth in Nuclear Energy Institute, NEI 07-07.

The REMP and GWPP programs are described in sections five, six and seven of the DODAM and conforms to the guidance of Appendix I to 10 CFR Part 50 and 10 CFR 72, Section eight of the DO DAM includes the requirement for the Annual Radiological Environmental Operating Report (AREOR). The Annual Radiological Environmental Operating Report covers the operation of the unit during the previous calendar year and is submitted by May 15 of each year.

The report includes summaries, interpretations, and analyses of trends of the results of the Radiological Environmental Monitoring Program for the reporting period. The material provided is consistent with the objectives outlined in the DODAM, and in 10 CFR 50, Appendix I, Sections IV.B.2, IV.B.3, and IV.C.

DAEC DODAM Page 5of196 Rev. 000

DEFUELED OFFSITE DOSE ASSESSMENT PROGRAM The methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and liquid effluents are included in sections two, three and four of the DODAM. These chapters describe acceptable methods of calculating radioactivity concentrations in the environment and the potentially resultant committed doses to a member of the public in the unrestricted areaa that are associated with LWR liquid and gaseous effluents.

The methodology stated in this Manual is acceptable for use in demonstrating operational compliance with 10 CFR 20.1301, 10 CFR 50 Appendix I, 10 CFR 72.104, and 40 CFR 190.

Only the dose attributable to the Duane Arnold Energy Centerb is considered in demonstrating compliance with 40 CFR 190 since no other nuclear facility exists within 50 miles of the DAEC.

Calculations are made monthly to assess the potential air doses offsite and to a nearby resident in order to guide the management of station effluents. The receptor is described such that the dose to any resident near the Station is unlikely to be underestimated. Calculations made to assess the radioactive noble gas dose to air are based on the location offsite that could be occupied by a person where the maximum air dose is expected. For these monthly-accumulated dose calculations, atmospheric dispersion and deposition of gaseous effluents may be based on reference meteorological conditions.c More conservative conditions (i.e.,

location and/or exposure pathways expected to yield higher computed doses) than appropriate for the maximally exposed person may be assumed in the dose estimated.

Calculations of dose committed from radioactive releases over extended time (3 and 12 months) are also made for the purpose of verifying compliance with regulatory limits on offsite dose. For these calculations the receptor is selected on the basis of the combination of applicable exposure pathways identified in the land use census and the maximum ground level x!Q at a residence, or on the basis of more conservative conditions such that the dose to any resident near the Station is unlikely to be underestimated.

a Unrestricted area means outside of the boundary of property owned, leased, or controlled by the Company on which DAEC is sited. The DAEC site boundary is identified by UFSAR Figure 1.2-1.

b The Duane Arnold Energy Center, also referred to henceforth as the Station, is defined as including BOTH the Nuclear Reactor Facility and the Independent Spent Fuel Storage Installation (ISFSI).

c Reference meteorological conditions are 1971, 1974 and 1975 data composited as discussed in "Duane Arnold Energy Center, Evaluation of Liquid and Gaseous Effluent Releases in Accordance With 10 CFR 50 Appendix I," submitted to the NRC June 3, 1976.

DAEC DODAM Page 6of196 Rev. 000

2.0 LIQUID EFFLUENT 2.1 Radioactivity In Liquid Waste The concentration of radionuclides in liquid waste is determined by sampling and analysis in accord with the surveillance requirements of Section 7.1.2, Table 7.1-2.

When a radionuclide is identified, it is reported as being present in the sample even if the concentration is below the required LLD for the analysis.

In November 2020 the plant began to discharge liquid radiation waste to the river. The aqueous concentration is managed and tracked batch by batch to maintain margin significantly below 50CFR, Appendix I regulatory limits. The system has a calibrated radiation monitor and an automatic isolation function. Filters were installed prior to the radiation monitor to ensure the process is ALARA; this focus on best practices has significantly lowered the dose to the public.

2.2 Aqueous Concentration Radioactive material in liquid effluent is diluted successively by water flowing in the discharge pipe and in the Cedar River. The diluted concentration of radionuclide i in a receiving stream is estimated with the equation where C =

concentration of radionuclide i in liquid radwaste released (µCi/ml)

C; =

concentration of radionuclide i in the receiving stream (µCi/ml)

F1 =

release rate of liquid radwaste (ml/sec)d F1 =

dilution flow of receiving stream of water (ml/sec)d For the purpose of calculating the radioactivity concentration in water at the restricted area boundary (section 2.5), the flow in the discharge pipe, Fe, is assigned to Fz. The water flow in the discharge pipe may include the liquid waste effluent flow, the liquid radwaste dilution water flow, the cooling tower blowdown flow and other streams such as RHR, GWPP discharges, and emergency service water discharged via the dilution structure and discharge pipe. These streams are illustrated in Figure 2-1.

ct F1, Fz, and Fe may have any convenient units of flow (i.e., volume/time) provided the units of all are identical.

DAEC DODAM Page 7of196 Rev. 000

In the Cedar River immediately beyond the discharge pipe and the restricted area boundary, the effective dilution is Where F c = discharge pipe flow M = factor of additional mixing in the River A near field mixing ratio from the pipe into the near field of the River, M = 5, is assigned when estimating maximum potential individual doses involving exposure by eating fish.

Current and historical field surveys of the Cedar River downstream of DAEC do not indicate the presence of irrigation systems withdrawing water for irrigated crops such as strawberries or other produce. In the event water is drawn from the Cedar River downstream of the Station for drinking water or another exposure pathway, Fz represents the portion of the Cedar River flow into which the liquid effluent from the Station is effectively mixed.

2.3 Basis of Mixing Ratios Downstream dilution of aqueous discharge from the DAEC has been estimated based on thermal plume studies conducted in 197 4 at the DAEC. e Measurements of the discharge temperature and river temperature indicated that the 1°F excess temperature isotherm was about 350 feet downstream of the discharge. This 1°F isotherm represented a dilution of the discharge by the Cedar River of about a factor of 12.

In determining additional dilution within the receiving water for evaluating doses from a plant with cooling towers, the NRC guideline *t is that the factor should be limited to a number such that the product of the number and the average blowdown flow to the receiving water body is 1000 cfs or less. At the DAEC, the discharge rate can be conservatively approximated by a cooling tower blowdown rate of 4000 gpm, or about 9 cfs. Using the NRC guideline, an additional dilution of 100 in the Cedar River could be assumed for evaluating doses due to liquid effluent. Since the average flow in the Cedar River is about 3, 775 cfs, the additional dilution in the Cedar River is achievable.

These results indicate both a dilution factor of 12 at a downstream distance of 350 feet and conformance to the NRC guideline.

Land Use Censuses (field surveys) have shown that the nearest use of river water (from alluvial wells) is 2.2 miles downstream for the City of Palo and more than 8 miles downstream for the City of Cedar Rapids.

e IELP, Cedar River Baseline Ecological Study, DAEC, annual report, Jan. 1974-Jan.1975.

t Boegli, J.S., et. al., Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants, NUREG-0133, p. 16, October, 1978 DAEC DODAM Page 8 of 196 Rev. 000

For the sake of simplification and conservatism in routine liquid dose calculations, a dilution factor of 5 is assumed for fish and a dilution factor of 1 O is assumed for drinking water for the evaluation of doses during DAEC operation.

2.4 Method of Establishing Alarm Setpoints The liquid radwaste effluent line has a monitor which provides automatic isolation when 10 times the water effluent concentration listed in 10 CFR 20 Appendix B, Table 2, is being exceeded in the unrestricted area. The other liquid effluent pathways have monitors which provide alarms when 1 O times the 10 CFR 20 water effluent concentrations is being exceeded in the unrestricted area. Given the nature and frequency of discharges, prompt action to reduce radioactive releases following an alarm, will assure the requirements of 1 O CFR Part 20. 1301; 1 O CFR Part 50 Appendix I,Section IV; and 40 CFR Part 190 are not exceeded.

The alarm setpoint for the liquid effluent radiation monitor is derived from the concentration limit provided in 10 CFR Part 20.1001-20.2402 Appendix B Table 2 Column 2 applied at the unrestricted area boundary where the discharge pipe flows into the river. The alarm setpoint does not consider dilution, dispersion, or decay of radioactive material beyond the site boundary. That is, the alarm setpoint is based on a concentration limit at the end of the discharge pipe. The radiation monitoring and isolation points are located in each line through which radioactive waste effluent is eventually discharged into the discharge pipe. ALARA is achieved by way of ensuring three times tank volume mixing, sample analysis, and filtration prior to release of individual batches.

The alarm setpoint for effluent monitors on batch releases is based on measurements, according to Table 7.1-2. For liquids released in continuous aqueous discharge which are normally radioactively clean, the setpoint is based on the effective Water Effluent Concentration (WEC) for the most likely contaminating source, i.e., the primary coolant water. A measured spectrum from the primary coolant water is used to determine the effective WEC based on WEC fractions according to 10 CFR 20 Appendix B.

2.4.1 Setpoint for a Batch Release where A sample of each batch of liquid radwaste is analyzed for 1-131 and other principal gamma emitters, or for total activity concentration prior to release. The ratio, FWECb, of the activity concentration in the tank to the unrestricted area WEC (10 CFR Part 20, Appendix B, Table 2, Column 2) is calculated with the equation FWECb = L~

WEC fraction of unrestricted area WEC in batch derived from activity measured prior to release.

concentration of radionuclide i (including 1-131 and principal gamma emitters) in batch sample taken prior to release (µCi/ml)

DAEC DODAM Page 9of196 Rev. 000

Whether radioiodine and primary gamma emitters are identified prior to a batch release or not, the liquid radwaste effluent line radiation monitor alarm setpoint is determined with the equation where s =

10 =

A:

g=

[

A Fs2

]

S=JOx

-*g +Bkg FWECb Fs1 radiation monitor alarm setpoint (cpm) factor to account for fact that DAEC's instantaneous release limit is ten times the listed WECs counting rate (cpm/ml) or activity concentration (µCi/ml) of sample in Icbi laboratory analysis. A equals ;

if an isotopic analysis were performed or Cb if a gross activity analysis was performed.

ratio of effluent radiation monitor counting rate to laboratory counting rate or activity concentration in a given batch of liquid (cpm per cpm/ml or cpm per µCi/ml) monitoring instrument background (cpm) flow in the batch release line (gal/min).* Value not greater than the discharge line flow alarm maximum setpoint.

minimum flow in the discharge pipe (gal/min). g Value not less than the discharge pipe flow alarm minimum setpoint.

Note that A/FWECb represents the counting rate of a solution having the same radionuclide distribution as the sample and having the water effluent concentration of that mixture.

2.4.2 Setpoint for a Continuous Release g Any suitable but identical units of flow (volume/time)

DAEC DODAM Page 10of196 Rev. 000

Continuous aqueous discharges are sampled and analyzed according to the schedule in Table 7.1-2. The ratio, FWECc, of the activity concentration in each of the continuous release streams to the unrestricted area WEC is calculated with the equations where FWECc =

Cc;=

FWECc = L~

WEC; fraction of unrestricted area WEC in continuous release based upon activity measured in primary coolant sample(s) concentration of radionuclide i in sample(s) (µCi/ml)

The alarm setpoint of the radiation monitor on a continuous radioactive discharge line is determined with the equation

[

A Fs2

]

S=JOx

-*g +Bkg FWECc Fs1 where I 0 =

factor to account for fact that DAE C's instantaneous release limit is ten times the listed WECs A =

activity concentration (µCi/ml) or counting rate (cpm/ml) in laboratory of monthly reactor primary coolant sample.

Fs, =

Flow in the liquid discharge line (ml/sec). h Value not greater than off discharge line flow alarm maximum setpoint.

Fs2 =

flow in the discharge pipe (ml/sec).h Value not less than discharge pipe flow alarm minimum setpoint.

g =

ratio of effluent radiation monitor counting rate to laboratory counting rate or activity concentration in a given batch of liquid (cpm per cpm/ml or cpm per µCi/ml)

The radioactivity concentration in continuous aqueous effluent is usually so low that measurement of a representative radionuclide in a sample of the water is uncertain.

Thus, the ratio, A/FWECc, which represents the WEC of a given spectrum of radionuclides, is usually derived from reactor primary coolant analysis(es). Alternatively, it may be determined from analyses of the continuous effluent itself.

In the event the concentration of radioactive material in the sample from the continuous release is below measurable levels (i.e., less than the lower limit of detection), the value h Any suitable but identical units of flow (volume/time)

DAEC DODAM Page 11 of 196 Rev. 000

of 1 x 1 o-0 µCi/ml or the equivalent counting rate ( cpm/ml) may be substituted for the factor A

A

--- (i.e.,

- I* 10*8 ).

FWECc FWECc 2.5 Radioactivity Concentration in Water at the Restricted Area Boundary Section 6.1.2 provides limits on instantaneous radioactivity concentration in the unrestricted area due to aqueous effluents from DAEC. Compliance is assessed by monitoring, sampling, analyzing and establishing setpoints according to Section 7.1.2.

As long as a liquid effluent monitor named in Table 6.1-1 does not exceed an alarm or trip setpoint, determined in accordance with section 2.3, or as long as the total or gross activity concentration, measured as required in Section 7.1.2, does not exceed 1 x 10-7

µCi/ml after dilution in the discharge pipe, Section 6.1.2 is satisfied.

In the event of an alarm, indicating concentrations in the unrestricted area in excess of section 6.1.2 limits, the release shall be terminated and dose calculations will be performed to assure the limits specified in sections 6.1.3 and 6.3.1 are not exceeded.

Compliance with 10 CFR 20.1301 shall not be demonstrated on the basis of determining the average annual liquid effluent concentration. But rather by demonstrating compliance with 40 CFR 190 (i.e., section 6.3.1). Such a practice was deemed acceptable by the NRC in their preamble to the revised 10 CFR 20. i 2.6 Accumulated Personal Maximum Dose Section 7.1.3 requires an assessment to be performed at least once every 30 days in any quarter in which radioactive effluent is discharged which determines whether the dose or dose commitment to a person offsite due to radioactive material released in liquid effluent calculated on a cumulative basis exceeds the limits of Section 6.1.3. The requirement is satisfied by computing the accumulated dose commitment to the most exposed organ and to the whole body of a hypothetical person exposed by eating fish and drinking water taken from the river offsite downstream of the discharge pipe.

The pathway(s) and or age group(s) selected may vary by season. For instance, fishing near the DAEC is practically non-existent during the winter; thus, a dose evaluation of the fish pathway is not required for aqueous effluent discharged during the winter months of January, February, or March.

The accumulated dose commitment is computed at least once every 30 days but may be computed as analyses become available.

Normally, DAEC employs the MIDAS computer program to calculate dose to a member of the public from aqueous effluent that uses the equations in Reg Guide 1.109i and standard values therein for maximally exposed people.

i Federal Register Volume 56, #98, Tuesday, May 21, 1991, p. 23360 i USN RC, Regulatory Guide 1.109, revision 1, Position C.1, pp. 1.109-2 thru 1.109-4, Oct. 1977 DAEC DODAM Page 12 of 196 Rev. 000

Alternatively, the dose may be calculated in the following way, for instance, in the event calculations by hand were necessary.

where

~Dank =

-3" A

"LJ..L L).Dank-3.785*xJO L.JCik

tlTk L.J F

Aeani 1

e 2ek Dan

= L Ll Dank k

the dose commitment (mrem) to organ n of age group a due to the isotopes identified in analysis k, where the analyses are those required by Table 7.1-2. Thus the contribution to the dose from gamma emitters become available on a batch basis for batch releases and on a weekly basis for continuous releases. Similarly the contributions from H-3 is available on a monthly basis and the contributions from Fe-55, Sr-89, and Sr-90 become available on a quarterly basis.

Dan =

the dose commitment during the quarter-to-date to organ n, including whole body, of the maximally exposed person in age group a (mrem)

Aeani =transfer factor relating a unit release of radionuclide i (Ci) in a unit stream flow (gal/min) to dose commitment to organ n, or whole body, of an exposed person in

[

mrem gal]

age group a Ci min via environmental pathway e.

Ck =

the concentration of radionuclide i in the undiluted liquid waste represented by sample k to be discharged (µCi/ml)

~ fk =

duration of radioactive release represented by sample k which occurs within time boundaries TB and TE and during which concentration Cik and flows F1 k and F2k exist. (min.)

3. 785

1 o-3 =

conversion constant (3785 ml/gal

1 o-6 Ci/µCi)

F h =

flow in the radioactive waste release line (gal/min)* represented by sample

k.

F 2ke =

flow into which radioactive release represented by sample k is mixed in the river at the point of exposure or withdrawal of water for use (same units as F1k)*

DAEC DODAM Page 13of196 Rev. 000

=

M x Fck where Fck =

discharge pipe flow (gal/min)k during release represented by sample k M =

factor of additional mixing in the Cedar River Pathway-to-dose transfer factors, Aeani, for use in calculating the dose commitment arising from radioactive material released in aqueous effluents are tabulated in Appendix C. These dose transfer factors were derived using LADTAP II and standard values from Regulatory Guide 1.109, revision 1, except where corrections have been incorporated in LADT AP 11. Appropriate tables representing applicable environmental pathways of exposure and most exposed age group(s) are selected and used in calculating the dose commitment. The pathway(s) and/or age group(s) selected may vary by season.

Pathways of Maximum Exposure to a Member of the Public:

Ingestion of Fish taken from the river near the discharge pipe o

Age Group: Adult o

Dilution: F2 = 5Fc o

Food: Sport Fish Drinking Water Pathway o

Age Group: Infant o

Dilution: F2 = 1 OFc o

Dilution: F2 = 5Fc only when Land Use Census identifies this pathway within 3 miles of the plant Variables F1, F2, and Fe are also defined in section 2.2.

2.7 Projected Maximum Dose to a Person Offsite The dose commitment to a person offsite due to radioactive material released in liquid effluent may be projected by calculating the extrapolated whole body and most exposed organ dose commitments to a hypothetical person exposed via the same pathways evaluated in section 2.6. The potential dose commitments to organs and to the whole body are computed separately.

The dose commitment to a maximally exposed hypothetical person will be projected by calculating the doses accumulated during the most recent three months (according to the method described in section 2.6) and by assuming the result represents the projected doses during the current quarter. Alternatively, the quarterly dose commitment may be projected by using the equation:

Pa11

=

k Any suitable, identical units of flow (volume/time) 92 Dan x

DAEC DODAM Page 14 of 196 Rev. 000

where Pan =

projected dose commitment (mrem) to organ n (including whole body) of age group a for the current quarter 92 =

number of days in a quarter X =

number of days to date in current quarter Dan =

dose commitment to organ n, including whole body, of the maximally exposed person in age group a based on available aqueous effluent measurements during the quarter to date (mrem) 2.8 Groundwater Pathway Low levels of radioactive contamination have been identified in sub-surface water on site. There is the possibility that this water could represent potential exposure to the public. Hydrogeology studies indicate that this water will migrate towards the Cedar River in sectors ranging from south-southeast to the southeast. The only potential exposure pathways are described in Section 2.6.

To monitor for the migration of any radioactive contamination beyond the owner controlled area, sampling of on-site ground water, Cedar River water, and down gradient drinking water is performed as a function of the REMP and GWPP. These programs are described in Section 5.0.

Release standards of contaminated groundwater are set forth in Section 6.0, Radiological Liquid Effluent Release 0.6.1.2, Table 7.1-2. In accordance with GWPP Administrative Control Procedure (ACP) 1411.35 and Environmental Protection Agency (EPA) drinking water standards for tritium, 20,000 pCi/L, groundwater batch and continuous releases are expected less than (<) 20,000 pCi/L. Groundwater samples are analyzed on-site and validated by off-site secondary laboratory. Off-site laboratory results are published in Annual Radiological Environmental Operating Report.

In February 2016, routine GWPP sampling identified a contaminate plume in the shallow aquifer (less than 25 feet deep). By February 2017, three Extraction Wells were installed in the shallow aquifer to facilitate continuous groundwater withdrawal to mitigate the contaminated plume. Extraction well EW01A (Table 5-1, D-68) located inside the Protected Area, is the primary well designed to remove tritiated groundwater at less than 17.3 gallons per minute from a narrow plume less than 25 feet below the surface.

Extraction wells EW02A (D-69) and EW03A (D-70) are located southeast of EW01A and were similarly designed to withdraw the same volume of contaminated or uncontaminated groundwater from the shallow aquifer. These Extraction Wells, their AC-powered pumps, and the associated piping system are considered to be tools that may be used by Chemistry for groundwater mitigation.

Based on calibration of pump speed, flow rate, dilution flow rates, and groundwater tritium concentrations, tritiated groundwater is released with anticipated concentrations less than the EPA drinking water limit of 20,000 pCi/L. Liquid effluent releases from groundwater are published in the Annual Radiological Material Release Report.

DAEC DODAM Page 15of196 Rev. 000

R~- DuildiflS t;!Oltd COQlillS W*u:rlwp RllR ilOd t>MERGENCY SlmVICJ!

WATliR SYSTilMS

~t-YSCNkn>ill

~mi<:411 Jtailwa!te WA!tt Wam WA!Wi RivetW.mt forOil<1JIM _________

~~ty!-~

Page 16 of 196 Rev. 000

3.0 GASEOUS EFFLUENT 3.1 Introduction The Station discharges gaseous effluent through a stack and discharges ventilation air from the reactor and radwaste building through the reactor building vents. Ventilation air from the Turbine Building is discharged through the Turbine Building vent and through the Reactor Building vent. Ventilation from the LLRPSF is discharged through the LLRPSF vent. These gaseous effluent streams, radioactivity monitoring points, and effluent discharge points are shown schematically in Figure 3-1. Gaseous release point locations and elevations at the Station are described in Table 3-1. Gaseous discharges from the stack are treated as an elevated release while discharges via the building vents are assumed to be ground-level, building wake, or split wake releases.

3.2 Radioactivity in Gaseous Effluent For the purpose of estimating offsite radionuclide concentrations and radiation doses, measured radionuclide concentrations in gaseous effluent and in ventilation air exhausted from the Station are relied upon.

The gross radioactivity of noble gases discharged is measured by the radioactive noble gas effluent monitors according to Tables 6.2-1 and 7.2-2. Radionuclides other than noble gases in gaseous effluents are measured by sampling and analyses in accordance with Table 7.2-2. Each radionuclide measured in an effluent may be assumed to be discharged uniformly during the sampling period. When radioactivity is identified at a concentration below the LLD for the analysis, that concentration is reported. When radioactivity is not identified in a sample, it is not reported as being present in that sample.

The quantity of radioactive noble gas discharged via the offgas stack or a vent during an interval of time is determined by integrating the release rate measurement of each effluent noble gas monitor. An hourly interval is normally used for dose rate assessments and a daily or longer interval is used for dose assessments. If ~Qi represents the gross activity of noble gas discharged via the offgas stack or a vent and gi represents the fraction of radionuclide i in the distribution of radioactive gases in that effluent stream, then the quantity of radionuclide i released in the gaseous effluent stream during counting interval j is estimated by the relation:

The distribution of radioactive noble gases in gaseous effluent streams is determined by gamma spectrum analysis of gaseous effluent samples in accordance with Table 7.2-2.

Results of one or more previous analyses may be averaged to obtain a representative spectrum. In the event a representative distribution is not available or is unobtainable from sample(s) of an effluent stream taken during the current quarter, it will be derived from past measurements, e.g., earlier sample results or annual radioactive material release reports. Alternatively, a noble gas spectrum for a given effluent stream in Table 3-2 herein, may be assumed.

DAEC DODAM Page 17 of 196 Rev. 000

An airborne discharge of radionuclides other than noble gases may be represented by multiple samples with each sample providing a measure of the concentration of specific radionuclides, Ci, in gaseous effluent discharged at flow, Fa, during a time increment ~t.

Thus, each release is quantified according to the relation:

where Fa1 =

Qik = L Ck Fa} Llfj j

the quantity of radionuclide i released in a given effluent stream based on analysis k (Ci) concentration of radionuclide i in gaseous effluent identified by analysis k

(µCi/ML or Ci/m3) effluent stream discharge rate during the increment Dti (m3/sec) time increment during which radionuclide i at concentration Cik is being discharged (sec)

The analysis index k may represent either a grab sample, integrated sample, or a composite sample required by the effluent sampling and analysis program specified in Table 7.2-2.

3.3 Not Used t DAEC DODAM Page 18 of 196 Rev. 000

3.4 Effluent Noble Gas Monitor Alarm Setpoint Section 6.2.2 provides limits on dose equivalent rates associated with airborne radioactive materials concentrations in the unrestricted area due to airborne effluents from the Station. Instrumentation is provided to monitor gamma radiation in the airborne effluents according to Table 6.2-1. Each effluent noble gas monitor includes an alarm that can be set to activate when the dose rate off site or the noble gas concentration at ground level offsite is expected (calculated) to exceed a specified level. Compliance with the limits on dose rate from noble gases is demonstrated by setting each gaseous effluent monitor alarm setpoint so that an alarm will occur at or before the dose rate limit for noble gases is reached. If an alarm occurs with the setpoint at the limit, compliance with Section 6.2.2.a is assessed as described in section 3.5.

On the basis of effluent noble gases from the DAEC during recent years, the gamma dose rate to a person's whole body is expected to be a larger fraction of the limit, 500 mrem/yr, than is the beta plus gamma dose rate to skin is to its limit, 3000 mrem/yr. As a result, a gaseous effluent monitor setpoint may be derived on the basis of the gamma dose rate to a person's whole body alone such that an alarm is set to occur at or before the whole body dose rate offsite exceeds 500 mrem/yr.

A noble gas monitor may be set to activate an alarm at a lower setting than the derived setpoint corresponding to the dose rate limit (or corresponding concentration limit). In the event an alarm occurs at the lower setting, the monitor record is compared with the derived setpoint. If the derived setpoint is exceeded, compliance with Section 6.2.2.a is assessed as described in section 3.5.

Each radioactive noble gas effluent monitor setpoint is derived on the basis of whole body dose equivalent rate in the unrestricted area. Setpoints for gaseous effluent monitors may be set independently because excessive effluent release via the turbine building vent is unlikely. Other releases are likely to be initiated independently and released from different levels, i.e., vent and stack releases with points of maximum concentration offsite not likely to coincide.

For the purpose of deriving a setpoint, the distribution of radioactive noble gases in an effluent stream is determined as described in section 3.2.

Setpoint Determination The alarm setpoint of a radioactive noble gas effluent monitor may be calculated on the basis of whole body dose equivalent rate offsite, 500 mrem/yr. A setpoint of a monitor of an elevated release, e.g., from the stack, may be calculated with the equation:

[

Ic 1 S= 1.06*.!!_*

+Bkg f

LC;XDFf i

DAEC DODAM Page 19 of 196 Rev. 000

The setpoint of a monitor of a ground-level or building release, e.g., from the turbine building vent or 3 reactor building vents or LLRPSF vent may be calculated with the equation:

I Ici S= 1.06* (h) Li I' +Bkg f X C;*DF; Q

i where s =

the alarm setpoint (cpm) or (MR/hr) h =

monitor response to activity concentration of effluent being monitored, C=

DFf:

Bkg =

DAEC DODAM

(

cpm

)

( mR I hr )

µCi I cm3 or

µCi I cm3 relative concentration of noble gas radionuclide i in effluent at the point of monitoring (µCi/cm3) atmospheric dispersion from point of ground-level or building wake release to the location of potential exposure (sec/m3) factor converting elevated release rate of radionuclide i to whole body dose equivalent rate at the location of potential exposure

[

mrem.J

µC1 yr* --

sec factor converting ground-level of split-wake release of radionuclide i to the whole body dose equivalent rate at the location of potential exposure

[

mremc;J yr*~

m flow of gaseous effluent stream, i.e., flow past the monitor (ft3/min) monitoring instrument background (cpm) or (MR/hr)

Page 20 of 196 Rev. 000

Kaman Industries performed primary calibrations using Xe-133 and Kr-85. The average response for Xe-133 was 4.83e+07, and for Kr-085 was 7.65e+07 cpm/µCi/cc. Because Xe-133 response factor is more conservative, h will be set at 4.83e+07 cpm/µCi/cc.

Response factor h for Kr-85 may be considered if conditions are more appropriate.

The concentration of each noble gas radionuclide, Ci, in a gaseous effluent is determined as discussed earlier in this section.

Since the dose rate limits for airborne effluents apply everywhere offsite, alarm setpoints are determined and compliance is assessed at the site boundary where the minimum atmospheric dispersion (maximum XI Q) occurs. The atmospheric dispersion factor and the dose conversion factor DFf depend on local conditions. The value of XI Q adopted in a setpoint calculation will be based either on prevailing meteorological conditions or on reference meteorological conditions at the DAEC. The minimum atmospheric dispersion offsite from a ground-level or building wake release derived from reference meteorological conditions is at the site boundary 1260 meters NNW of the Station where:

(xJ

= 4.3*10-6 sec/ 1113 Q l'ent The dose conversion factors, DFf, used in setpoint calculations for gaseous effluent monitors are in Table 3-4. In the event DFf is derived on the basis of prevailing meteorology, it will be calculated in accordance with Regulatory Guide 1.109, Appendix B.

DAEC DODAM Page 21of196 Rev. 000

3.5 Dose Equivalent Rate Offsite Section 6.2.2 provides limits on dose equivalent rates associated with airborne radioactive materials concentrations in the unrestricted area due to airborne effluents from the Station. Compliance is assessed on the basis of measurements specified in Table 7.2-2.

3.5.1 Noble Gas Limits on radioactive noble gas in the unrestricted area are provided in Section 6.2.2.a.

Each radioactive noble gas effluent monitor is set to alarm when, or below when, the noble gas in airborne effluent from a monitored stack or vent is expected to cause either dose rate limit in Section 6.2.2.a to be exceeded. In the event an airborne effluent release from the Station exceeds the derived setpoint (limit) for an effluent noble gas monitor (except when caused by the performance of a Surveillance Test Procedure), an assessment of compliance is performed as described herein.

The quantity of radioactive noble gas released in a increment of time is measured by the radioactive noble gas effluent monitors and the distribution of radioactive noble gases in a gaseous effluent stream is determined as described in section 3.2 herein.

Compliance with Section 6.2.2.a may be assessed by calculating the dose equivalent rate as described hereafter and by comparing it with the limiting dose rate in the Specification.

3.5.1.1 Total Body Dose Rate For evaluating compliance with Effluent Control, Section 6.2.2.a, the total body dose equivalent rate due to noble gas gamma radiation is calculated with the equation:

where Dr=

Qg/t =

DFf:

DAEC DODAM 1 [ (Qg; s)

[Qg; (X) v) ]

Dy=--

~ --* DF;

+L~ -* -

DF; J 600 I
t S
V I f
Q V
noble gas gamma dose rate to total body (mrem/yr) quantity of noble gas radionuclide i discharged (µCi) during time increment t (hr) factor converting unit noble gas nuclide i stack release to total body dose at ground level received from the overhead plume
[
mrem
]
(µCi yr) I sec Page 22 of 196 Rev. 000
1 3600 =
factor converting time integrated, ground level concentration of noble gas nuclide i to total body dose from gamma dose from gamma radiation
(
mrem
)
µCi yr I m3 conversion (hr/sec)
Dose factor DFJ, for exposure to noble gases released from an elevated stack are calculated by a finite plume model implemented in the MIDAS program. 1a It assumes decay of short-lived nuclides, an air dose-to-tissue dose conversion of 1.11, and that the dose to internal organs is equivalent to the tissue dose. In this model, meteorological data concurrent with the period of release are used to evaluate the dose rate.
The dose from noble gases released from a vent (near ground level) or to skin from an elevated release is derived from a semi-infinite cloud model. Noble gas semi-infinite cloud gamma-to-total body dose factors, DF;', are listed in Table 3-4.
When the total body and organ doses from noble gases are computed as required by Section 7.3.1, the nearby resident exposed to the maximal ground-level noble gas concentration (maximum x!Q) is selected as the receptor.
Alternatively, the dose from noble gases may be computed at 1260 meters NNWof the reactor, a location identified in Figure 3-2, where the nearby resident who may be exposed to maximal ground-level noble gas concentrations (maximum x!Q) is selected as the receptor.c In that case, values of the dose factors DFJ and DF;' in Table 3-4 are employed. m Total body dose factors for exposure from a plume from an elevated, stack release, DFf, in Table 3-4 were computed with the aid of an NRC code, RABFIN. In those computations, reference meteorology was assumed as the basis of atmospheric dispersion. For discharge from a vent, reference meteorological dispersion at the 1260 m NNW, (xlQJv, is 4.3x10-s sec/m3.
David Slade, ed., Meteorology and Atomic Energy 1968, TID-24190,pp. 350-355.
m Dose transfer factors DF!' in Table 3.4 are a units conversion of values in Regulatory Guide 1.109, Table B-1, column
5.
c Due to limitations of the Midas© software used to perform these calculations, a conservative higher calculated dose may be reported. When using Annualized Average Meteorological data, the Midas system uses known X/Q values from the 1 mile radius to extrapolate X/Q values at the site boundary. The resulting maximum site boundary X/Q value is greater than 4.3 x 1 o-<> sec/m3 and is located on the site boundary toward the SSE.
DAEC DODAM Page 23 of 196 Rev. 000
3.5.1.2 Skin Dose Rate The skin dose equivalent rate due to radioactive noble gas is calculated with the equation:
/3=-1 [J;,Spi(Q; *(XJ) +L

l;, Spi(Q; *(XJ) l 3600 t
Q s v,
f Q v where
=
noble gas beta dose rate to skin (mrem/yr)
Qi t =
quantity of noble gas radionuclide i (µCi) discharged during time increment t (hr)
S /Ji =
factor converting time integrated ground level concentration of noble gas to skin dose from beta radiation [mrer~ mJ]
µCT yr 1
3600 =
conversion (hr/sec)
Compliance with Section 6.2.2.a dose rate to skin is evaluated by calculating the noble gas beta dose equivalent rate offsite at a location 1260 meters NNW of the Station, which is also identified in Figure 3-2. d At that location, the reference atmospheric dispersion factors to be used in the calculations are:
(£)
4. 3
10-6 sec I m3 and (£)
2. 8
J o-7 sec I m3 Q I' Q s Alternatively, averaged meteorological dispersion data coincident with the period of release may be used to evaluate the dose rate. The semi-infinite noble gas cloud-to-skin dose equivalent factors are in Table 3-4. They are also derived from Regulatory Guide 1.109, Table B-1.
d Due to limitations of the Midas© software used to perform these calculations, a conservative higher calculated dose may be reported. When using Annualized Average Meteorological data, the Midas system uses known X/Q values from the 1 mile radius to extrapolate X/Q values at the site boundary. The resulting maximum site boundary X/Q value is greater than 4.3 x 1 o.e sec/m3 and is located on the site boundary toward the SSE.
DAEC DODAM Page 24 of 196 Rev. 000
3.5.2 Iodine, Tritium, and Particulates Section 6.2.2.b provides a limit on iodine-131, iodine-133, H-3, and on radioactive particulates having 8 day or longer half-lives in air in the unrestricted area around the Station. In the event airborne effluent from the Station causes a radioactive noble gas effluent monitor to alarm (except when alarm is due to the performance of a Surveillance Test Procedure) or if the assessment required by Section 7.2.4 shows Section 6.2.4 to have been exceeded, an assessment of compliance with Section 6.2.2.b will be performed using a method described in this section.
3.5.2.1 Organ Dose Ratee Compliance with Section 6.2.2.b is assessed by calculating the dose rate* to the most exposed organ of an assumed adult member of the public inhaling airborne 1-131, 1-133, H-3, and inhaling radioactive particulates having half-lives of 8 days or longer at the location in the unrestricted area having the maximum potential concentration of the effluents (i.e., the location at which reference meteorological data indicates minimum atmospheric dispersion from the Station (max XI Q ).
The organ dose rate is calculated with the following equations:
For a vent discharge:
8.766E-3 (x)
Danv TE - TB
~ ~ Qikv TAani Q l'
For an offgas stack discharge:
8.766E-3 (X)
Dans TE - TB
~ ~ Qiks TAani Q s Combining separate release points gives Dan
=
Dans + L Danv where Dan=
the dose equivalent rate to organ n of a person in age group a due to radionuclides discharged in airborne effluents during time interval TB to TE (mrem/yr)
Dans=
dose equivalent rate from a stack discharge (mrem/yr)
°For inhaled or ingested radioactive material, the consequent "dose" means the committed dose equivalent. The "dose rate" is the committed dose equivalent per unit of time of exposure to the radioactive material in the environment.
DAEC DODAM Page 25 of 196 Rev. 000
Danv =
dose equivalent rate from a vent discharge (mrem/yr)
Qiks' Q;kv = quantity of radionuclide i released in a given effluent stream based on analysis k (µCi) during discharged time increment TB to TE (hr) of interest Q;ks' Qikv =
quantity of radionuclide i released in a given effluent stream based on analysis k (µCi) during discharged time increment TB to TE (hr) of interest TAani =
factor converting airborne concentration of radionuclide i to dose commitment to organ n of a person in age group a where exposure is directly to airborne material
[
mrem J (Ci sec); m3 (XiJ (Xi)
Q s' Q v atmospheric dispersion from stack and vent, respectively, to ground level at location of interest (sec/m3)
8. 766E -3 = Conversion (1 Ci/1E6 µCi)(8766 hr/yr)
Radionuclides other than noble gases airborne effluent are measured and quantified as described in section 3.2. Normally, radioactive material measured in effluent is assumed to be discharged uniformly over the period represented by the sample.
The averaging time of the measured releases used to evaluate compliance will not exceed 92 days for Sr-89 and Sr-90 and will not exceed 31 days for the other radionuclides.
The maximum offsite exposure potential is expected to occur at 1260 meters NNW of the Station where the reference atmospheric dispersion, to be used in the calculation is
(~), =
[~l =
4.3
10-5 sec/m3 and 2.8
10-7 sec/m3 Currently, compliance with Section 6.2.2.b is evaluated by calculating an adult inhalation dose rate at 1260 meters NNW of the Stationnt. The dose transfer factors, TAani, used in the computation are tabulated in Appendix A.
roue to limitations of the Midas© software used to perform these calculations, a conservative higher calculated dose may be reported.
When using Annualized Average Meteorological data, the Midas system uses known X/Q values from the 1 mile radius to extrapolate X/Q values at the site boundary. The resulting maximum site boundary X/Q value is greater than 4.3 x 10.0 sec/m3 and is located on the site boundary toward the SSE.
DAEC DODAM Page 26 of 196 Rev. 000
3.5.2.2 Rainwater Recapture of Tritium The phenomenon of rainwater recapture of the tritium present in gaseous effluents has been observed on site. A liquid pathway analysis of the activity present in the rainwater runoff has been performed. The maximum dose to a member of the public from this liquid has been conservatively estimated to be less than 0.01 mrem per year.
3.6 Noble Gas Gamma Radiation Dose Accumulated in Air Section 6.2.3 requires that the offsite air dose during any calendar quarter not exceed 5 mrad and the annual air dose not exceed 1 O mrad from noble gas gamma radiation.
Section 7.2.3.1 requires a monthly calculation assessment to verify that the cumulative air dose due to gamma radiation from radioactive noble gas released in gaseous effluents during the quarter and year do not exceed Section 6.2.3.
The distribution of radioactive noble gases in gaseous releases and the quantity of radioactive noble gas discharged during an interval of time are determined as described in section 3.2 herein.
The gamma radiation dose to air offsite as a consequence of noble gas discharge from DAEC is calculated with the where Dr=
DAEC DODAM noble gas gamma dose to air due to effluent from stack and vent (mrad) total measured radioactivity release via stack or vent measured by noble gas effluent monitor during counting interval j (µCi) the fraction of radioactive gas in a given effluent stream attributable to noble gas radionuclide i.
factor converting unit release of noble gas radionuclide i from the stack to air dose at ground-level received from gamma radiation from the overhead plume (mrad/µCi) factor converting time integrated, ground-level concentration of noble gas to air dose from gamma radiation
[
mrad J
(µCi sec)! 1113 Page 27 of 196 Rev. 000
(~l =
atmospheric dispersion factor for a vent (ground-level or building wake) discharge (sec/m3)
Section 7.2.3.1 is satisfied by calculating the noble gas gamma radiation dose to air at the offsite location identified in Figure 3-2. At that location, 1260 meters NNW of the Stationh, the reference*g atmospheric dispersion factor to be used is
(~l =4.3* 10-6 sec/ m3 Values of Ays and Ayv appropriate for use at that location, assuming reference meteorological conditions, are listed in Table 3-3. An NRG code, RABFIN, modified for sector width averaged meteorology was used to calculate the air dose transfer factors, Ar: for a stack discharge, in DO DAM Table 3-3. They represent air dose at ground level 1260 meters NNW of the station from a unit release of each radionuclide i from the stack.
Dose transfer factors for vent discharges, Ar;*, are equivalent to factors in Regulatory Guide 1.109, Table B-1, g-air expressed in different units.
g Due to limitations of the Midas© software used to perform these calculations, a conservative higher calculated dose may be reported. When using Annualized Average Meteorological data, the Midas system uses known X/Q values from the 1 mile radius to extrapolate X/Q values at the site boundary. The resulting maximum site boundary X/Q value is greater than 4.3 x 10-6 sec/m3 and is located on the site boundary toward the SSE.
h Reference atmospheric conditions are summarized and discussed in "Duane Arnold Energy Center, Evaluation of Liquid and Gaseous Effluent Releases in Accordance with 10 CFR 50 Appendix I," submitted to NRC June 3, 1976, Reference atmospheric dispersion factors tabulated therein, also appear in Appendix B herein.
DAEC DODAM Page 28 of 196 Rev. 000
3.6.1 Alternate Method of Evaluating Compliance with Gamma Air Dose Limits Alternatively, the gamma radiation dose to air offsite may be calculated with the equation where 0.8 =
an effective dose conversion factor based on the typical radionuclide distribution in stack releases converting unit release of radioactive noble gases from the stack to air dose at ground level at a specific location (mrad/µCi).
an effective dose conversion factor based on the typical radioactive distribution in vent releases converting a time integrated, ground level concentration of noble gases to air dose from gamma radiation
(
mrad
)
(µCi sec/ m3) a factor of conservatism which compensates for variability in radionuclide distribution The derivation and basis of the effective gamma air dose conversion factor are provided in Appendix B. Values of the effective factors are tabulated in Table 3-3. By inserting the appropriate values for Dy (5 mrad/quarter y-air dose) and for Ayseff (1.6 x 10-11 mrad/µCi) or Agveff (6.4 x 10-5 mrad/(µCi sec/m3)) into the equation above and solving for either (,1Qi)s or (,1Qi)v, respectively, release quantities of noble gases from either the stack or vent corresponding to the technical specification limit of 5 mrad/quarter (total for all release points) may be determined. The limit of 5 mrad/quarter is described in section 6.2.3 and is for the total of all release points. At the location, 1260 meters NNW of the station, (which is the controlling location based on reference meteorology) the release limits are individually Release Quarterly Limit (Ci)
Annual Limit Point (Ci)
Stack 2.5 x 105 5.0 x 105 Vent 1.25x104 2.5x104 DAEC DODAM Page 29 of 196 Rev. 000
The following equations may be used to assess both the stack and vent discharges for compliance with the quarterly release limits on noble gas gamma dose to air.
+ -~}_* __ _
250,000 12,500 or, on a monthly rate basis (although not a requirement)
L (f..Qj)s L L (1:-.Q)v j
+ -'-'~}_* ---
250,000 12,500
~ 1 1
~
3 The equations which may be used to assess both the stack and vent discharges for compliance with the annual air dose limits from noble gas are:
L: r 1:-.Q;J"
_;);_' --- +
j
~ 1 500,000 25,000 or, on a monthly rate basis (although not a requirement)
L (f..Q)s L L (1:-.Q)v j
+ -'-' ---'}_* ---
500, 000 25,000 1
~
12 As long as these relations are satisfied for both stack and vent releases of noble gases, no additional calculations are needed to verify compliance with the gamma-air dose limits of Section 6.2.3. Calculations of beta air doses per Section 3.6 may be omitted as discussed in Appendix B.
DAEC DODAM Page 30 of 196 Rev. 000
3. 7 Noble Gas Beta Radiation Dose Accumulated in Air Section 6.2.3 requires that the offsite air dose during any calendar quarter not exceed 1 O mrad from noble gas beta radiation and not exceed 20 mrad during any calendar year.
Section 7.2.3.1 requires a monthly assessment to verify that the cumulative air dose due to beta radiation from radioactive noble gas released in gaseous effluents not exceed either limit of Section 6.2.3.
The radioactive noble gas distribution and activity discharged are determined as described in paragraph 3.6 herein.
The beta radiation dose to air offsite as a consequence of noble gas released from the Station is calculated with the equation:
where Dp =
Ap, =
(~1 =
(~l =
noble gas beta dose to air due to stack and vent releases (mrad) factor converting time-integrated, ground-level concentration of noble gas
(
mrad - /11 3 J radionuclide i to air dose from beta radiation
µCi - sec atmospheric dispersion factor for a discharge via the stack (sec/m3) atmospheric dispersion factor for a vent (ground level or building wake) discharge (sec/m3).
Specification 7.2.3.1 is satisfied by calculating the noble gas beta radiation dose to air at the location identified on Figure 3-2. At that location, 1260 meters NNW of the reactori, the reference atmospheric dispersion factors to be used are
(~), =
2.8 x 10-7
(~l =
4.3 x 10-6 iDue to limitations of the Midas© software used to perform these calculations, a conservative higher calculated dose may be reported.
When using Annualized Average Meteorological data, the Midas system uses known X/Q values from the 1 mile radius to extrapolate XIQ values at the site boundary. The resulting maximum site boundary X/Q value is greater than 4.3 x 10"°sec/m3 and is located on the site boundary toward the SSE.
DAEC DODAM Page 31 of 196 Rev. 000
3.8 Dose Due to Iodine and Particulates in Gaseous Effluentsi Section 6.2.4 requires that 1-131, 1-133, H-3, and radioactive material in particulate form having half-lives greater than 8 days in gaseous effluents released to the area offsite cause no more than 7.5 mrem to any organ of a member of the public during a calendar quarter and no more than 15 mrem during any calendar year. Section 7.2.4 requires an assessment at least once every month to verify that the cumulative dose commitment does not exceed either limit of Section 6.2.4.
Airborne releases are discharged either via the offgas stack as an elevated release or via building vents and treated as a ground-level, building wake, or split wake release.
Radionuclides mentioned above in airborne effluents that are measured by the sampling and analysis schedule in Table 7.2-2 are included in the release term used to calculate doses. Section 3.2 describes the quantification of these radionuclides other than noble gases.
A person may be exposed directly to an airborne concentration of radioactive material discharged in effluent and indirectly via pathways involving deposition of radioactive material onto the ground. Dose estimates account for the separate exposure pathways.
The dose commitment to a person offsite associated with a gaseous release, Qik, of radioactive material other than noble gas is calculated with the appropriate one(s) of the following equations for a stack release:
for a vent release:
iThe dose to any organ of a person arising from radioactive iodine-131, iodine-133, tritium, and radioactive material in particulate form having half-lives greater than 8 days. Noble gases not considered.
DAEC DODAM Page 32 of 196 Rev. 000
where Danske =
Danvke =
TAanie =
TGanie =
the dose commitment (mrem) to organ n of a person in age group a via exposure pathway e due to radionuclides identified in analysis k of a stack release where the analysis is required by Table 7.2-2.
the dose commitment via pathway e from a vent release (mrem) factor converting airborne concentration of radionuclide i to dose commitment to organ n of a person in any group a where exposure is directly to airborne material via exposure pathway e.
(
mrem
)
(Ci sec) I nl factor converting ground deposition of radionuclide i to dose commitment organ n of a person in age group a where exposure is directly or indirectly to radioactive material that has been deposited on the ground via exposure
( mrem) pathway e.
Ci 11112 quantity of radionuclide i released in a given effluent stream based on analysis k (Ci)
(D) (D) =
Q.:
Q v relative deposition factor, i.e., factor converting airborne effluent discharge from stack or vent respectively, to a real deposition on land (m-2).
The analysis index k may represent either an analysis of a grab sample, a weekly composite analysis, a monthly composite analysis, or a quarterly composite analysis.
Since tritium in water vapor is absorbed directly by vegetation, the tritium concentration in growing vegetation is proportional to the airborne concentration rather than to relative deposition as in the case of particulates. Thus the dose commitment from airborne tritium via vegetation (fruit and vegetables), air-grass-cow-milk, or air-grass-cow-meat pathways is calculated with the appropriate one(s) of the equations:
for a stack release for a vent release DAEC DODAM Page 33 of 196 Rev. 000
Danve = (z) " " Q
'T'A Q " f f ikv 1./iame The dose commitment accumulated by a person offsite is computed at least every 30 days to satisfy Section 7.2.4.1 but may be calculated as analytical results of effluent measurements, performed as specified in Table 7.2-2, become available.
The dose accumulated as a result of stack discharge is computed with Dans = L Danse e
and the dose accumulated as a result of vent discharge is computed with Danv = L Danve e
Doses committed during the same time period due to discharges from the stack and vents are additive, thus Dan Dans
+ L Danv where Dan =
the dose commitment accumulated during the quarter to date as a result of all measured radioactive gaseous discharges except noble gases to any organ n, including total body, of a person offsite in age group a (mrem).
When the dose to a person from iodine and particulates discharged in gaseous effluents is calculated as required by Section 7.2.4, appropriate environmental pathways (from among those for which dose transfer factors are provided in Appendix A) will be evaluated. The dose calculated is to a receptor at the location of the nearby residence experiencing the minimum atmospheric dispersion at ground-level from the station, i.e.,
maximum X, concurrent with the effluent discharge. Alternatively, the dose may be Q
calculated to a receptor at the location identified in Figure 3-2 where reference atmospheric dispersion and deposition factors are:
(X) =3.9*J0"6 sec/m3 (D) =l.3*J0-8 m*2 Q "
Q v Food pathways are evaluated at the location of food production based on minimum atmospheric dispersion at ground-level concurrent with the effluent discharge or, alternatively, with reference meteorology applicable at that location. Seasonal DAEC DODAM Page 34 of 196 Rev. 000
appropriateness of pathways is considered. The air-grass (fresh or stored)-cow-milk-man pathway is evaluated where a cow is located, 2650 meters WNW of DAEC, reference atmospheric deposition factors are:
(D) 2.1*10-9 111-2 (D) 4.28*10-9 111-2 Q s Q *
"This receptor is historical in nature. See the current land use census to verify this point as the most conservative receptor location for the pathway.
3.8.1 Alternate Method of Evaluating Doses Due to Iodine and Particulates in Gaseous Effluents Alternatively, the dose commitment to a maximally exposed, hypothetical individual may be calculated by the equation where:
Di1if-11~, =
Dinf-thy = 0
~8
L [Qi* TGinf-thy-1-131*(D!Q)1 I
= 0
~8
L:[Qi*TGi1if-thy-1-131*(D!Q)l, I
the dose commitment accumulated during the quarter to date to a hypothetical infant's thyroid as a result of the releases of 1-131 (mrem) the measured quantity of 1-131 released in a given effluent stream, stack or
vent (Ci)
TG;iif-thy-i-m =the dose transfer factor for the infant thyroid from the cow-milk pathway for 1-131 measured in the effluent stream
( mrem)
Ci I nl 1
0.8 =
a factor of conservatism which accounts for the dose contribution for releases of particulate radioactive material other than 1-131 When the maximum organ dose is evaluated by using the equation above, analyses of other organ doses via other pathways are not needed to demonstrate compliance within the dose limits of Section 6.2.4.
DAEC DODAM Page 35 of 196 Rev. 000
The rationale for only evaluating the dose contribution of 1-131 is derived from an evaluation of the radioactive material releases and the environmental pathways. The air-grass-cow-milk-man pathway is by far the controlling pathway and the infant's thyroid is the limiting organ. This pathway typically contributes greater than 90% of the total calculated dose to the infant's thyroid and 1-131 contributes essentially all of the dose
(-95%). Therefore, it is possible to demonstrate compliance with the dose limits of Section 6.2.4 by the conservative calculation method presented above.
3.9 Dose to a Person from Noble Gases Section 7.3.1 requires the calculation of the dose or dose commitment to a person offsite exposed to 12 consecutive months of radioactive liquid and gaseous effluents from the Station. One component of personal dose is total body irradiation by gamma rays from noble gases. Another is irradiation of skin by beta and gamma radiation from noble gases. The methods of calculating these doses are presented in sections 3.9.1 and 3.9.2.
The amount of radioactive noble gas discharged is determined in the manner described in section 3.2.
3.9.1 Gamma Dose to Total Body The gamma radiation dose to the whole body of a member of the public as a consequence of noble gas released from the Station is calculated with the equation:
where:
Dr=
DAEC DODAM noble gas gamma dose to total body (mrem) quantity of noble gas nuclide i released via stack or vent (Ci) factor converting unit noble gas nuclide i stack release to total body dose at ground level received from the overhead plume (mrem/Ci) factor converting time integrated, ground level concentration of noble gas nuclide i to total body dose from gamma radiation
(
mrem )
Ci sec/ nl Page 36 of 196 Rev. 000
The dose to total body and organs other than skin from noble gases released from an elevated stack are calculated by a finite plume model. k It assumes decay of short-lived nuclides, a residential shielding factor of 0.7, an air dose-to-tissue dose conversion of 1.11, and that the dose to internal organs is equivalent to the tissue dose. Dose factors for exposure to noble gas plume gamma radiation, Pr:, are computed by the MIDAS program.
The dose from noble gases released from a vent (near ground level) or to skin from an elevated release is derived from a semi-infinite cloud model. Noble gas semi-infinite cloud gamma-to-total body dose factors, Pr;*, are listed in Appendix A under the plume pathway.
When the total body and organ doses from noble gases are computed as required by Section 7.3.1, the nearby resident exposed to the maximal ground-level noble gas concentration (minimum X 1 Q) is selected as the receptor.
Alternatively, the dose from noble gases may be computed at 1260 meters NNW of the reactor where the nearby resident who may be exposed to maximal ground-level noble gas concentrations (minimum X 1 Q) is selected as the receptor. In that case, values of the dose factors Pr: and Pr;* in Table 3-5 are employed.1 Reference meteorological dispersion for vent discharges at that location, ( X 1 Q )", is 4. 3 x I o*
6 sec/ ni3.
3.9.2 Dose to Skin The beta radiation dose to the skin of a member of the public due to beta radiation from noble gas released from the Station may be calculated with the equation where Dp =
noble as dose to skin (mrem)
Sp; =
factor converting time integrated ground level concentration of noble gas to skin dose from beta radiation
(
mrem
)
Ci sec/ nl kDavid Slade, ed., Meteorology and Atomic Energy 1968, TID-24190, pp. 350-355.
DAEC DODAM Page 37 of 196 Rev. 000
Semi-infinite cloud noble gas beta-to-skin dose factors, S~i appear in Table 3-5.
The total dose to the skin from noble gases is approximately equal to the beta radiation dose to the skin plus the gamma radiation dose to the total body.
When the skin dose due to noble gas beta radiation is computed as required by Section 7.3.1, the receptor selected is the nearby resident exposed to maximal ground-level concentrations (maximum XI Q ).
Alternatively, the skin dose to a postulated receptor (resident) at 1260 meters NNW of the reactor may be calculated.
1Dose transfer factors Py~ in Table 3.5 and in Appendix A under the plume pathway are the same.
DAEC DODAM Page 38 of 196 Rev. 000
Figure 3.1 Gaseous Radioactive Waste Flow Diagram r-::i-~~~ Rerue1 1--~~~~~~~~~~~~~~~~~~~-1-c:?
l-="'.":":".'"'."'1 IV*EF*IO
~------.--1-C?
Normal lV*Ef.11 B RfM645
,_.. ---._ _ _,u11per Tu1111ne Bld;j. lo Roof Exhaust Turbine Turuhe Bldg, B uHdlng Potential)'
Contaminated Heal ft II Condeose1 Bas 40oot8000 32500Cfli1 R3 Offgas Stack Radiation Monitoring System R4 Reactor Building Exhaust Vent Monitoring System R5 Turbine Building Exhaust Vent Monitoring System R7 LLRPSF Exhaust Vent Monitoring System DAEC DODAM Page 39 of 196 Adirin Bldo.
Hot labs "1 aln Exhau$1 Plenum 7925 CHI RIM647 RM*7649 Acci4enl RM-7644 RM*764~
RM-7648 Reactor Bldg.
Vents EIE:.Y. 158 Ft.
Rev. 000
Figure 3-2 Dose Calculation Sites Site Description Distance from Plant A
Noble gas gamma air dose:
481 meters South-Southeast B
Noble gas beta air dose:
481 meters South-Southeast c
Iodines and Particulates:
805 meters West D
Aquatic pathways:
Cedar River E
Most Exposed resident:
805 meters West DAEC DODAM Page 40 of 196 Rev. 000
Parameter Off gas Stack Release Height 328 feet Release Mode Elevated Effluent Source Waste Gas System Table 3-1 Atmospheric Gaseous Release Points at the Duane Arnold Energy Center RELEASE POINT Reactor Turbine Building Vent Building Vent 156 feet 90 feet Wake-split Wake-split Reactor Building Upper Turbine Standby Gas Treatment Radwaste Building Building System Lower Turbine Building DAEC DODAM Page 41of196 LLRPSF Building Vent 65 feet Wake-split LLRPSF Building and Storage Facility Rev.ODO
c ted Rel Nuclide Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 Xe-131m Xe-133m Xe-133 Xe-135m Xe-135 Xe-137 Xe-138 TABLE NOTATION Table 3-2 f Radioactive Noble Gases in G STACK RELEASE (Ci/vr)a Fractionb 4.90E+01 2.53E-03 2.34E+03 1.21 E-01 1.40E+02 7.23E-03 1.56E+02 8.06E-03 1.65E+03 8.52E-02 6.40E+02 3.31E-02 4.80E+01 2.48E-03 3.50E+01 1.81E-03 1.24E+04 6.41E-01 1.80E+01 9.30E-04 5.10E+02 2.63E-02 7.80E+02 4.03E-02 5.90E+02 3.05E-02 19356 1.0 Effl t fi D
Arnold E
.-. c PLANT VENTS RELEASE (Ci/vr)a Fractionb 0
0 7.40E+01 1.98E-02 0
0 1.36E+02 3.64E-02 2.36E+02 6.32E-02 0
0 0
0 0
0 3.92E+02 1.05E-01 7.42E+02 1.99E-01 7.43E+02 1.99E-01 0
0 1.41E+03 3.78E-01 3733.
1.0 a Releases computed by BWR-GALE for DAEC Base Case gaseous radwaste treatment. Computed releases are included only to show the basis of the radionuclide distribution.
b This is the calculated distribution of radionuclides in gaseous effluents in each release pathway. To estimate radionuclide concentrations in a sample in which only the total activity concentration has been measured, multiply the total activity concentration by the fraction of respective radionuclides listed above.
DAEC DODAM Page 42 of 196 Rev. ODO
Table 3-3 Transfer Factors for Maximum Offsite Air Dose Radionuclide Air Dose Transfer Factors a
b Ar; A,,
Y; A{J,
( mra~)
µC1
(
mrad
)
µCi sec/ m3
(
mrad
)
µCi sec/ m3 Kr-83m 4.3E-14 6.1 E-7 9.1 E-6 Kr-85m 6.0E-12 3.9E-5 6.2E-5 Kr-85 8.4E-14 5.4E-7 6.2E-5 Kr-87 2.3E-11 2.0E-4 3.3E-4 Kr-88 6.4E-11 4.8E-4 9.3E-5 Kr-89 3.0E-11 5.5E-4 3.4E-4 Kr-90 5.2E-4 2.5E-4 Xe-131m 1.8E-12 4.9E-6 3.5E-5 Xe-133m 1.4E-12 1.0E-5 4.7E-5 Xe-133 1.5E-12 1.1 E-5 3.3E-5 Xe-135m 1.1 E-11 1.1 E-4 2.3E-5 Xe-135 9.5E-12 6.1 E-5 7.8E-5 Xe-137 2.6E-12 4.8E-5 4.0E-4 Xe-138 3.6E-11 2.9E-4 1.5E-4 Ar-41 4.4E-11 2.9E-4 1.0E-4 TABLE NOTATIONS a
b An NRC code, RABFIN, modified for sector width averaged meteorology, was used to calculate the air dose transfer factors, Ar: for a stack discharge. They represent air dose at ground level 1260 meters NNW of the station from a unit release of each radionuclide i from the stack and dispersed by reference meteorology at the DAEC.
Dose transfer factors for vent discharges, A Y ;* and Ap; are equivalent to factors in Regulatory Guide 1.109, Table B-1, g-air and b-air, expressed in different units.
DAEC DODAM Page 43 of 196 Rev. 000 b
Radionuclide Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 Kr-90 Xe-131m Xe-133m Xe-133 Xe-135m Xe-135 Xe-137 Xe-138 Ar-41 TABLE NOTATIONS Table 3-4 Transfer Factors for Dose Equivalent Rate to A Person Offsite Due to Radioactive Noble Gases Dose Transfer Factors a, b, c
DFJ DF;'
[
mrem l
(µCi yr) I sec
[
mrem l
(µCi yr)/m 3
6.27E-9 7.56E-2 1.81 E-4 1.17E+3 2.51 E-6 1.61 E+1 6.97E-4 5.92E+3 1.91E-3 1.47E+4 9.14E-4 1.66E+4 1.56E+4 4.83E-5 9.15E+1 3.61 E-5 2.51E+2 4.09E-5 2.94E+2 3.39E-4 3.12E+3 2.84E-4 1.81 E+3 7.90E-5 1.42E+3 1.08E-3 8.83E+3 1.32E-3 8.84E+3 a
Receptor located 1260 meters NNW of Station Based on reference meteorology at DAEC d
s /Ji
[
mrem l
( µc; yr)lm3 0
1.46E+3 9.73E+3 9.73E+3 2.37E+3 1.01E+4 7.29E+3 4.76E+2 9.94E+2 3.06E+2 7.11 E+2 1.86E+3 1.22E+4 4.13E+3 2.69E+3 c
Factors DFJ computed by computer code RABFIN, modified for sector width averaged meteorology d
Factors DF;' from Regulatory Guide 1.109, revision 1, Table B-1, column 5 DAEC DODAM Page 44 of 196 Rev. 000
Radionuclide Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 Kr-90 Xe-131 m Xe-133m Xe-133 Xe-135m Xe-135 Xe-137 Xe-138 Ar-41 TABLE NOTATIONS Table 3-5 Transfer Factors for Dose Equivalent Rate to A Person Offsite Due to Radioactive Noble Gases Dose Transfer Factors a,
b, c
c, d Pr;*
p
\\'
Y;
[m~m]
[
mrem
]
(Ci sec )/1113 1.39E-10 1.68E-3 4.03E-6 2.60E+1 5.58E-8 3.58E-1 1.55E-5 1.31 E+2 4.25E-5 3.26E+2 2.03E-5 3.68E+2 3.46E+2 1.07E-6 2.03 8.05E-7 5.57 9.03E-7 6.52 7.49E-6 6.92E+1 6.31E-6 4.01 E+1 1.75E-6 3.15E+1 2.39E-5 1.96E+2 2.92E-5 1.96E+2 a
Receptor located 1260 meters NNW of Station b
Based on reference meteorology at DAEC Sp;
[
mrem
]
(Ci sec)/m3 4.63E+1 4.25E+1 3.08E+2 7.51 E+1 3.20E+2 2.31E+2 1.51 E+1 3.15E+1 9.70 2.25E+1 5.89E+1 3.87E+2 1.31 E+2 8.52E+1 s
p
\\'
p s
c Factors PY; and Y; already account for a 0.7 residential shielding factor. Factors Y; were computed by computer code RABFIN, modified for sector width averaged meteorology d
Factors Py;* and S~i from Regulatory Guide 1.109, revision 1, Table B-1 DAEC DODAM Page 45 of 196 Rev. 000 d
4.0 DOSE COMMITMENT FROM RELEASE OVER EXTENDED TIME 4.1 Dose Assessment for 10 CFR Part 50, Appendix I Sections 7.1.3, 7.2.3, and 7.2.4 require quarterly and annual assessments to demonstrate compliance with Appendix I dose limits. The assessment includes the following calculations of dose as described by equations for:
1.
total body and maximally exposed organ doses due to liquid effluent via drinking water and eating fish from the River and from consuming food irrigated with river water as in paragraph 2.5.
2.
total body and maximally exposed organ doses due to gaseous effluentsa other than noble gases as in paragraph 3.8.
3.
doses to air offsite due to noble gas g as in paragraph 3.6 and due to noble gas ~
as in paragraph 3.7.
The dose calculations are based on liquid and gaseous effluents from the Station during each calendar quarter and for a calendar year, determined in accord with Tables 7.1-2 and 7.2-2.
Environmental concentrations depend on dispersion and dilution of the effluent. For aqueous effluents over extended time, the aquatic concentration is estimated according to section 2.2. Atmospheric dispersion and deposition factors used to estimate the dose commitment due to gaseous effluents are ordinarily derived from reference meteorological data. Otherwise, quarterly averaged or annual averaged meteorological conditions concurrent with the gaseous release being evaluated will be used to estimate atmospheric dispersion and deposition.
The receptor of the dose is described such that the dose to any resident near the Station is unlikely to be underestimated. That is, the receptor is selected on the basis of the combination of applicable pathways of exposure to gaseous effluent identified in the annual land use census and maximum ground level X 1 Q at the residence. Conditions (i.e., location, X 1 Q, and/or pathways) more conservative (i.e., expected to yield higher calculated doses) than appropriate for the maximally exposed individual may be assumed in the dose assessment.
Radioactive iodine-131, iodine-133, tritium, and radioactive material in particulate form having half-lives greater than 8 days.
DAEC DODAM Page 46 of 196 Rev. 000
Seasonal appropriateness of exposure pathways may be considered. Exposure by eating fresh vegetation or drinking milk from cows or goats fed fresh forage is an inappropriate assumption during the first or fourth calendar quarter; rather consumption of stored vegetation and stored forage is assumed during those quarters. Otherwise, during the second and third calendar quarters, exposure by eating fresh vegetation and/or drinking milk from cows or goats fed fresh forage is assumed where those pathways exist. Similarly, the liquid effluent-river-fish-man pathway is not assumed during the winter quarter.
Factors converting stack-released noble gas to gamma radiation dose from the overhead plume are calculated on the basis of reference meteorological data for the receptor location or alternatively, by the MIDAS program for a residential location offsite where maximum X 1 Q at ground level occurs.
Other environmental pathway-to-dose transfer factors used in the dose calculations are provided in Appendix A 4.2 Dose Assessment for 40 CFR Part 190 and 10 CFR 72.104 The regulations governing the maximum allowable dose or dose commitment to a member of the public from all uranium fuel cycle-sources of radiation and radioactive material in the environment is stated in 40 CFR Part 190 and 10 CFR 72.104. It requires that the dose or dose commitment to a member of the public from all sources not exceed 25 mrem/yr to the whole body or 25 mrem/yr to any organ or 75 mrem/yr to the thyroid.
Section 7.3.1 requires calculation of the dose at least once every year to assess compliance with the regulation. More frequent calculations may be performed if higher than normal releases are experienced (twice the design objective rates in a single quarter).
Fuel cycle sources or nuclear power reactors other than the Stationb itself do not measurably or significantly increase the radioactivity concentration in the vicinity of the Station; therefore, only radiation and radioactivity in the environment attributable to the Station itself are considered in the assessment of compliance with 40 CFR Part 190 and 10 CFR 72.104.
Contributions to the dose due to liquid and gaseous effluent are calculated as described by the equations for:
1.
total body and maximally exposed organ doses due to liquid effluent via drinking water, consuming irrigated food and from eating fish from the River as in paragraph 2.5
2.
total body dose due to noble gas y as in paragraph 3.9.1
3.
skin dose due to noble gas p as in paragraph 3.9.2 b The Station is defined as BOTH the Nuclear Reactor Facility and the Independent Spent Fuel Storage Installation (ISFSI).
DAEC DODAM Page 47 of 196 Rev. 000
4.
total body and maximally exposed organ doses due to gaseous effluentsc other than noble gases as in Paragraph 3.8.
Additionally, the contribution to total dose from direct radiation is assessed annually by using environmental TLDs.
The doses are calculated on the basis of liquid and gaseous effluents from the Station during 12 consecutive months, determined in accord with Tables 7.1-2 and 7.2-2. For the purpose of the Annual Radiological Environmental Report, doses are based upon release during a calendar year.
Aqueous radioactive material concentrations are estimated according to paragraph 2.2 on the basis of annual averaged stream flow. Annual averaged meteorological conditions concurrent with gaseous releases being evaluated are used to estimate atmospheric dispersion, deposition, and elevated plume gamma exposure.
The receptor of the dose is described such that the dose to any resident near the Station is not likely to be underestimated, although conditions more conservative than appropriate for the maximally exposed person may be assumed in the dose assessment.
Ordinarily, the receptor is selected on the basis of the applicable combination of existing pathways of exposure to gaseous effluent identified in the annual land use census and the maximum ground level XI Q at the residence.
When assessing compliance with 40 CFR 190, Radiological Environmental Monitoring Program results may be used to indicate actual radioactivity levels in the environment attributable to the DAEC. These measured levels may be used to supplement the evaluation of doses to members of the public for assessing compliance with 40 CFR 190.
Factors converting stack-released noble gas to gamma radiation dose from the overhead plume are calculated on the basis of annual averaged meteorological data for the receptor location. Other environmental pathway-to-dose transfer factors are listed in Appendices A, B and C.
cRadioactive iodine-131, iodine-133, tritium, and radioactive material in particulate form having half-lives greater than 8 days.
DAEC DODAM Page 48 of 196 Rev. 000
5.0 ENVIRONMENTAL MONITORING PROGRAMS Section 5.0 of the DO DAM provides a description of the Radiological Environmental Monitoring Program (REMP) and the Ground Water Protection Program (GWPP). This section also contains descriptions of the Environmental Sampling Program Station Locations.
5.1 Radiological Environmental Monitoring Program A program shall be provided to monitor the radiation and radionuclides in the environs of the station.
The program shall provide:
(1) representative measurements of radioactivity in the highest potential exposure
pathways, (2) verification of the accuracy of the effluent monitoring program and modeling of environmental exposure pathways.
The program shall:
(1) be contained in the DODAM, (2) conform to the guidance of Appendix I to 1 O CFR Part 50 and 10 CFR 72, (3) include the following:
(a)
Monitoring, sampling, analysis, and reporting of radiation and radionuclides in the environment in accordance with the methodology and parameters in the DODAM.
(b)
A Land Use Census to ensure that changes in the use of areas at and beyond the SITE BOUNDARY are identified and that modifications to the monitoring program are made if required by the results of this census.
(c)
Participation in an lnterlaboratory Comparison Program to ensure that independent checks on the precision and accuracy of the measurements of radioactive materials in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring.
5.2 Ground Water Protection Program (GWPP)
A program shall be provided to prevent, detect and respond to inadvertent and radiological releases with the potential to reach ground water.
The program shall provide:
(1) for the prevention of inadvertent/unplanned radiological releases from plant systems, structures and components (SSCs) or during plant evolutions or work practices that represent an elevated risk of experiencing a release of licensed radiological material into the environment.
DAEC DODAM Page 49 of 196 Rev. 000
(2) aspects for monitoring, detecting and responding to unplanned/unmonitored releases of licensed radioactive material to the environment and a communications/notification plan that addresses internal notifications to management and communications/reporting to State and local stakeholders and regulators for specified events or conditions.
The program shall:
(1) be contained in the site administrative control procedure ACP 1411.35, 'The DAEC Groundwater Protection Program".
(2) implement the Ground Water Protection Initiative Final Guidance Document, NEl-07-0?[Final].
5.3 Sampling Station Locations DODAM Table 5-1 "ENVIRONMENTAL SAMPLE STATIONS" is a list of locations where samples may be collected and does not represent a list of required samples.
Environmental monitoring locations are shown on Figures 5-1 and 5-2. DAEC may conduct additional environmental monitoring exclusive of the requirements of Specifications 6.3.2 and ACP 1411.35.
DAEC DODAM Page 50 of 196 Rev. 000
DAEC DODAM Figure 5-1 Environmental Monitoring Programs Sampling Near the Duane Arnold Energy Center
'~*--.... ~~--.-.-.
r---- *91 I
32 I
I '
I I
31 I
I I
30 i
I t
I 29 I
I I
28 I
L~----
00.
GATE 113
?i£ t\\H' ft N
m DAEC ll!lj tu in 1H il!
~1 U1
~
HI
!ill Page 51 of 196 Rev. 000
DAEC DODAM Figure 5-2 Radiological Environmental Monitoring Program Sampling Stations Outside 0.5 Miles from DAEC 110 ATKINS.
10 04 CENTER POINT eos 34 35 99 11:748 76 36 37 TODDVILLE 46 45 36 *11 4443 39 40 42 109 05a PALOil 96 Page 52 of 196 CEDAR RAPIDS ALBURNETT 13*
Rev. 000
Station Program Number 1
REMP 2
REMP 3
REMP 4
REMP 5
REMP 5a REMP 6
REMP 7
REMP 8
REMP 9
10 REMP 11 REMP 12 13 REMP 14 15 REMP 15a GWPP 16 REMP 16a GWPP 17 REMP DAEC DODAM Table 5-1 ENVIRONMENTAL SAMPLE STATIONS Station Location and Sample Type Location:
Cedar Rapids, 20,800 meters SE Type:
TLD Control Airborne Particulate and Iodine Control - Not Currently Active Location:
Marion, 16,900 meters ESE Type:
TLD Control Airborne Particulate and Iodine Control - Not Currently Active Location:
Hiawatha, 10,800 meters SE Type:
TLD Control Airborne Particulate and Iodine - Not Currently Active Location:
Pleasant Creek SRA, 4960 meters NW Type:
TLD Control Airborne Particulate and Iodine Location:
Palo, 4,500 meters SSW Type:
TLD Control Location:
Palo, 3,470 meters SSW Type:
TLD Control Airborne Particulate and Iodine Location:
Center Point, 9,660 meters N Type:
TLD Control Airborne Particulate and Iodine - Not Currently Active Location:
Shellsburg, 7,950 meters W Type:
TLD Control Airborne Particulate and Iodine - Not Currently Active Location:
Urbana, 15,000 meters NNW Type:
TLD Control Airborne Particulate and Iodine Control - Not Currently Active Not Used Location:
Atkins, 13,600 meters SSW Type:
TLD Control Airborne Particulate and Iodine Control - Not Currently Active Location:
Toddville, 4,980 meters E Type:
TLD Control Airborne Particulate and Iodine - Not Currently Active Not Used Location:
Alburnett, 14,500 meters ENE Type:
TLD Control Airborne Particulate and Iodine Control Not Used Location:
On-site, 1,050 meters NNW Type:
TLD Airborne Particulate and Iodine Location:
On-site, 505 meters NNW Type:
Soil - discontinued Location:
On-site, 520 meters SSE Type:
TLD Airborne Particulate and Iodine Vegetation Meteorology Tower Location:
On-site, 520 meters SSE Type:
Soil - discontinued Precipitation - discontinued Location:
On-site, 1,050 meters N Type:
TLD Page 53 of 196 Rev. 000
Station Program Number 18 REMP 19 REMP 20 REMP 21 REMP 22 REMP 23 REMP 24 GWPP 25 GWPP 26 GWPP 27 GWPP 28 REMP 29 REMP 30 REMP 31 REMP 32 REMP 33 REMP 34 REMP 35 REMP 36 REMP 37 REMP 38 REMP 39 REMP 40 REMP 41 REMP DAEC DODAM Table 5-1 ENVIRONMENTAL SAMPLE STATIONS Station Location and Sample Type Location:
630 meters NNE Type:
TLD Location:
On-site, 590 meters NE Type:
TLD Location:
On-site, 550 meters ENE Type:
TLD Location:
On-site, 515 meters ENE Type:
TLD Location:
On-site,=535 meters ESE Type:
TLD Location:
On-site,-490 meters SE Type:
TLD Location:
MW104 electrical vault W of lower level RadWaste Building inside Protected Area Type:
Ground Water Location:
MW105 electrical vault N of contractor parking lot along DAEC Road Type:
Ground Water Location:
MW106 electrical vault W of Lower Level RadWaste Building inside Protected Area Type:
Ground Water Location:
MW107 electrical vault N of contractor parking lot along DAEC Road Type:
Ground Water Location:
On-site, 730 meters WSW Type:
TLD Location:
On-site, 630 meters W Type:
TLD Location:
On-site, 640 meters WNW Type TLD Location:
On-site, 1,020 meters NW Type:
TLD Location:
On-site, 1,110 meters NNW Type:
TLD Location:
4,340 meters N Type:
TLD Location:
3,930 meters NNE Type:
TLD Location:
2,800 meters NE Type:
TLD Location:
3,500 meters ENE Type:
TLD Location:
2,960 meters E Type:
TLD Location:
3,180 meters ESE Type:
TLD Location:
2,510 meters SE Type:
TLD Location:
Wickiup Hill Learning Center 2,430 meters SSE Type:
TLD Airborne Particulate and Iodine - Not Currently Active Location:
5,680 meters S Type:
TLD Page 54 of 196 Rev. 000
Station Program Number 42 REMP 43 REMP 44 REMP 45 REMP 46 REMP 47 REMP 48 REMP 49 REMP 50 REMP 51 REMP 52 REMP 53 REMP 54 REMP 55 REMP 56 REMP GWPP 57 REMP 58 REMP 59 REMP 60 61 REMP 62 GWPP 63 GWPP DAEC DODAM Table 5-1 ENVIRONMENTAL SAMPLE STATIONS Station Location and Sample Type Location:
4,380 meters SSE Type:
TLD Location:
1, 590 meters SSW Type:
TLD Location:
1,580 meters WSW Type:
TLD Location:
1,420 meters W Type:
TLD Location:
1,580 meters WNW Type:
TLD Location:
1,760 meters NW Type:
TLD Location:
1,680 meters NNW Type:
TLD Location:
Lewis Access, upstream of DAEC 6,750 meters NNW Type:
Fish Control Surface Water Control Bottom Sediment Control Location:
Plant Intake, 560 meters SE Type:
Bottom Sediment Control - discontinued Surface Water - discontinued Location:
Plant Discharge, 600 meters SE Type:
Bottom Sediment Surface Water Location:
Plant potable water supply Type:
Drinking Water Location:
Treated Municipal Water, 13,900 meters SE Type:
Drinking Water Location:
Inlet to Municipal Water Treatment System, 13,900 meters SE Type:
Drinking Water Location:
On-site, Production Wells Type:
Ground Water Location:
Generic control sample for sampling quality assurance Type:
Water, soil, vegetation, milk, sediment, fish, special samples Location:
Farm, 805 meters W Type:
Drinking Water Vegetation Location:
Farm, 974 meters WSW-SW Type:
Drinking Water Vegetation Meat sample Location:
Farm, 2,615 meters SE Type:
Vegetation
}!ot Used Location:
Cedar River, 670 meters SSE Type:
Fish Surface Water Location:
Onsite Monitoring Well MW-18A near SE corner of the turbine building Type:
Ground Water Location:
Onsite Monitoring Well MW-19A near S wall of the turbine building Type:
Ground Water - discontinued (well sealed)
Page 55 of 196 Rev. 000
Station Program Number 64 GWPP 65 GWPP 66 GWPP 67 GWPP 68 GWPP 69 GWPP 70 GWPP 71 72 REMP 73 GWPP 74 GWPP 75 GWPP 76 REMP 77 REMP 78 79 GWPP 80 GWPP 81 GWPP 82 REMP 83 REMP 84 REMP 85 REMP 86 REMP 87 GWPP 88 GWPP DAEC DODAM Table 5-1 ENVIRONMENTAL SAMPLE STATIONS Station Location and Sample Type Location:
Onsite Monitoring Well MW-20A near S wall of the turbine building Type:
Ground Water Location:
Onsite Monitoring Well MW-21A near S wall of the turbine building Type:
Ground Water Location:
Onsite Monitoring Well MW-22A S turbine building wall and W of MW-OBA Type:
Ground Water Location:
Onsite Monitoring Well MW-23A S of MW-22A and NW of MW-14A Type:
Ground Water Location:
Extraction Well EW-01 A SE of MW-23A and W of MW-14A Type:
Ground Water Location:
Extraction Well EW-02A SSE of MW-12A in the Owner Controlled Area Type:
Ground Water Location:
Extraction Well EW-03A SSE between MW-24A and MW-26A. Formerly D-166.
Type:
Ground water Not Used Location:
Farm, 3,200 meters SSW Type:
Drinking Water Location:
2MH216/1 MH117 electrical vault, West of the Offgas Stack Type:
Surface Water Location:
2MH215/1MH116 electrical vault, E. of RB RR, W. of Condensate Storage Tanks Type:
Surface Water Location:
2MH207 electrical vault, East of South End of Pump House Type:
Surface Water Location:
Farm, 2,888 meters East Northeast Type:
Milk - discontinued Location:
Farm on Palo Marsh Road, 2288 meters SW Type:
Vegetation - discontinued Not Used Location:
On-site monitoring well MW-33A SSE in Owner Controlled Area Type:
Ground Water Location:
On-site monitoring well MW-34A SSE in Owner Controlled Area Type:
Ground Water Location:
On-site monitoring well MW-35A SSE in Owner Controlled Area Type:
Ground Water Precipitation - discontinued Location:
On-site, 660 meters SSE Type:
TLD Location:
On-site, 620 meters SSE Type:
TLD Location:
On-site, 610 meters S Type:
TLD Location:
On-site, 660 meters SSW Type:
TLD Location:
On-site, 850 meters SW Type:
TLD Location:
M H218 electrical vault, East of the Turbine Building Type:
Surface Water Location:
MH219 electrical vault, North of Air Compressor Building Type:
Surface Water Page 56 of 196 Rev. 000
Station Program Number 89 GWPP 90 GWPP 91 REMP 92 GWPP 93 GWPP 94 GWPP 95 GWPP 96 REMP 97 GWPP 98 GWPP 99 REMP 100 GWPP 101 GWPP 102 GWPP 103 GWPP 104 GWPP 105 GWPP 106 GWPP 107 GWPP 107 a REMP 108 REMP 109 REMP 110 REMP 111 GWPP DAEC DODAM Table 5-1 ENVIRONMENTAL SAMPLE STATIONS Station Location and Sample Type Location:
MH221 electrical vault, Between Air Compressor Building and H2 Skid Type:
Surface Water Location:
MH222 electrical vault, North of "B" Well Type:
Surface Water Location:
On-site, 1,090 meters NNW Type:
TLD Location:
MH202 electrical vault, West of XR1/XR2 Transformers Type:
Surface Water Location:
MH213 electrical vault, East of the Pump House Type:
Surface Water Location:
MH214 electrical vault, South of "B" Cooling Tower Type:
Surface Water Location:
MH217 electrical vault, Southwest of Intake Building Type:
Surface Water Location:
Farm, 11,400 meters SSW Type:
Vegetation - discontinued Location:
MH102 electrical vault, "A" Well Road North of the Substation Type:
Surface water Location:
MH103 electrical vault, "A" Well Road West of the Substation Type:
Surface Water Location:
Pleasant Creek Lake, 3,880 meters WNW Type:
Surface Water and deer meat sample - discontinued Location:
MH206 electrical vault, West of Pump House Type:
Surface Water Location:
1MH109 electrical vault, East of the North End of the Pump House Type:
Surface Water Location:
2MH208/1MH110 electrical vault, Road to Intake Building Type:
Surface Water Location:
MH101 electrical vault, North of PAB, East of Security Fence Type:
Surface Water Location:
MH115 electrical vault, South of "A" Cooling Tower Type:
Surface Water Location:
MH114 electrical vault, South of "A" Cooling Tower Type:
Surface Water Location:
MH201 electrical vault, South of Turbine Building Type:
Surface Water Location:
DAEC Sewage Plant Effluent Type:
Surface Water Location:
On-Site: North Drainage Ditch Type:
Bottom Sediments - discontinued Location:
4,590 meters SSW Type:
Vegetation - discontinued Location:
5,890 meters SW Type:
Vegetation - discontinued Location:
12,700 meters SW Type:
Milk - discontinued Location:
Onsite Monitoring Wells MW01A and MW01 B (SSE)
Type:
Ground Water - discontinued Precipitation - discontinued Page 57 of 196 Rev. 000
Station Program Number 112 GWPP 113 GWPP 114 GWPP 115 GWPP 116 GWPP 117 118 REMP 119 GWPP 120 GWPP 121 GWPP 122 GWPP 123 GWPP 124 GWPP 125 GWPP 127 GWPP 128 GWPP 129 GWPP 130 GWPP 131 GWPP 132 GWPP 133 GWPP 134 GWPP 135 GWPP DAEC DODAM Table 5-1 ENVIRONMENTAL SAMPLE STATIONS Station Location and Sample Type Location:
Onsite Monitoring Wells MW02A and MW02B (ESE)
Type:
Ground Water - discontinued Precipitation - discontinued Location:
Onsite Monitoring Wells MW03A and MW03B (ESE)
Type:
Ground Water - discontinued Location:
Onsite Monitoring Wells MW04A and MW04B (South)
Type:
Ground Water - discontinued Precipitation - discontinued Location:
Onsite Monitoring Wells MW05A and MW05B (SSW)
Type:
Ground Water - discontinued Precipitation - discontinued Location:
Onsite Monitoring Wells MW06A and MW06B (NE)
Type:
Ground Water - discontinued Precipitation - discontinued Not Used Location:
2,230 meters NW Type:
Vegetation - discontinued Location:
2MH209/1 MH111 electrical vault, Road to Intake Building Type:
Surface Water Location:
2MH210/1 MH112 electrical vault, Road to Intake Building Type:
Surface Water Location:
2MH211/1MH113 electrical vault, Road to Intake Building Type:
Surface Water Location:
Onsite Sluice Pond, in OCA Type:
Surface Water Location:
Onsite South Drainage Ditch Type:
Surface Water Location:
Onsite North Drainage Ditch Type:
Surface Water Location:
Onsite South Storm Drain Outfall Type:
Surface Water Location:
Protected Area, North of CST Pit, Monitoring Wells MW07 A and MW07B Type:
Ground Water Precipitation - discontinued Location:
Protected Area, CAD Shack, Monitoring Wells MW08A and MW08B Type:
Ground Water Precipitation - discontinued Location:
Protected Area, SE Corner of CST Pit, Monitoring Wells MW09A and MW09B Type:
Ground Water Location:
Protected Area, SW Corner of CST Pit, Monitoring Wells MW1 OA and MW1 OB Type:
Ground Water - discontinued Location:
On-site Monitoring Wells MW11 A and 11 B SE in Owner Controlled Area Type:
Ground Water Location:
On-site Monitoring Wells MW12A and MW12B SE in Owner Controlled Area Type:
Ground Water Location:
On-site Monitoring Wells MW13A and MW13B SW in Owner Controlled Area Type:
Ground Water - discontinued Location:
On-site Monitoring Wells MW14A and MW14B SSE in Protected Area Type:
Ground Water Location:
On-site Monitoring Wells MW15A and MW15B SE in Owner Controlled Area Type:
Ground Water - discontinued Page 58 of 196 Rev. 000
Station Program Number 136 GWPP 137 GWPP 138 REMP 161 REMP 162 REMP 163 REMP 164 REMP 165 GWPP 166 GWPP 167 GWPP 168 GWPP 169 GWPP 170 GWPP 171 GWPP 172 GWPP 173 GWPP DAEC DODAM Table 5-1 ENVIRONMENTAL SAMPLE STATIONS Station Location and Sample Type Location:
On-site Monitoring Wells MW16A and MW16B ENE in Protected Area Type:
Ground Water - discontinued Location:
On-site Monitoring Well MW17C NE in Protected Area Type:
Ground Water - discontinued Location:
21,600 meters WSW Type:
Milk Control - discontinued Vegetation Control - discontinued Location:
On-site, ISFSI, East Fence Line Type:
TLD Location:
On-site, ISFSI, South Fence Line Type:
TLD Location:
On-site, ISFSI, West Fence Line Type:
TLD Location:
On-site, ISFSI, North Fence Line Type:
TLD Location:
On-site Monitoring Well MW24A ESE in Owner Controlled Area Type:
Ground Water Location:
On-site Monitoring Well MW25A ESE in Owner Controlled Area Type:
Ground Water - discontinued Location:
On-site Monitoring Well MW26A ESE in Owner Controlled Area Type:
Ground Water Location:
On-site Monitoring Wells MW27 A and MW27B SE in Owner Controlled Area Type:
Ground Water - discontinued Location:
On-site Monitoring Wells MW28A and MW28B SE in Owner Controlled Area Type:
Ground Water Location:
On-site Monitoring Wells MW29A and MW29B SE in Owner Controlled Area Type:
Ground Water Location:
On-site Monitoring Wells MW30A and MW30B SE in Owner Controlled Area Type:
Ground Water Location:
On-site Monitoring Wells MW31A and MW31 B SE in Owner Controlled Area Type:
Ground Water - discontinued Location:
On-site Monitoring Wells MW32A and MW32B SE in Owner Controlled Area Type:
Ground Water Page 59 of 196 Rev. 000
Definitions 0 6.0.1.1 6.0 RADIOLOGICAL EFFLUENT CONTROLS AND SURVEILLANCE REQUIREMENTS 0 6.0.1 Use and Application 0 6.0.1.1 Definitions NOTE The defined terms of this section appear in capitalized type and are applicable throughout these OLCOs and Bases ACTIONS CHANNEL CALIBRATION CHANNEL CHANNEL CHECK CHANNEL FUNCTIONAL TEST DAEC DODAM Definition ACTIONS shall be that part of an DODAM Specification that prescribes Required Actions to be taken under designated Conditions within specified Completion Times.
A CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel output such that it responds within the necessary range and accuracy to known values of the parameter that the channel monitors. The CHANNEL CALIBRATION shall encompass the entire channel, including the required sensor, alarm, display, and trip functions, and shall include the CHANNEL FUNCTIONAL TEST. The CHANNEL CALIBRATION may be performed by means of any series of sequential, overlapping, or total channel steps so that the entire channel is calibrated.
A channel is an arrangement of a sensor and associated components used to evaluate plant variables and produce discrete outputs used in logic. A channel terminates and loses its identity where individual channel outputs are combined in logic.
A CHANNEL CHECK shall be the qualitative assessment, by observation, of channel behavior during operation. This determination shall include, where possible, comparison of the channel indication and status to other indications or status derived from independent instrument channels measuring the same parameter.
A CHANNEL FUNCTIONAL TEST shall be the injection of a simulated or actual signal into the channel as close to the sensor as practicable to verify FUNCTIONALITY, including required alarm, interlock, display, and trip functions, and channel failure trips. The CHANNEL FUNCTIONAL TEST may be performed by means of any series of sequential, overlapping, or total channel steps.
(continued)
Page 60 of 196 Rev. 000
GASEOUS RADWASTE TREATMENT SYSTEM MEMBER(S) OF THE PUBLIC FUNCTIONAL-FUNCTIONALITY SITE BOUNDARY SOURCE CHECK UNRESTRICTED AREA DAEC DODAM Definitions 0 6.0.1.1 6.0.1.1 Definitions (continued)
A GASEOUS RADWASTE TREATMENT SYSTEM is any system designed and installed to reduce radioactive gaseous effluents by collecting primary coolant system offgases from the primary system and providing delay or holdup for the purpose of reducing radioactivity prior to release to the environment.
MEMBER(S) OF THE PUBLIC are persons who are not occupationally associated with the Company and who do not normally frequent the DAEC site. The category does not include contractors, contractor employees, vendors, or persons who enter the site to make deliveries or to service equipment.
An SSC is functional or has functionality when it is capable of performing its function(s), as set forth in the CLB.
The SITE BOUNDARY is that line beyond which the land is neither owned, nor leased, nor otherwise controlled by the Company. UFSAR Figure 1.2-1 identifies the DAEC SITE BOUNDARY.
A SOURCE CHECK is the assessment of channel response when the channel sensor is exposed to a source of radiation.
The UNRESTRICTED AREA is that land (offsite) beyond the SITE BOUNDARY.
Page 61 of 196 Rev. 000
0 6.0.1 Use and Application 0 6.0.1.2 Logical Connectors PURPOSE BACKGROUND DAEC DODAM Definitions 06.0.1.1 The purpose of this section is to explain the meaning of logical connectors.
Logical connectors are used in Defueled Offsite Dose Assessment Manual (DODAM) to discriminate between, and yet connect, discrete Conditions, Required Actions, Completion Times, Surveillances, and Frequencies. The only logical connectors that appear in the DODAM are AND:
and OR. The physical arrangement of these connectors constitutes logical conventions with specific meanings.
Several levels of logic may be used to state Required Actions. These levels are identified by the placement (or nesting) of the logical connectors and by the number assigned to each Required Action. The first level of logic is identified by the first digit of the number assigned to a Required Action and the placement of the logical connector in the first level of nesting (i.e., left justified with the number of the Required Action). The successive levels of logic are identified by additional digits of the Required Action number and by successive indentions of the logical connectors.
When logical connectors are used to state a Condition, Completion Time, Surveillance, or Frequency, only the first level of logic is used, and the logical connector is left justified with the statement of the Condition, Completion Time, Surveillance, or Frequency.
Page 62 of 196 Rev. 000
Completion Times 0 6.0.1.3 0 6.0.1 Use and Application 0 6.0.1.3 Completion Times PURPOSE BACKGROUND DESCRIPTION DAEC DODAM The purpose of this section is to establish the Completion Time convention and to provide guidance for its use.
OLCOs specify minimum requirements for ensuring safe operation of the unit. The ACTIONS associated with an OLCO state Conditions that typically describe the ways in which the requirements of the OLCO can fail to be met. Specified with each stated Condition are Required Action(s) and Completion Times(s).
The Completion Time is the amount of time allowed for completing a Required Action. It is referenced to the time of discovery of a situation (e.g., non-functional equipment or variable not within limits) that requires entering an ACTIONS Condition unless otherwise specified, providing the unit is in a specified condition stated in the Applicability of the OLCO. Required Actions must be completed prior to the expiration of the specified Completion Time. An ACTIONS Condition remains in effect and the Required Actions apply until the Condition no longer exists or the unit is not within the OLCO Applicability.
If situations are discovered that require entry into more than one Condition at a time within a single OLCO (multiple Conditions), the Required Actions for each Condition must be performed within the associated Completion Time. When in multiple Conditions, separate Completion Times are tracked for each Condition starting from the time of discovery of the situation that required entry into the Condition.
When "Immediately" is used as a Completion Time, the Required Action should be pursued without delay and in a controlled manner.
The DODAM implements Completion Times in precisely the same manner they are applied in the Technical Requirements Manual (TRM) and the Technical Specifications (TS).
Page 63 of 196 Rev. 000
Frequency 06.0.1.4 0 6.0.1 Use and Application 0 6.0.1.4 Frequency PURPOSE The purpose of this section is to define the proper use and application of Frequency Requirements.
DESCRIPTION DAEC DODAM Each DODAM Surveillance Requirement (OSR) has a specified Frequency in which the Surveillance must be met in order to meet the associated OLCO. An understanding of the correct application of the specified Frequency is necessary for compliance with the OSR.
The "specified Frequency" is referred to throughout this section and each of the Specifications of Section 6.0.3.0, Surveillance Requirement (SR)
Applicability. The "specified Frequency" consists of the requirements of the Frequency column of each OSR, as well as certain Notes in the Surveillance column that modify performance requirements.
Sometimes special situations dictate when the requirements of a Surveillance are to be met. They are "otherwise stated" conditions allowed by OSR 7.0.3.0.1. They may be stated as clarifying Notes in the Surveillance, as part of the Surveillance or both.
Situations where a Surveillance could be required (i.e., its Frequency could expire), but where it is not possible or not desired that it be performed until sometime after the associated OLCO is within its Applicability, represent potential OSR 7.0.3.0.4 conflicts. To avoid these conflicts, the OSR (i.e., the Surveillance or the Frequency) is stated such that it is only "required" when it can be and should be performed. With an OSR satisfied, OSR 6.0.3.0.4 imposes no restriction.
The use of "met" or "performed" in these instances conveys specific meanings.
A Surveillance is "met" only when the acceptance criteria are satisfied. Known failure of the requirements of a Surveillance, even without a Surveillance specifically being "performed," constitutes a Surveillance not "met."
"Performance" refers only to the requirement to specifically determine the ability to meet the acceptance criteria. OSR 7.0.3.04 restrictions would not apply if both the following conditions are satisfied:
a. The surveillance is not required to be performed; and
b. The Surveillance is not required to be met or, even if required to be met, is not known to be failed.
Page 64 of 196 Rev. 000
6.0.3 Limiting Conditions for Operation (OLCO) Applicability LCO Applicability 0 6.0.3.0 OLCO 6.0.3.0.1 OLCOs shall be met during the specified conditions in the Applicability, except as provided in OLCO 6.0.3.0.2.
OLCO 6.0.3.0.2 Upon discovery of a failure to meet an OLCO, the Required Actions of the associated Conditions shall be met, except as provided in OLCO 6.0.3.0.5. If the OLCO is met or is no longer applicable prior to expiration of the specified Completion Time(s), completion of the Required Action(s) is not required, unless otherwise stated.
OLCO 6.0.3.0.3 Not Used.
OLCO 6.0.3.0.4 When an OLCO is not met, entry into a specified condition in the Applicability shall not be made except when the associated ACTIONS to be entered permit continued operation in the specified condition in the Applicability for an unlimited period of time.
OLCO 6.0.3.0.5 Equipment removed from service or declared non-functional to comply with ACTIONS may be returned to service under administrative control solely to perform testing required to demonstrate its FUNCTIONALITY or the FUNCTIONALITY of other equipment. This is an exception to OLCO 6.0.3.0.2 for the system returned to service under administrative control to perform the testing required to demonstrate FUNCTIONALITY.
DAEC DODAM Page 65 of 196 Rev. 000
OSR Applicability 0 7.0.3.0 0 7.0.3 Surveillance Requirement (OSR) Applicability OSR 7.0.3.0.1 OSR 7.0.3.0.2 OSR 7.0.3.0.3 OSR 7.0.3.0.4 DAEC DODAM OSRs shall be met during the specified conditions in the Applicability for individual OLCOS, unless otherwise stated in the OSR. Failure to meet a Surveillance, whether such failure is experienced during the performance of the Surveillance or between performances of the Surveillance, shall be failure to meet the OLCO. Failure to perform a Surveillance within the specified Frequency shall be failure to meet the OLCO except as provided in OSR 7.0.3.0.3. Surveillances do not have to be performed on non-functional equipment or variables outside specified limits.
The specified Frequency for each OSR is met if the Surveillance is performed within 1.25 times the interval specified in the Frequency, as measured from the previous performance or as measured from the time a specified condition of the Frequency is met.
For Frequencies specified as "once," the above interval extension does not apply.
If a Completion Time requires periodic performance on a "once per... " basis, the above Frequency extension applies to each performance after the initial performance. Exceptions to this OSR are stated in the individual OLCOs.
If it is discovered that a Surveillance was not performed within its specified Frequency, then compliance with the requirement to declare the OLCO not met may be delayed, from the time of discovery, up to 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or up to the limit of the specified Frequency, whichever is more. This delay period is permitted to allow performance of the Surveillance.
If the Surveillance is not performed within the delay period, the OLCO must immediately be declared not met, and the applicable Condition(s) must be entered.
When the Surveillance is performed within the delay period and the Surveillance is not met, the OLCO must immediately be declared not met, and the applicable Condition(s) must be entered.
Entry into a MODE or other specified condition in the Applicability of an OLCO shall not be made unless the OLCO's Surveillances have been met within their specified Frequency.
Page 66 of 196 Rev. 000
0 6.1 0 6.1.1 OLCO 6.1.1 APPLICABILITY:
ACTIONS CONDITION A.
One or more channels non-functional B.
As required by Required Action A.1 and referenced in Table 6.1-1 C.
As required by Required Action A.1 and referenced in Table 6.1-1 D.
Less than the minimum required channels FUNCTIONAL.
E.
Required Action and associated Completion Time of Condition A not met.
DAEC DODAM Radioactive Liquid Instrumentation 0 6.1.1 Radioactive Liquid Effluent Controls and Surveillance Requirements Radioactive Liquid Instrumentation The Radioactive Liquid Instrumentation for each function in Table 6.1-1 shall be FUNCTIONAL with their alarm and trip setpoints set to ensure that the limits of Section 6.1.2 are not exceeded.
As shown in Table 6.1-1 REQUIRED ACTION COMPLETION TIME A.1 Enter the condition(s)
Immediately referenced in Table 6.1-1 for the channel(s).
AND A.2 Restore required channel(s) to 30 days FUNCTIONAL status.
8.1 Obtain at least two samples and Prior to release analyze in accordance with Section 6.1.2 and Table 7.1-2 AND 8.1 Independently verify release Prior to release rate calculations and discharge valving by technically qualified Facility Staff member.
C. 1 Obtain sample and analyze for Once per 8 Hours either gross beta/gamma or gamma radioactivity.
D.1 Estimate flow rate at least once Immediately per batch.
E.1 Explain in next Annual Next submittal of the Radioactive Material Release Annual Radioactive Report why the instrument was Material Release not made functional in a timely Report manner.
Page 67 of 196 Rev. 000
SURVEILLANCE REQUIREMENTS Radioactive Liquid Instrumentation 0 6.1.1

NOTE-----------------------------------------------

1 nstrumentation shall be FUNCTIONAL and in service except that channels out of service are permitted for the purpose of required tests, checks, and calibrations without declaring the channel to be non-functional.
SURVEILLANCE FREQUENCY OSR 7.1.1.1 Perform CHANNEL CHECK 24 Hours OSR 7.1.1.2 Perform SOURCE CHECK Prior to release OSR 7.1.1.3 Perform SOURCE CHECK 30 Days OSR 7.1.1.4 Perform CHANNEL FUNCTIONAL TEST 92 Days OSR 7.1.1.5 Perform CHANNEL CALIBRATION 18 Months OSR 7.1.1.6 Perform Monitor Setpoint Calculation.
18 Months OSR 7.1.1.7 Perform CHANNEL FUNCTIONAL TEST 92 Days OSR 7.1.1.8 Perform CHANNEL CALIBRATION 18 Months OSR 7.1.1.9 Perform Monitor Setpoint Calculation.
Prior to release DAEC DODAM Page 68 of 196 Rev. 000
Radioactive Liquid Instrumentation 0 611 TABLE 6.1-1 /7.1-1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION Minimum Conditions Referenced from Surveillance Instrument Applicability Channels Required Action Requirements Functional A.1
1. Gross Radioactive Monitors Providing Automatic Termination of Release OSR 7.1.1.1 <a>
OSR 7.1.1.2 (bl During 1
B OSR 7.1.1.7 (d)
a. Liquid Radwaste Effluent Line Releases
{e)
OSR 7.1.1.8 <c>
OSR 7.1.1.9
2. Gross Radioactive Monitors Not Providing Automatic Termination of Release
a. RHR Service Water System During 1
OSR 7.1.1.1 <a>
Releases OSR 7.1.1.3
b. General Service Water During 1
c OSR 7.1.1.4 <e>
System Releases OSR 7.1.1.5 <cl RHRSW/ESW Rupture Disc During OSR 7.1.1.6
c.
1 Effluent Line Releases
3. Flow Rate Measurement Devices
a. Liquid Radwaste Effluent Line During 1
OSR 7.1.1.1 <a>
Releases D
(f)
During OSR 7.1.1.7
b. Liquid Radwaste Dilution Line Releases 1
OSR 7.1.1.8 TABLE NOTATIONS (a) During releases via this pathway.
(b) On any day on which a release is made, a SOURCE CHECK shall be made at least once, prior to the first release.
(c) The CHANNEL CALIBRATION shall include the use of a known radioactive source (traceable to the NIST radiation measurement system or acceptable non-NIST standards) positioned in a reproducible geometry with respect to the sensor and emitting beta or gamma radiation in the range measured by the channel. CHANNEL CALIBRATION may normally be done during refueling outages.
(d) The CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway if the following condition exists:
1.
Instrument indicates measured levels above the alarm/trip setpoint.
(e) The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exist:
1.
Instrument indicates measured levels above the alarm/trip setpoint.
2.
Circuit failure.
3.
Instrument indicates a downscale failure.
4.
Instrument controls not set in operate mode.
(!) CHANNEL CHECK shall consist of verifying indication of flow during periods of release. CHANNEL CHECK shall be made at least once daily on any day on which continuous, periodic, or batch releases are made.
DAEC DODAM Page 69 of 196 Rev. 000
0 6.1 0 6.1.2 OLCO 6.1.2 APPLICABILITY:
ACTIONS CONDITION Radioactive Liquid Instrumentation 0 6.1.1 Radioactive Liquid Effluent Controls and Surveillance Requirements Liquid Effluent Concentration The concentration of radioactive material in liquid effluent released from the site to the UNRESTRICTED AREA shall not exceed ten times the concentrations specified in 10 CFR 20, Appendix B, Table 2, Column 2 to 10 CFR 20.1001 - 20.2402.
At all times.
REQUIRED ACTION COMPLETION TIME A.
Concentration of A.1 Restore concentration Immediately radioactive material to within limits.
released from site to UNRESTRICTED AREAS not within the limit.
DAEC DODAM Page 70 of 196 Rev. 000
Radioactive Liquid Effluent Concentration 0 7.1.2 SURVEILLANCE REQUIREMENTS

NOTE------------------------------------------

Refer to DODAM Table 7.1-2 for details concerning Sampling and Analysis OSR 7.1.2.1 OSR 7.1.2.2 OSR 7.1.2.3 DAEC ODAM SURVEILLANCE

NOTE--------------------------

Portions of each sample are "split out" and added to the Monthly and Quarterly Composite sample.
Sample the Batch Release.
FREQUENCY PRIOR TO EACH RELEASE The results of pre-release analyses shall be used PRIOR TO EACH with the calculation methods in the DODAM to RELEASE establish trip setpoints for batch releases to assure that the concentration at the UNRESTRICTED AREA boundary does not exceed the limit in OLCO 6.1.2.

NOTE--------------------------

7 Days Portions of each sample are split out and added to the Monthly and Quarterly Composite sample.

NOTE--------------------------

1 n the event of a positive identification of reactor by-product radioactivity in the service water, additional sampling and analysis shall be performed as specified in Table 7.1-2, Table Items B.2 through B.5.
Sample the Continuous Release during releases to the environment via this pathway.
AND Analyze the sample from the release for Gross Beta/Gamma.
Analyze the sample from the release for Principal Gamma Emitters and 1-131.
Page 71 of 196 (continued)
Rev. 000
OSR 7.1.2.4 OSR 7.1.2.5 OSR 7.1.2.6 OSR 7.1.2.7 DAEC ODAM Radioactive Liquid Effluent Concentration 0 7.1.2 Analyze the sample from the release for Principal Gamma Emitters and 1-131.
Analyze the "Monthly" Composite sample for Tritium.

NOTE--------------------------

For Service Water, this OSR is only required following a positive identification of reactor by-product radioactivity in the sample as determined during OSR 7.1.2.3 or OSR 7.1.2.5.

NOTE----------------------------

For "clean" water systems, this OSR is only required following a positive identification of reactor by-product radioactivity in the sample as determined during OSR 7.1.2.4.

NOTE----------------------------

For GWPP Mitigation system, this OSR is only required following a positive identification of a radioactive reactor by-product in the sample as determined during OSR 7.1.2.3.
Analyze the Quarterly Composite sample for Sr-89, Sr-90, Fe-55 PRIOR TO EACH RELEASE 30 Days 92 Days Analyze the "Monthly" Composite sample for Gross 30 Days Alpha.
Page 72 of 196 Rev. 000
TABLE 7.1-2 Radioactive Liquid Effluent Concentration 0 6.1.2 RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM Liquid Release Type A. Radwaste Tanks Batch Release
8. Continuous Service Water Release Sample Points:
General Services Water
RHR Service Water System A
RHR Service Water System B C. "Clean" Systems Batch Release Sample Points:
CST Pit
Transformer Pit
Neutralizing Tank 1T022
FRAC tanks
Temporary groundwater D. GWPP Mitigation System Continuous Release TABLE NOTATIONS DAEC DODAM Surveillance Table Requirements item/note OSR 7.1.2.1 A.1: Each Batch OSR 7.1.2.4 OSR 7.1.2.2 OSR 7.1.2.1 A.2: (b), (d)
OSR 7.1.2.5 OSR 7.1.2.7 OSR 7.1.2.1 A.3: (b),(d)
OSR 7.1.2.6 OSR 7.1.2.3 8.1: (d)
OSR 7.1.2.3 8.2: (d)
OSR 7.1.2.5 8.4: (b),(d)
OSR 7.1.2.7 OSR 7.1.2.6 8.5: (b),(d)
OSR 7.1.2.1 C.1:
OSR 7.1.2.4 OSR 7.1.2.5 C.2: (bl (d) (e)
OSR 7.1.2.6 C.3: (b)(d)
OSR 7.1.2.3 D.1:
OSR 7.1.2.5 D.2: (b)(d)(e)
OSR 7.1.2.6 D.3: (b)(d)
Page 73 of 196 Type of Activity Lower Limit of Analysis Detection (LLD)<a)
(µCi/ml)
Principal Gamma 5 x 10-7 Emitters 1-131C 1x10-5 H-3 1x10-5 Gross alpha 1x10-7 Sr-89, Sr-90 5 x 10-8 Fe-55 1x10-5 Gross beta/gamma 1x10-7 Principal Gamma 5 x 10-7 Emitters 1-131 1 x 10-6 H-3 1 x 10-5 Gross alpha 1 x 10-7 Sr-89, Sr-90 5 x 10-s Fe-55 1x10-5 Principal Gamma 5 x 10-7 Emitters!!)
1-131(1) 1 x 10-5 H-311) 1 x 10-5 Sr-89, Sr-90 5 x 10-s Fe-55 1 x 10-6 Principal Gamma 5.0 x 10-7 Emitters 1-131(c) 1.ox10.e H-3<1) 1.0 X 10-5 Sr-89, Sr-90 5.0 X 10-8 Fe-55 1.0X 10.e Rev. 000
Radioactive Liquid Effluent Concentration 0 6.1.2
<a>The LLD is defined, for purposes of these controls, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.
DAEC DODAM Page 74 of 196 Rev.000
Radioactive Liquid Effluent Concentration 0 6.1.2 For a particular measurement, which may include radiochemical separation:
4.66 Sb LLD Ex V x 2.22E6 x e-AAi where:
LLD is the "a priori" lower limit of detection as defined above (microcuries per unit mass or volume) and where:
Sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (counts per minute)
E is the counting efficiency (counts per disintegration)
Vis the sample size (units of mass or volume) 2.22E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable,
').., is the radioactive decay constant for the particular radionuclide (sec-1), and
~ t for effluents is the elapsed time between the midpoint of sample collection and the time of counting (sec-1).
Alternatively, exp may be replaced by At e-J.12 I
e. e-J.12 1-e-J.i, Where:
t1 is the total sampling time or sample compositing time tz is the elapsed time between the end of sample collection and the time of counting.
It should be recognized that the LLD is defined as an.S!. priori (before the fact) limit representing the capability of a measurement system and not as an.S!. posteriori (after the fact) limit for a particular measurement.
Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions with typical values of E, V, Y, and Dt for the radionuclides Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141, and Ce-144. Occasionally background fluctuations, unavoidably small sample sizes, interfering radionuclides, or other uncontrollable circumstances may render these LLDs unachievable.
When calculating the LLD for a radionuclide determined by gamma ray spectrometry, the background may include the typical contributions of other radionuclides normally present in the samples. The background count rate of a Ge(Li) detector is determined from background counts that are determined to be within the full width of the specific energy band used for the quantitative analysis for that radionuclide.
The principal gamma emitters for which the LLD specification will apply are exclusively the following radionuclides:
Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137 and Ce-141. Ce-144 shall be measured, but with an LLD of 5E-6. This list does not mean that only these nuclides are to be detected and reported. Other peaks which are measurable and identifiable, together with the above nuclides, shall also be identified and reported. Nuclides which are below the LLD for the analyses should not be reported as being present at the LLD level. When unusual circumstances result in LLDs higher than required, the reasons shall be documented in the Annual Radioactive Material Release Report.
(b) A composite sample is one in which the quantity of liquid sampled is proportional to the quantity of liquid waste discharged and in which the method of sampling employed results in a specimen which is representative of the liquids released.
(c) In the event a gross ~ or y analysis is performed in lieu of an isotopic analysis before a batch is discharged, a sample shall be analyzed for principal gamma emitters afterward.
(d) Analysis may be performed after release.
(e) Analysis at a frequency of less than 30 days is allowed.
(f)
If liquids from these systems are released from the site via a pathway that is NOT directly to the Cedar River, the required LLDs of Table 6.3.2 are applicable.
DAEC DODAM Page 75 of 196 Rev.ODO
0 6.1 0 6.1.3 OLCO 6.1.3 APPLICABILITY:
ACTIONS Dose Due to Liquid Radioactive Effluents 0 6.1.3 Radioactive Liquid Effluent Controls and Surveillance Requirements Dose Due to Liquid Radioactive Effluents The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released to the UNRESTRICTED AREA shall not exceed:
1.5 mrem to the total body during any calendar quarter, 5.0 mrem to any organ during any calendar quarter, 3.0 mrem to the total body during any calendar year, or 10.0 mrem to any organ during any calendar year.
At All Times CONDITION REQUIRED ACTION COMPLETION TIME A.
Calculated dose from the A.1 Prepare and submit a Special 30 days release of radioactive Report to the Commission materials in liquid which identifies the cause(s) effluents exceeds limits.
for exceeding the limit and defines the action to be taken.
DAEC DODAM Page 76 of 196 Rev. 000
Dose Due to Liquid Radioactive Effluents 0 7.1.3 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY OSR 7.1.3.1 In any quarter in which radioactive liquid effluent is 30 Days discharged, an assessment shall be performed in accordance with the DO DAM in order to verify that the cumulative dose commitment does not exceed the limits in OLCO 6.1.3.
DAEC DODAM Page 77 of 196 Rev. 000
0 6.1 0 6.1.4 OLCO 6.1.4 APPLICABILITY:
ACTIONS A.
CONDITION Radioactive liquid waste being discharge without treatment and in excess of limits.
DAEC DODAM Liquid Waste Treatment 0 6.1.4 Radioactive Liquid Effluent Controls and Surveillance Requirements Liquid Waste Treatment Appropriate liquid radwaste equipment shall be used to treat any untreated batch of liquid waste prior to discharge when a pre-released analysis indicates a radioactivity concentration (exclusive of tritium and dissolved gases) of 0.01 µCi/ml or higher.
At all times.
REQUIRED ACTION COMPLETION TIME A.1 Prepare and submit a Special 30 days Report to the Commission which includes identification of non-functional equipment or subsystems and the reason, actions taken to restore the non-functional equipment, and description of action(s) taken to prevent recurrence.
Page 78 of 196 Rev. 000
Liquid Waste Treatment 0 7.1.4 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY OSR 7.1.4.1 Each radioactive liquid waste batch shall be PRIOR TO EACH sampled and analyzed in accordance with Section RELEASE 7.1.2 and Table 7.1-2.
DAEC DODAM Page 79of196 Rev. 000
0 6.1 0 6.1.5 OLCO 6.1.5 APPLICABILITY:
ACTIONS Liquid Holdup Tanks 0 6.1.5 Radioactive Liquid Effluent Controls and Surveillance Requirements Liquid Holdup Tanks The quantity of radioactive material contained in the unprotected outdoor tanks shall be limited to less than or equal to 50 Curies, excluding tritium and dissolved or entrained noble gases.
At all times.

NOTE-------------------------------------------------------

Tanks included in this specification are those outdoor tanks that are not surrounded by liners, dikes, or walls capable of holding the tanks' contents and that do not have tank overflows and surrounding area drains connected to the liquid radwaste treatment system. (The liquid radwaste storage tanks (1T-88 and 1T-269) located in the Low-Level Radwaste Processing and Storage Facility are considered unprotected outdoor tanks.)
CONDITION A.
Quantity of radioactive material in the tanks exceeding the limit.
REQUIRED ACTION A.1 Suspend all additions of the radioactive material to the tanks.
AND A.2 Reduce tank contents to within the limit.
A.3 Describe in next Annual Radioactive Effluent Release Report the events leading to this condition.
COMPLETION TIME Immediately 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months 1 year A.4 Prepare and submit a 30 Days Special Report to the Commission which identifies the cause(s) for exceeding the limit and defines the action to be taken.
(10CFR20.2203)
DAEC DODAM Page 80of196 Rev. 000
Liquid Holdup Tanks 0 7.1.5 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY OSR 7.1.5.1 When radioactive materials are being added to a 7 Days tank, the quantity of radioactive material contained in all tanks shall be determined to be within the 50Curie limit by analyzing a representative sample of the tanks' contents.
DAEC DODAM Page 81 of 196 Rev. 000
06.2 0 6.2.1.1 OLCO 6.2.1.1 APPLICABILITY:
ACTIONS CONDITION A.
One or more channels non-functional.
B.
As required by Required Action A.1 and referenced in Table 6.2-1 C.
As required by Required Action A.1 and referenced in Table 6.2-1 DAEC DODAM Radioactive Gaseous Effluent Instrumentation 0 6.2.1.1 Radioactive Gaseous Effluent Controls and Surveillance Requirements Radioactive Gaseous Effluent Instrumentation The Radioactive Gaseous Effluent Instrumentation for each function in Table 6.2-1 shall be FUNCTIONAL During releases via this pathway.
REQUIRED ACTION COMPLETION TIME A.1 Enter the condition referenced Immediately in Table 6.2-1 for the channel.
AND A.2 Restore required channel(s) to 30 days FUNCTIONAL status.
B.1 Collect gaseous grab sample.
once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months AND B.2 Analyze sample for radioactivity.
Within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months of sample collection C.1 Establish preplanned alternate 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months monitoring method.
OR C.2.1 Collect gaseous grab sample.
once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months AND C.2.2 Analyze sample for radioactivity.
Within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months of sample collection (continued)
Page 82 of 196 Rev. 000
A CTIONS (continued)
D.
As required by D.1 Required Action A. 1 and referenced in Table 6.2-1 AND D.2 AND D.3 E.
As required by E.1 Required Action A.1 and referenced in Table 6.2-1 F.
As required by F.1 Required Action A.1 and referenced AND in Table 6.2-1 F.2 G.
Minimum required G.1 instrumentation not returned to FUNCTIONAL status within 30 days.
DAEC DODAM Radioactive Gaseous Effluent Instrumentation 0 6.2.1.1 Establish continuous sampling 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months with auxiliary equipment.
Collect sample(s)
Once per 7 days Analyze sample(s) for Within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months of radioactivity.
sample collection Estimate flow rate initially and 8 Hours whenever operation of a main exhaust fan combination is changed in the system.
Collect gaseous grab sample.
once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months Analyze sample for radioactivity.
Within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months of sample collection Explain in next Annual Radioactive Material Release Report why the instrument was not made functional in a timely manner.
Page 83 of 196 Rev. 000
Radioactive Gaseous Effluent Instrumentation 07.2.1.1 SURVEILLANCE REQUIREMENTS

N()TE-----------------------------------------------

1 nstrumentation shall be FUNCTl()NAL and in service except that channels out of service are permitted for the purpose of required tests, checks and calibrations without declaring the channel to be non-functional.
SURVEILLANCE FREQUENCY
()SR 7.2.1.1.1 Perform CHANNEL CHECK 24 Hours

N()TE-----------------------------

During releases via this pathway.
()SR 7.2.1.1.2 Perform CHANNEL CHECK 7 Days
()SR 7.2.1.1.3 Perform S()URCE CHECK 30 Days
()SR 7.2.1.1.4 Determine the monitor setpoints in accordance with 92 Days the method described in the D()DAM.
()SR 7.2.1.1.5 Perform CHANNEL FUNCTl()NAL TEST 92 Days
()SR 7.2.1.1.6 Determine the monitor setpoints in accordance with 18 Months the method described in the D()DAM.
OSR 7.2.1.1.7 Perform CHANNEL CALIBRATl()N 18 Months DAEC DODAM Page 84 of 196 Rev. 000
Radioactive Gaseous Effluent Instrumentation 0 6.2.1.1 I
TABLE 6.2-1 T
TABLE 7.2-1 NORMAL RANGE RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION Instrument 1.0ffgas Stack Monitoring System Minimum Channels Functional
b Conditions Referenced from Required Action A.1 Surveillance Requirements OSR 7.2.1.1.1, OSR 7.2.1.1.3
a. Noble Gas Activity Monitor C
OSR 7.2.1.1.4,
......................................................................................................................... ?.~.~.. ?.:.2..:.1.:.~.".~(~\\.?.~.~--?.:.2..:.1.:_1_:.?<<c>.................
b. Iodine Sampler Cartridge 1
D OSR 7.2.1.1.2
c. Particulate Sampler Filter D
OSR 7.2.1.1.2
d. Effluent Flow Measuring
......................P~Y.i.9.e...............................................................
e. Sample Flow Measuring Device
2. Reactor Building Exhaust Vent E
OSR 7.2.1.1.1, OSR 7.2.1.1.5, OSR 7.2.1.1.7 E
OSR 7.2.1.1.1, OSR 7.2.1.1.5, OSR 7.2.1.1.7
............. J\\!!<>..11.i!<>.r.i.1!9.. l?.Y.~!~~---******************************* ****************************************................................................................ ****************************************************************************************************************
OSR 7.2.1.1.1, OSR 7.2.1.1.3,
a. Noble Gas Activity Monitor B
OSR 7.2.1.1.5 <d>,
OSR 7.2.1.1.6, OSR 7.2.1.1.7<c>
b. Iodine Sampler Cartridge 1
D OSR 7.2.1.1.2
c. Particulate Sampler Filter D
OSR 7.2.1.1.2
d. Effluent Flow Measuring E
OSR 7.2.1.1.1, OSR 7.2.1.1.5,
...................... P~Y.ic:~........................................................ **************************************** ****************************************************************........................................ '?..~.~.
.!..:~:.~.:.~.:.'.........................................
e. Sample Flow Measuring Device
3. Turbine Building Exhaust Vent Monitoring System E
OSR 7.2.1.1.1, OSR 7.2.1.1.5, OSR 7.2.1.1.7 OSR 7.2.1.1.1, OSR 7.2.1.1.3,
a. Noble Gas Activity Monitor B
OSR 7.2.1.1.5 <d>,
OSR 7.2.1.1.6, OSR 7.2.1.1.7<c>
b. Iodine Sampler Cartridge 1
D OSR 7.2.1.1.2
c. Particulate Sampler Filter 1
D OSR 7.2.1.1.2
d. Effluent Flow Measuring E
OSR 7.2.1.1.1, Device OSR 7.2.1.1.5, OSR 7.2.1.1.7
e. Sample Flow Measuring Device
4. Low-Level Radwaste Processing and Storage Facility Exhaust Vent E
OSR 7.2.1.1.1, OSR 7.2.1.1.5, OSR 7.2.1.1.7
............. J\\!!<>..11.i!<>.r.i.'!9.. l?.Y.~!~~---******************************* **************************************** **************************************************************** ****************************************************************************************************************
a. Noble Gas Activity Monitor F
OSR 7.2.1.1.1, OSR 7.2.1.1.3 OSR 7.2.1.1.5<d>,
OSR 7.2.1.1.6 OSR 7.2.1.1.7<c>
b. Iodine Sampler Cartridge 1
D OSR 7.2.1.1.2
c. Particulate Sampler Filter 1
D OSR 7.2.1.1.2
d. Effluent Flow Measuring E
OSR 7.2.1.1.1, OSR 7.2.1.1.5,
......................P~Y.iC:.e......................................................................................................................................................................................................... '?..~~.!.:.2..:.1.:.~.:!........................................
e. Sample Flow Measuring E
OSR 7.2.1.1.1, OSR 7.2.1.1.5, Device OSR 7.2.1.1.7 continued DAEC DODAM Page 85 of 196 Rev. 000
Radioactive Gaseous Effluent Instrumentation 0 6.2.1.1 TABLE 6.2-1 NOTATIONS (a>ouring releases via this pathway.
(b) Instrumentation shall be FUNCTIONAL and in service except that channels out of service are permitted for the purpose of required tests, checks and calibrations without declaring the channel to be non-functional.
TABLE 7.2-1 NOTATIONS (c) The CHANNEL CALIBRATION shall include the use of a known radioactive source (traceable to the NIST radiation measurement system or other acceptable non-NIST standards) positioned in a reproducible geometry with respect to the sensor and emitting beta and/or gamma radiation in the range measured by the channel in accord with established station calibration procedures.
Alternatively, after the initial calibration, noble gas activity monitors maybe calibrated by laboratory analyzed gas samples collected and analyzed per Table 7.2-2, item A.
(d) The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exist:
1.0 Instrument indicates measured levels above the alarm setpoint.
2.0 Circuit failure.
3.0 Instrument indicates a downscale failure.
4.0 Deleted.
DAEC DODAM Page 86 of 196 Rev. 000
06.2 0 6.2.2 OLCO 6.2.2 APPLICABILITY:
ACTIONS CONDITION Gaseous Effluent Dose Rate 06.2.2 Radioactive Gaseous Effluent Controls and Surveillance Requirements Gaseous Effluent Dose Rate The dose rate in the UNRESTRICTED AREA due to the release of gaseous effluents shall not exceed:
a. 500 mrem/year to the total body or 3000 mrem/year to skin due to radioactive noble gas; and
b.
1500 mrem/year to any organ due to 1-131, 1-133, H-3, and to radioactive particulates having half-lives of 8 days or more.
During Releases.
REQUIRED ACTION COMPLETION TIME A.
Dose rate not within A.1 Reduce the release rate Immediately limits.
within limit.
DAEC DODAM Page 87 of 196 Rev. 000
Gaseous Effluent Release Concentration 0 7.2.2 SURVEILLANCE REQUIRMENTS SURVEILLANCE FREQUENCY OSR 7.2.2.1 Monitor for Radioactive Noble Gas gamma Continuously activity.
OSR 7.2.2.2 Sample the Effluent Stream for 1-131.
Continuously AND Analyze for 1-131 within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months of sample 7 Days pull.

NOTE-----------------------

OSR 7.2.2.3 Retain samples for Quarterly Composite analysis.
(OSR 7.2.2.8)
Sample the Effluent Stream for particulates.
Continuously AND Analyze for principal gamma emitters from 7 Days particulates within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months of sample pull.
OSR 7.2.2.4 Perform gas grab sample of the effluent stream 30 Days and analyze for principal gamma emitters.
OSR 7.2.2.6 Perform grab sample of the effluent stream and 92 Days analyze for Tritium.
OSR 7.2.2.8 Analyze Particulate Composite sample for 92 Days Sr-89, Sr-90, Gross Alpha, Fe-55, Ni-63 DAEC DODAM Page 88 of 196 Rev. 000
TABLE 7.2-2 Gaseous Effluent Release Concentration 0 7.2.2 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Gaseous Release Type Surveillance Frequency Type of Activity Lower Limit of Requirements Analysis Detection (LLD)(aJ A. Deleted B. Offgas Stack, Reactor OSR 7.2.2.2 (el Routine Charcoal Sample 1 x 10-12 Building Vent, Turbine 1-131 Building Vent, and Particulate Sample Low-Level Radwaste Processing Storage OSR 7.2.2.3 (el Routine Principal Gamma 1 x 10-11 (d)
Facility Vent Emitters (1-131, Others)
Gas Grab Sample OSR 7.2.2.4 Routine Principal Gamma 1 x 1 Q-4(d)
Emitters OSR 7.2.2.6 Routine Tritium Grab 1 x 10-6 Sample (H-3)
Composite Particulate Sample 1 x 10-11 OSR 7.2.2.8 (el Routine (9l Sr-89, Sr-90 Gross Alpha 1 x 10-11 Fe-55, Ni-63 1 x 10-11 C. Offgas Stack, Reactor Building Vent, Turbine Monitor Building Vent, and OSR 7.2.2.1 Continuous Radioactive Noble 1 x 10-6 Low-Level Radwaste Gas gamma Processing and activity Storage Facility TABLE NOTATIONS (a) Units for the listed values are µCi/cc. See Table 7.1-2 for a definition of the lower limit of detection (LLD).
(dl The principal gamma emitters for which the LLD will apply are exclusively the following radionuclides:
Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, and Xe-138 for gaseous emissions and Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99,Cs--134, Cs-137, Ce-141 and Ce-144 for particulate emissions. This list does not mean that only these nuclides are to be detected and reported. Other peaks which are measurable and identifiable, together with the above nuclides, shall also be identified and reported. Nuclides which are below the LLD may be reported as "less than" their respective LLD and should not be reported as being present at the LLD of the nuclide. Each measured radionuclide concentration is used in a required concentration or dose calculation only if it is detected at or above the LLD. When unusual circumstances persist more than 30 days and cause LLD higher than required, the reasons shall be documented in the Annual Radioactive Material Release Report.
(el The ratio of the sample flow rate to the sampled stream flow rate shall be known for the time period covered by each dose or dose rate calculations made in accordance with Sections 6.2.2, 6.2.3, and 6.2.4.
DAEC DODAM Page 89 of 196 Rev. 000
Gaseous Effluent Concentration 0 7.2.2
<fl Sample media shall be changed at least once per seven days and the analysis completed within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months after changing (or after removal from the sampler). When samples collected for 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or less are analyzed, the corresponding LLD may be increased by a factor of 10.
(g) A quarterly composite sample shall include an equal fraction of each weekly particulate sample collected during the quarter. Quarterly samples are sent to an offsite laboratory to perform analysis.
DAEC DODAM Page 90 of 196 Rev. 000
06.2 0 6.2.3 OLCO 6.2.3 APPLICABILITY:
ACTIONS CONDITION Doses Due to Noble Gases 0 6.2.3 Radioactive Gaseous Effluent Controls and Surveillance Requirements Doses Due to Noble Gases The Air Dose in the UNRESTRICTED AREA due to noble gases released in gaseous effluents shall not exceed:
5.0 mrad from gamma radiation during any calendar quarter; 10.0 mrad from beta radiation during any calendar quarter; 10.0 mrad from gamma radiation during any calendar year; or 20.0 mrad from beta radiation during any calendar year.
During Releases REQUIRED ACTION COMPLETION TIME A.
Calculated air dose not within limits.
A.1 Submit a Special Report to 30 days the NRC identifying the cause(s) for exceeding the limit and define the corrective actions taken.
DAEC DODAM Page 91 of 196 Rev. 000
Doses Due to Noble Gases 0 7.2.3 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY OSR 7.2.3.1 An assessment shall be performed in accordance 30 Days with the DODAM to verify that the cumulative air dose during the quarter and year due to noble gases does not exceed the limits in DODAM section 6.2.3.
DAEC DODAM Page 92 of 196 Rev. 000
06.2 0 6.2.4 OLCO 6.2.4 APPLICABILITY:
ACTIONS CONDITION Doses Due to Iodine and Particulates in Air 0 6.2.4 Radioactive Gaseous Effluent Controls and Surveillance Requirements Doses Due to Iodine and Particulates in Air The dose to a MEMBER OF THE PUBLIC from lodine-131, 1-133, H-3, and from radionuclides in particulate form having half-lives greater than eight days in gaseous effluents released from the site to the UNRESTRICTED AREA shall not exceed:
7.5 mrem to any organ during any calendar quarter; or 15.0 mrem to any organ during any calendar year.
During Releases.
REQUIRED ACTION COMPLETION TIME A.
Calculated dose not within limits.
A.1 Submit a Special Report to 30 days the NRG identifying the cause(s) for exceeding the limit and define the corrective actions taken.
DAEC DODAM Page 93 of 196 Rev. 000
Doses Due to Iodine and Particulates in Air 0 7.2.4 SURVEILLANCE REQUIREMENTS OSR 7.2.4.1 DAEC DODAM SURVEILLANCE FREQUENCY An assessment shall be performed in accordance 30 Days with the DODAM to verify that the cumulative dose commitment due to 1-131, 1-133, H-3, and radioactive particulates having half-lives greater than eight days in gaseous effluents does not exceed the limits in DODAM Section 6.2.4.
Page 94 of 196 Rev. 000
06.3 0 6.3.1 OLCO 6.3.1 APPLICABILITY:
ACTIONS CONDITION A.
Calculated dose from radioactive material released in liquid or gaseous effluents exceeds twice the limits of Dose 0 6.3.1 Offsite Dose Assessment Controls and Surveillance Requirements Dose The annual dose or dose commitment to any MEMBER OF THE PUBLIC due to radiation and radioactive material in effluents from DAEC shall not exceed 75 mrem to the thyroid or 25 mrem to the total body or any other organ.
At all times.
REQUIRED ACTION COMPLETION TIME A.1 Perform an assessment of compliance 7 days with 40 CFR 190 and 1 O CFR 72.104 and limit subsequent releases such that the dose or dose commitment to a MEMBER OF THE PUBLIC is -:;,.75 mrem to his thyroid Sections 6.1.3, 6.2.3 and -:;,.25 mrem to his total body or any or 6.2.4 other organ over 12 consecutive months including the period of elevated release.
B.
The estimated dose B.1 Prepare and submit a Special Report 30 days exceeds either limit to the NRC in lieu of any other report; in Section 6.3.1.
it shall include the cause of the release of exposure, an estimate of the dose to the likely most exposed MEMBER(s) OF THE PUBLIC, corrective actions taken or planned to prevent a recurrence, and a schedule for achieving compliance. If the condition causing the limit(s) to be exceeded has not been corrected, the Special Report may also state a request for a variance in accordance with the provisions of 40 CFR Part 190. In that event, the request is timely, and a variance is granted until NRC action on the request is complete.
DAEC DODAM Page 95 of 196 Rev. 000
Dose 0 7.3.1 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY OSR 7.3.1.1 Cumulative dose contributions from liquid and 12 Months gaseous effluents to a MEMBER OF THE PUBLIC offsite shall be evaluated as described in the DO DAM.
DAEC DODAM Page 96 of 196 Rev. 000
Radiological Environmental Monitoring Program 06.3.2 06.3 Offsite Dose Assessment Controls and Surveillance Requirements 0 6.3.2 Radiological Environmental Monitoring Program (REMP) and Ground Water Protection Program (GWPP)
OLCO 6.3.2 A radiological environmental monitoring program shall be conducted as specified in Table 6.3-1.
APPLICABILITY:
At all times.
ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A.
Deviation from Table A.1 Deviations are permitted from Table Once per year 6.3-1 6.3-1 if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next sampling period. All deviations from Table 6.3-1 shall be documented in the Annual Radiological Environmental Report.
B.
In the event B.1 Prepare and submit to the Commission 30 Days radioactivity in a within 30 days after discovery a Special sampled Report which includes an evaluation of environmental any release conditions, environmental medium, averaged factors or other conditions which over a calendar caused the value(s) of Table 6.3-3 or quarter, is two times the quarterly dose limit to be attributable to DAEC exceeded and which defines the and exceeds an corrective actions to be taken. If the appropriate value radioactivity in environmental sample(s) listed in Table 6.3-3 is not attributable to releases from the or, if not listed, Station, the Special Report is not causes a potential required. Instead, the sample(s) annual dose result(s) shall be reported and exceeding two times explained in the Annual Radiological the quarterly dose Environmental Report.
limit in Section 6.1.3 or 6.2.4 (continued)
DAEC DODAM Page 97 of 196 Rev. 000
A CTIONS (continued)
CONDITION C.
When environmental sampling medium is not available from a sampling location or the location is no lonaer annropriate.
D.
A location is identified at which the calculated personal dose associated with one or more exposure pathways exceeds by 20% the maximum calculated dose associated with like pathway(s) at a location where sampling is conducted as specified by Table 6.3-1 DAEC DODAM C. 1 D.1 Radiological Environmental Monitoring Program 06.3.2 REQUIRED ACTION COMPLETION TIME The cause and the location where Once per year replacement samples were obtained and/or will be obtained shall be reported in the Annual Radiological Environmental Report.
The pathway(s) having maximum Once per year exposure potential at the newly identified location will be added to the radiological monitoring program at a subsequent Operations Committee meeting, if samples are reasonably attainable at the new location. Like pathway(s) monitored (sampled) at a location, excluding the control station location(s), having a lesser associated calculated personal dose may be deleted from the program at the time the new pathway(s) and location are added.
Page 98 of 196 Rev. 000
Radiological Environmental Monitoring Program 07.3.2 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY OSR 7.3.2.1 Sampling and analyses required in Table 6.3-1 12 Months shall be performed such that the detection capabilities specified in Table 6.3-2 are achieved under routine conditions. If a sample analysis does not meet the LLD specified, report the reason attributed in the next Annual Radiological Environmental Reoort.
OSR 7.3.2.2 DAEC shall conduct annually a land use census 12 Months within three miles of the Station to identify radiologically important changes in land use.
DAEC DODAM Page 99 of 196 Rev. 000
Radiological Environmental Monitoring Program 06.3.2 TABLE 6.3-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Exposure Minimum Sampling and Type and Frequency of Analysis Pathway and/or Number of Collection Schedule (a)
Sample Type Sampling Stations Airborne Five Continuous operation of sampler with Analyze for gross beta activity<: 72 hours8.333333e-4 days 0.02 hours 1.190476e-4 weeks 2.7396e-5 months Particulates sample collection WEEKLY or as required after filter change.
by dust loading Perform gamma isotopic analysis on each sample having gross beta activity > 10 times the yearly mean of control samples.
Perform gamma isotopic analysis on composite (by sampling location) of samples collected durinq each auarter Airborne Iodine Five Continuous operation of sampler with Analyze each cartridge for 1-131 within sample collection WEEKLY 8 days of collection.
Ambient Forty-Two QUARTERLY Read gamma radiation dose quarterly.
Radiation Surface Water Two MONTHLY Tritium and Gamma isotopic analysis of each sample.
Drinking Water Two MONTHLY Tritium and Gamma isotopic analysis of each sample. If reactor by-product gamma emitters are identified, OR tritium concentration is >MDA, then analyze, Sr-89, Sr-90, Fe-55 and Ni-63.
Drinking Water Five QUARTERLY Tritium and Gamma isotopic analysis of each sample.
If reactor by-product gamma emitters are identified, OR tritium concentration is
> MDA, then analyze for Sr-89, Sr-90, Fe-55 and Ni-63.
River Sediment One SEMIANNUALLY Gamma isotopic analysis of each sample.
Fish Two SEMIANNUALLY Gamma isotopic analysis on edible portion.
Vegetation Four ANNUALLY at harvest time. At least two Gamma isotopic and 1-131 analysis of each samples of each:
sample.
grain green leafy vegetation forage.
(a)The following definitions of schedule timing shall apply to Table 6.3-1 only:
WEEKLY - Not less than once per calendar week. A maximum interval of 11 days is allowed between the collection of any two consecutive samples.
BIWEEKLY - Not less than once every two calendar weeks. A maximum interval of 18 days is allowed between the collection of any two consecutive samples.
MONTHLY - Not less than once per calendar month. An interval of not less than 10 days will be provided between collection of any two consecutive samples.
QUARTERLY - Not less than once per calendar quarter. An interval of not less than 30 days will be provided between collection of any two consecutive samples.
SEMIANNUALLY - One sample each between calendar dates (January 1 - June 30) and (July 1 - December 31). An interval of not less than 60 days will be provided between collection of any two consecutive samples.
ANNUALLY - Not less than once per calendar year with an interval of not less than 120 days between collection of any two consecutive samples.
DAEC DODAM Page 100 of 196 Rev. 000
TABLE 6.3-2 Radiological Environmental Monitoring Program 06.3.2 GROUNDWATER PROTECTION PROGRAM Exposure Pathway Minimum Sampling and Type and Frequency of Analysis and/or Sample Number of Collection Schedule (a)
Type Sampling Stations Groundwater Twenty-QUARTERLY Tritium and Gamma isotopic analysis of Eight (bl each sample. If reactor by-product gamma emitters are identified, OR tritium concentration is >MDA, then analyze for Sr-89, Sr-90, Fe-55 and Ni-63.(d)
Groundwater One (c)
MONTHLY Tritium and Gamma isotopic analysis of Conditional each sample. If reactor by-product gamma emitters are identified, OR tritium concentration is >MDA, then analyze for Sr-89, Sr-90, Fe-55 and Ni-63.(d)
Electrical Vaults One SEMIANNUALLY Tritium and Gamma isotopic analysis of each sample.
DAEC Sewage One BIWEEKLY Tritium and Gamma isotopic analysis of Plant Effluent each sample.
<alThe following definitions of schedule timing shall apply to Table 6.3-2 only:
WEEKLY - At least once per calendar week.
BIWEEKLY - Not less than once every two calendar weeks. A maximum interval of 18 days is allowed between the collection of any two consecutive samples.
MONTHLY - Not less than once per calendar month. An interval of not less than 10 days will be provided between collection of any two consecutive samples.
QUARTERLY - Not less than once per calendar quarter. An interval of not less than 30 days will be provided between collection of any two consecutive samples.
SEMIANNUALLY - One sample each between calendar dates (January 1 - June 30) and (July 1 -
December 31). An interval of not less than 60 days will be provided between collection of any two consecutive samples.
ANNUALLY - Not less than once per calendar year with an interval of not less than 120 days between collection of any two consecutive samples.
As of January 1, 2017, fifty-six groundwater wells are operational.
(c>The number of conditional wells sampled in a calendar month depends upon identified isotope, concentration of isotope, targeted aquifer, and extraction well operations.
<d>An offsite laboratory performs the analysis of Sr-89, Sr-90, Fe-55 and Ni-63. Gross alpha is not analyzed due to the interference of naturally occurring radiological material in groundwater, and subsequently, groundwater samples.
DAEC DODAM Page 101 of 196 Rev.000
Radiological Environmental Monitoring Program 0 6.3.2 TABLE 6.3-3 MAXIMUM VALUES OF THE LOWER LIMIT OF DETECTION FOR ENVIRONMENTAL SAMPLE ANALYSIS <a>
Analysis Medium Water Airborne Fish Milk (pCi/L)
Food Sediment (pCi/L)
Particulate or (pCi/kg, Products (pCi/kg, dry)
Gas (pCi/m3) wet)
(pCi/kg, wet)
Gross beta 4
1 x 10-2 H-3 2000 (b) 3000 (c)
Mn-54 15 130 Fe-59 30 260 Co-58, Co-60 15 130 Zn-65 30 260 Zr-95 30 Nb-95 15 1-131 1 (d) 7 x 10-2 1
60 Cs-134 15 5 x 10-2 130 15 60 150 Cs-137 18 6 x 10-2 150 18 80 180 Ba-140 60 60 La-140 15 15 Other 30 (e) 30 (e)
TABLE NOTATIONS Applies to Table 6.3-1 & Table 6.3-2
{a) The LLD is defined, for purposes of these specifications, as the smallest concentration of radioactive material in a sample that will yield a new count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.
For a particular measurement, which may include radiochemical separation LLD= (4.66Sb)/(E. v. 2.22. y. e -AA!) where:
LLD is the lower limit of detection as defined above (picocuries per unit mass or volume)
Sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (counts per minute)
E is the counting efficiency (counts per disintegration)
Vis the sample size (units of mass or volume) 2.22 is the number of disintegrations per minute per picocurie, Y is the fractional radiochemical yield, when applicable,
).. is the radioactive decay constant for the particular radionuclide, and D t for environmental samples is the elapsed time between sample collection, or end of the sample collection period, and time of counting Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions. With typical values of E, V, Y, and t.t for the radionuclides named in the Table. Occasionally background fluctuations, unavoidably small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable. In such cases, the contributing factors shall be identified and described in the Annual Radiological Environmental Report. When a radionuclide attributable to DAEC but not listed in this table is measured it shall be reported.
DAEC DODAM Page 102of196 Rev. 000
(b} For Drinking Water.
(c) For samples of water not used as a source of drinking water.
(d) If no drinking water pathway exists, a value of 15 pCi/I may be used.
Radiological Environmental Monitoring Program 06.3.2 (e} "Other" refers to non-specified gamma emitters resulting from operation of DAEC. Naturally occuring radioculides are not included.
DAEC DODAM Page 103of196 Rev.000
TABLE 6.3-4 Radiological Environmental Monitoring Program 06.3.2 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES Reporting Levels(aJ Analysis Water Airborne Fish Milk Food Products (pCi/liter)
Particulate (pCi/Kg, wet)
(pCi/liter)
(pCi/Kg, wet) or Gases (pCi/m3)
H-3 2 x 104 (b) 3 X 104 (c)
Mn-54 1 x 103 3 x 104 Fe-59 4 x 102 1 x 104 Co-58 1 x 103 3 x 104 Co-60 3 x 102 1 x 104 Zn-65 3 x 102 2 x 104 Zr-Nb95 4 X 102 (c) 1-131 2d 0.9 3
1 x 102 Cs-134 30 10 1 x 103 60 1 x 103 Cs-137 50 20 2 x 103 70 2x103 Ba-La140 2 X 102 (e) 3 X 102 (e)
Other 30 (f) 30 (f)
TABLE NOTATIONS Table 6.3-3 (aJ The reporting level is exceeded when one or more radionuclides are detected in a sample and r[(concentration)/(reporting level)];::;:: 1.
(bJ For drinking water samples. This is 40 CFR Part 141 value.
(cJ For samples of water not used as a source of drinking water.
(dJ If no drinking water pathway exists, a value of 20 pCi/I may be used.
(eJ Concentration of parent or daughter.
(fl "Other" refers to non-specified gamma emitters resulting from operation of DAEC. Naturally occurring radionuclides are not included.
DAEC DODAM Page 104of196 Rev. 000
BASES BASES SECTION 6.1 I 7.1 6.1.1 Radioactive Liquid Effluent Instrumentation and 7.1.1 The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the release of radioactive material in liquid effluents. The FUNCTIONALITY and use of these instruments implements the requirements of 10 CFR Part 50, Appendix A, General Design Criteria 60, 63, and 64. The alarm and/or trip setpoints for these instruments are calculated in the manner described in the DO DAM to assure that the alarm and/or trip will occur before ten times the values specified in 1 O CFR Part 20.2001 - 20.2402, Appendix B are exceeded.
Instrumentation is expected to be FUNCTIONAL and in service when required by controls. An instrument may be removed from service voluntarily for the purpose of tests, checks, or calibration, without declaring the channel non-functional.
DAEC DODAM The radwaste effluent line radiation monitor recorder RR3972 is not required in order to comply with the controls stated in the DODAM. It is provided for recording trends during a release and need not be maintained FUNCTIONAL - i.e. calibrated and functionally tested - other than during a release.
Page 105 of 196 Rev. 000
BASES BASES SECTION 6.1 / 7.1 6.1.2 Liquid Effluent Concentration and 7.1.2 The basic requirements concerning effluents from nuclear power are stated in 10 CFR 50.36a. These requirements indicate that compliance with Technical Specifications will keep average annual releases of radioactive material in effluents to a small percentage of the limits specified in 10 CFR 20.106. These (new 10 CFR 20.1301) requirements further indicate that operational flexibility is allowed, compatible with considerations of health and safety, which may temporarily result in releases higher than such small percentages, but still within the limits specified in the old 10 CFR 20.106. These referenced concentrations are specific values which relate to an annual average dose of 500 millirems.
DAEC DODAM As stated in the Introduction to Appendix B of the new 10 CFR 20, the liquid effluent concentrations limits, given in the appendix, are based on an annual dose of 50 millirem. Prior to the issuance of the revision to Part 20, a release concentration corresponding to a limiting dose of 500 millirem had been acceptable as a TS limit for liquid effluents. The limit was applicable at all times and has been used to provide assurance that the limits of 1 O CFR 50 Appendix I were not likely to be exceeded. Since the limits of 10 CFR 50 are the ultimate value to which a license must adhere, and since the old concentration limits adequately provide such assurance, it should not be necessary to reduce this limit by a factor of 10.
Conformance with the dose limits in section 6.1.3 will necessitate average annual liquid effluent concentrations being below those specified in 10 CFR 20.1001 -
20.2402 Appendix B to §§ 20.1001-20.2402.
Demonstrating compliance with section 6.1.3 will result in a de facto demonstration of compliance with 1 O CFR 20 limits.
The continuous service water sample points noted in Table 7.1-2 are adequate to ensure sampling of potential liquid radioactive effluents from the service water systems. The sample points include the General Service Water System and the RHR Service Water Systems A and B. The sample point for the RHR Service Water Systems is at a location downstream of the point where Emergency Service Water discharge joins with the RHR Service Water System, and upstream of the point where the RHRSW/ESW Rupture Disc Line branches off the RHR Service Water System. This sample point will therefore provide for sampling effluents from the RHR Service Water System, Emergency Service Water System and/or RHRSW/ESW Rupture Disc Line.
The "clean" system water sample points noted in Table 7.1-2 are adequate to ensure sampling of potential liquid radioactive effluents from systems believed to NOT contain principal gamma emitters and iodine. The sample points include the Transformer Pit, the CST Pit, FRAC tanks, and the Neut. Tank (1T022).
Page 106of196 Rev.000
6.1.2 /
7.1.2 (cont'd) 6.1.3 and 7.1.3
1.
2.
BASES The GWPP mitigation system sample points noted in Table 7.1-2 are adequate to ensure sampling of potential liquid radioactive effluents in the shallow groundwater. Further, the GWPP mitigation plan support a reduction in contaminate concentration such that releases are expected below Administrative Control Procedure (ACP) 1411.35 and Environmental Protection Agency (EPA) drinking water limit of 20,000 pCi/L.
Dose Due to Radioactive Effluents Section 6.1.3, 6.2.3 and 6.2.4 implement the requirements of 10 CFR Part 50.36a and of 10 CFR Part 50, Appendix I, Section IV. These sections keep levels of radioactive materials in LWR effluents as low as is reasonably achievable.
Compliance with these sections will also keep average releases of radioactive material to effluent at small percentages of the limits specified in 10 CFR Part 20.106. Surveillance requirements provide for the measurement of releases and calculation of doses to verify compliance with the controls. Action statements in these sections implement the requirements of 10 CFR Part 50.36( c)(2) and 10 CFR Part 50, Appendix I, Section IV.A in the event a control is not met.
Liquid Effluents With the implementation of Section 6.1.3, there is reasonable assurance that Station operation will not cause a radionuclide concentration in public drinking water taken from the Cedar River that exceeds the standard for anthropogenic radioactivity in community drinking water. The equations in the DODAM for calculating doses due to measured releases of radioactive material in liquid effluent are consistent with the methodology in Regulatory Guide 1.109 and 1.113. The assessment of personal doses will examine potential exposure pathways including, as appropriate, consumption of fish and water taken from the Cedar River downstream of the discharge pipe.
6.1.4 and 7.1.4 Liquid Waste Treatment DAEC DODAM This section implements the requirements of 10 CFR Part 50.36a (a)(1) that operating procedures be established and followed, and that equipment be maintained and used to keep releases to the environment as low as is reasonably achievable. The section intends that appropriate portions of the system which were used to establish compliance with the design objectives in 10 CFR Part 50, Appendix I, Section II be used when specified to provide reasonable assurance that releases of radioactive material in liquid effluent will be kept as low as is reasonably achievable. The components in the liquid radwaste system which are appropriate to process liquid waste in order to satisfy Section 7.1.4 are the floor drain demineralizer and the radwaste demineralizer. The activity concentration, µCi/ml, below which liquid radwaste treatment would not be cost-beneficial, and therefore not required, is demonstrated below. The quantity of radioactive material in liquid effluent released annually from the DAEC has been calculated to be:
total iodines 0.11 curie total others (less H3) 0.25 Total 0.36 curie Page 107of196 Rev. 000
DAEC DODAM BASES The population dose commitment resulting from the radioactive material in liquid effluent released annually has been calculated to be*
thyroid total body Total 0.164 man rem 0.114 0.278 man rem Therefore, population doses are about 1.5 man rem per curie of iodine released and about 0.5 man rem per curie of other radionuclides (less H3) released in liquids. On the basis of gross activity, the population dose is about one man rem per curie released in liquids.
The volume of liquid waste processed and intended for discharge is estimated to be:
Low Purity Waste Chemical Waste 5700 gal/day = 1.8 x 106 gal/yr 600 gal/day = 1.9 x 105 gal/yr Since the same DAEC equipment is used to process both streams, the total volume to be processed is about 2 x 106 gal/yr. The annual cost to operate the radwaste processing equipment, based on Dirty Waste Ion Exchange operation, has been estimated* (neglecting credit for capital recovery) to be $88,000 per year. Thus the unit volume operating cost is about:
$88,000 I yr
$O.OS / gal 2 x 106 gal I yr Thus, the operating cost to treat a 4000 gallon batch of chemical waste by ion exchange would be about $200. The operating cost to treat a 10000 gallon batch of floor drain waste by ion exchange would be about $500. Assuming the cost-benefit balance is $1000 expenditure per man rem reduced and assuming treatment removes all radioactivity from the liquid, then (1) the activity concentration in a Chemical Waste batch below which treatment is not cost-beneficial is C
$200 x I curie x J 06 µCi x I man rem 4000 gal x 3785 !!!i_
man rem curie
$1000 gal C =0.013 µCi/ml (continued)
Page 108 of 196 Rev. 000
6.1.4 and 7.1.4 BASES (2) the activity concentration in a batch of Floor Drain Waste below which treatment is not cost-beneficial is
$500 I curie J 06 µCi I man rem C-x x~~x ml man rem curie
$1000 10000 gal x 3785-gal C=0.013 µCi/ml Liquid waste treatment with the evaporator at DAEC has been shown to be neither cost-beneficial nor necessary to comply with 1 O CFR 50 Appendix I,Section II.
Consequently, liquid radwaste treatment to achieve an activity concentration below 0.01 µCi/ml in liquid effluent is not justified.
6.1.5 Liquid Holdup Tanks and 7.1.5 The tanks listed in the specification include all liquid radwaste tanks (1T-88 and 1T-269) located in the Low-Level Radwaste Processing Facility (LLRPSF).
Because the LLRPSF is not seismically designed, these tanks are considered as outdoor tanks that are not surrounded by liners, dikes, or walls capable of holding the tanks' contents.
DAEC DODAM Restricting the quantity of radioactive material contained in the specified tanks provides assurance that in the event of an uncontrolled release of the tanks' contents, the resulting concentrations would be less than the limits of 10 CFR 20, Appendix B to 20.1001 - 20.2402, Table 2, Column 2, at the nearest potable water supply in an UNRESTRICTED AREA.
Page 109 of 196 Rev. 000
BASES BASES SECTION 6.2 / 7.2 6.2.1 and 7.2.1 DAEC DODAM Radioactive Gaseous Effluent Instrumentation The radioactive gaseous effluent instrumentation is provided to monitor the release of radioactive materials in gaseous effluents and, as appropriate, to control potential releases. The presence of instruments for monitoring radioactive effluents is depicted in DODAM Figure 3-1. The FUNCTIONALITY and use of these instruments implement the requirements of 1 O CFR Part 50, Appendix A, General Design Criteria 60, 63, and 64.
DAEC is equipped with a radioactive gaseous effluent monitoring system which includes detectors at the offgas stack (R3), the reactor building vent (R4), the turbine building vent (R5), and the LLRPSF vent (R7). A remote indication and control unit located near each detector displays the detector reading and, whenever the setpoint is exceeded, an indicator light. The data are also routed to a control computer and a control room display, but do not cause a trip to isolate the ventilated area. In the event the control computer and/or control room display fail to function or are voluntarily taken out of service, each remote indication and control unit is designed to acquire data for up to 30 hours3.472222e-4 days 0.00833 hours 4.960317e-5 weeks 1.1415e-5 months . It is intended that each affected remote indication and control unit display be observed at least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months (in which case the affected channel remains FUNCTIONAL).
If an alarm trip setpoint is exceeded at the same time the control computer and/or control room display are neither functioning nor in service, alarm annunciation will still occur in the control room. In the event the detector reading and the indication of exceeding the monitor setpoint are not provided at either the control room or the remote indication and control unit, then the affected channel is not FUNCTIONAL and DAEC will either perform the appropriate ACTION or will provide an alternate monitoring system. This permits DAEC to retain the GE gaseous monitoring system as an alternate system for normal effluent monitoring when the Kaman system is temporarily non-functional. When used as an alternate monitoring system, the GE system is subject to the requirements stated in Sections 6.2.1 and 7.2.1 and to LLD requirements stated in Table 7.2-2, Note (d).
2. Not used
3. Gaseous Effluents Assessments of dose required by Sections 7.2.3 and 7.2.4 to verify compliance with Appendix I,Section IV are based on measured radioactivity in gaseous effluent and on calculation methods stated in the DODAM. Pathways of exposure and location of individuals are selected such that the dose to a nearby resident is unlikely to be underestimated. Dose assessment methodology described in the DODAM for gaseous effluent will be consistent with the methodology in Regulatory Guides 1.109 and 1.111. Cumulative and projected assessments of dose made during a quarter are based on historical average meteorological conditions measured at DAEC. Assessment made for the annual radiological environmental report will be based on annual averages of atmospheric conditions during the period of release.
Page 110 of 196 Rev. 000
6.2.2 and 7.2.2 6.2.3 and 7.2.3 6.2.4 and 7.2.4 DAEC DODAM BASES Gaseous Effluent Concentration The basic requirements concerning effluents from nuclear power are stated in 10 CFR 50.36a. These requirements indicate that compliance with Technical Specifications will keep average annual releases of radioactive material in effluents to a small percentage of the limits specified in 1 O CFR 20. These (new 1 O CFR 20.1301) requirements further indicate that operational flexibility is allowed, compatible with considerations of health and safety, which may temporarily result in releases higher than such small percentages, but still within the limits specified in the old 1 O CFR 20.106. These referenced concentrations are specific values which relate to an annual average dose of 500 millirems.
As stated in the Introduction to Appendix B of the new 10 CFR 20, the gaseous effluent concentration limits given in the appendix are based on an annual dose of 50 millirem for isotopes for which inhalation or ingestion is limiting or 100 millirem for isotopes for which submersion (noble gases) is limiting. Prior to the issuance of the revision to Part 20 a release concentration corresponding to limiting dose rates less than or equal to 500 mrem/yr to the whole body, 3000 mrem/yr to the skin from noble gases, and 1500 mrem/yr to any organ from iodine, and tritium, had been acceptable as a TS limit for airborne effluents. This limit was applicable at all times and had been used to provide assurance that the limits of 10 CFR 50 Appendix I and 40 CFR 190 were not likely to be exceeded.
Since the limits of 10 CFR 50 Appendix I and 40 CFR 90 are more restrictive than 10 CFR 20, and because the dose limits specified have been successfully used to assure compliance with these regulations, it should not be necessary to reduce the dose rate basis to 50 or 100 millirem.
Conformance with the dose limits of 7.3.1 will necessitate the average annual airborne effluent concentrations being below those specified in 10 CFR 20 Appendix B. Demonstrating compliance with section 6.3.1 will result in a de facto demonstration of compliance with 10 CFR 20 limits. Assessment of compliance is based upon an effluents measurement program defined in Table 7.2-2 and methodology stated in the DO DAM. The resolving time of the measurements, i.e.,
the sample integration time, bounds the minimum averaging time of the effluent measurements waste streams.
Doses due to Noble Gases These specifications implement the requirements of 10 CFR Part 50, Appendix I.
Doses due to Iodine and Particulates in Air These specifications implement 10 CFR Part 50, Appendix I. The dose calculation methods in the DO DAM depend on existing pathways of exposure to a member of the public or more conservative conditions assumed (yielding a higher calculated dose). Calculations and methods are such that an estimate of the dose to a member of the public is not likely to be underestimated substantially.
Page 111 of 196 Rev. 000
BASES SECTION 6.3 / 7.3 6.3.1 and 7.3.1 Dose BASES Section 6.3.1 is provided to comply with the dose limitation requirement of 40 CFR 190. This section requires the assessment of dose to demonstrate that a person (a nearby resident) has not received a radiation dose exceeding that specified in 40 CFR 190 including doses from direct radiation. There is no other licensed nuclear fuel cycle facility within 50 miles of DAEC, thus it is assumed that the dose from other uranium fuel cycle facilities is negligible. In the event a report is required to satisfy Action b, it shall be deemed adequate to satisfy the reporting requirement in Section 8.2.2.
By demonstrating compliance with 40 CFR 190, DAEC will be, de facto, in compliance with the dose limits specified in 10 CFR 20. 1301 and 10 CFR 72.104. Such a position is in keeping with that stated by the NRC in the preamble to the revised 1 O CFR 20 (56 CFR 23360).
6.3.2 and 7.3.2 Radiological Environmental Monitoring DAEC DODAM The radiological environmental monitoring program, including the land use census, is conducted to satisfy the requirements of 1 O CFR Part 50, Appendix I,Section IV.B.2 and.3. The minimum radiological monitoring program required by this specification provides measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides which lead to the highest potential radiation exposures of individuals resulting from the station operation. This monitoring program thereby supplements the radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and modeling of the environmental exposure pathways.
The land use census is conducted annually to identify changes in use of the UNRESTRICTED AREA in order to recommend modifications in monitoring programs for evaluating individual doses from principal exposure pathways. It may be conducted by door-to-door survey, by aerial survey, or by consulting with local agricultural or governmental authorities.
In order that radiological environmental monitoring stations may be relocated to reflect current conditions, the locations of stations required by Table 6.3-1 are described in the Offsite Dose Assessment Manual. Revisions thereto are administered in accordance with TS 5.5.1 and DO DAM 8.3.1. DAEC may conduct additional environmental monitoring exclusive of the requirements of Sections 6.3.2.
Page 112 of 196 Rev. 000
8.0 ADMINISTRATIVE CONTROLS 8.1 Programs and Manuals 8.1.1 Radioactive Effluent Controls Program PROGRAMS AND MANUALS 8.1 This program, conforming to 1 O CFR 50.36a, provides for the control of radioactive effluents and for maintaining the doses to members of the public from radioactive effluents as low as reasonably achievable. The program shall be contained in the DODAM, shall be implemented by procedures, and shall include remedial actions to be taken whenever the program limits are exceeded. The program shall include the following elements.
a. Limitations on the functional capacity of radioactive liquid and gaseous monitoring instrumentation including surveillance tests and setpoint determination in accordance with the methodology in the DODAM;
b. Limitations on the concentrations of radioactive material released in liquid effluents from the site to UNRESTRICTED AREAs, conforming to ten times (10x) the concentrations listed in Appendix B, Table 2, Column 2 to 10 CFR 20.1001 - 20.2402;
c. Monitoring, sampling, and analysis of radioactive liquid and gaseous effluents pursuant to 10 CFR 20.1302 and with the methodology and parameters in the DO DAM conforming to 1 OCFR50, Appendix I;
d. Limitations on the annual and quarterly doses or dose commitment to a member of the public from radioactive materials in liquid effluents released to UNRESTRICTED AREAs;
e. Determination of cumulative and projected dose contributions from radioactive effluents for the current calendar quarter and current calendar year in accordance with the methodology and parameters in the DODAM at least every 30 days. If 30-day projected quarterly dose exceeds quarterly dose limits, a utilization evaluation of liquid waste processing system is needed;
f. Limitations on the functional capability and use of the liquid and gaseous effluent treatment systems to ensure that the appropriate portions of these systems which were used to establish compliance with the design objectives in 10 CFR 50, Appendix I, Section II be used when specified to provide reasonable assurance that releases of radioactive material in liquid and gaseous effluents be kept as low as reasonably achievable;
g. Limitations on the dose rate resulting from radioactive material released in gaseous effluents to areas at or beyond the site boundary shall be limited to the following:
1. For noble gases: less than or equal to a dose rate of 500 mrem/yr to the whole body and less than or equal to a dose rate of 3000 mrem/yr to the skin, and
2. For iodine-131, iodine-133, tritium, and for all radionuclides in particulate form with half-lives > 8 days: less than or equal to a dose rate of 1500 mrem/yr to any organ;
h. Limitations on the annual and quarterly air doses resulting from noble gases released in gaseous effluents to areas beyond the site boundary, conforming to 1 O CFR 50, Appendix I; I. Limitations on the annual and quarterly doses to a member of the public from iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half-lives> 8 days in gaseous effluents released to areas beyond the site boundary, conforming to 10 CFR 50, Appendix I; and
j. Limitations on the annual dose or dose commitment to any member of the public due to releases of radioactivity and to radiation from uranium fuel cycle sources, conforming to 40 CFR 190 and 10 CFR 72.104.
DAEC DODAM Page 113 of 196 Rev. 000
8.1.2 Radiological Environmental Monitoring Program REPORTING REQUIREMENTS (continued) 8.2 The Radiological Environmental Monitoring Program is described in section 5 of the DO DAM.
Specifications for implementation are located in section 6.3.2 8.1.3 lnterlaboratory Comparison Program Analyses shall be performed on radioactive materials supplied in an lnterlaboratory Comparison Program.
In the event analyses were not performed as required in Section 8.1.3, report the corrective actions taken to prevent a recurrence in the Annual Radiological Environmental Report.
The requirement for participation in an lnterlaboratory Comparison Program is provided to ensure that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are reasonably valid.
DAEC DODAM Page 114 of 196 Rev.000
8.2 Reporting Requirements 8.2.1 Annual Radioactive Material Release Report REPORTING REQUIREMENTS 8.2 (1)
A report of radioactive materials released from the Station shall be submitted to the NRC on or before May 1 of each year in accordance with 1 O CFR 50.36a.
Each report shall include the information specified in item (2) below covering the preceding twelve months.
(2)
An Annual Radioactive Material Release Report shall include a summary by calendar quarter of the quantities of radioactive liquid and gaseous effluents and radioactive solid waste released from the Station. The data on radioactive liquid and gaseous effluents should be reported in the format in Tables 8.2-1 and 8.2-2.
The data on radioactive solid waste should include:
1.
classification of the waste (per 10 CFR Part 61)
2.
total volume shipped
3.
total radioactive material shipped (curies)
4.
identification of principal radionuclides
5.
solidification agent
6.
physical description of the waste (3)
A summary description of any changes to the DODAM.
(4)
A summary of meteorological data collected during the year will be submitted in the annual report following January 1. Alternatively, summary meteorological data may be retained by DAEC and made available to the NRC upon request.
(5)
Include a description for all sample analyses/conditions for which communications were made to State and Local officials due to exceeding the applicable DODAM reporting levels for environmental samples for locations that have not been added to the plant's Radiological Environmental Monitoring Program.
(6)
Include a description of all spills or leaks (of radioactive material) that were communicated to State/Local Stakeholders.
DAEC DODAM Page 115 of 196 Rev.ODO
TABLE 8.2-1 REPORTING REQUIREMENTS (continued) 8.2 (continued)
ANNUAL RADIOACTIVE MATERIAL RELEASE REPORT (YEAR)
LIQUID EFFLUENTS Nuclides Released Unit Quarter Quarter strontium-89 Ci E
E strontium-90 Ci E
E cesium-134 Ci E
E cesium-137 Ci E
E iodine-131 Ci E
E cobalt-58 Ci E
E cobalt-60 Ci E
E iron-55 Ci E
E iron-59 Ci E
E zinc-65 Ci E
E manganese-54 Ci E
E chromium-51 Ci E
E zirconium-niobium-95 Ci E
E molybdenum-99 Ci E
E technetium-99m Ci E
E barium-lanthanum-140 Ci E
E cerium-141 Ci E
E Other (specify)
Ci E
E Ci E
E Ci E
E Ci E
E Ci E
E Total for period (above)
Ci E
E xenon-133 Ci E
E xenon-135 Ci E
E DAEC DODAM Page 116 of 196 Rev.000
TABLE 8.2-2 REPORTING REQUIREMENTS (continued) 8.2 ANNUAL RADIOACTIVE MATERIAL RELEASE REPORT (YEAR)
GASEOUS EFFLUENTS Nuclides Released Unit Quarter Quarter
1. Fission gases krypton-85 Ci E
E krypton-85m Ci E
E krypton-87 Ci E
E krypton-88 Ci E
E xenon-133 Ci E
E xenon-135 Ci E
E xenon-135m Ci E
E xenon-138 Ci E
E Others (specify)
Ci E
E Ci E
E Ci E
E Total for period Ci E
E
2. Iodines iodine-131 Ci E
E iodine-133 Ci E
E iodine-135 Ci E
E Others (specify)
Total for period Ci
.E
.E
3. Particulates strontium-89 Ci E
E strontium-90 Ci E
E cesium-134 Ci E
E cesium-137 Ci E
E barium-lanthanum-140 Ci E
E Others (specify)
Ci E
E Ci E
E DAEC DODAM Page 117 of 196 Rev. 000
REPORTING REQUIREMENTS (continued) 8.2 8.2.2 Annual Radiological Environmental Operating Report An annual report of radiological environmental surveillance activities required by Section 6.3.2 shall be submitted to the NRC by May 15th of each year. Each report shall be consistent with the objectives outlined in the DODAM, and with 10 CFR 50, Appendix I, Sections IV.B.2, IV.B.3, and IV.C. The report shall include the following information:
(1)
A summary description of the radiological environmental monitoring program required by Section 6.3.2.
(2)
A map and a table of distances and directions of locations of sampling stations required in Table 6.3-1.
(3)
A summary of the land use census required in Section 7.3.2.2.
(4)
Results of analyses of samples required by the radiological environmental monitoring program, Table 6.3-1. In the event some results are not available, the reasons shall be explained in the report. In the event the missing results are obtained, they shall be submitted in a supplementary report as soon as is reasonable.
(5)
An assessment of radiation doses to a MEMBER OF THE PUBLIC likely to be the most exposed due to radioactive liquid and gaseous effluents released from DAEC during the year. The assessment shall be performed as described in the DODAM.
(6)
Deleted.
(7)
Results of participation in the lnterlaboratory Comparison Program.
(8)
Deviation from environmental sampling schedule.
(9)
A report of all analyses in which the LLD, required by Table 6.3-2, was not achieved.
(10) A report of any changes in sample locations.
(11) Include a description for all sample analyses/conditions for which communications were made to State and Local Stakeholders due to exceeding the REMP reporting levels provided in the plant's OCDM/DODAM for locations that are described in the plant's REMP or GWPP programs.
(12) Include onsite ground water sample results.
DAEC DODAM Page 118 of 196 Rev.000
8.2.3 Special Reports REPORTING REQUIREMENTS (continued) 8.2 Special reports shall be submitted to the Director of Inspection and Enforcement Regional Office within the time period specified for each report. These reports shall be submitted covering the activities identified below pursuant to the requirements of the applicable reference specification.
1. Radioactive Liquid or Gaseous Effluent - calculated dose exceeding specified limit (DODAM Sections 6.1.3, 6.2.3, and 6.2.4).
2. Deleted.
3. Measured levels of radioactivity in an environmental sampling medium determined to exceed the reporting level values of DODAM Table 6.3-3 when averaged over any calendar quarter sampling period (DODAM Section 6.3.2). Report to State and Local authorities in accordance with Administrative Control Procedure (ACP) 1402.3.
4. Annual dose to a MEMBER OF THE PUBLIC determined to exceed 40 CFR Part 190 dose limit (DODAM Section 6.3.1.1).
5. Radioactive liquid waste release without treatment when activity concentration is equal to or greater than 0.01 µCi\\ml (DODAM Section 6.1.4).
DAEC DODAM Page 119 of 196 Rev. 000
8.3 Changes to the DODAM REPORTING REQUIREMENTS (continued) 8.2
a. Shall be documented, and records of reviews performed shall be retained for the duration of the facility operating license. This documentation shall contain:
1) Sufficient information to support the change together with the appropriate analyses or evaluations justifying the change(s) and:
2) A determination that the change will maintain the level of radioactive effluent control required by 10 CFR 20.1302, 40 CFR Part 190, 1 O CFR 72.104, 1 O CFR 50.36a, and Appendix I to 10 CFR Part 50 and not adversely impact the accuracy or reliability of effluent dose or setpoint calculations.
b. Shall become effective after review and acceptance by the Onsite Review Group and approval by the DAEC Decommissioning Director.
c. Shall be submitted to the commission in the form of a complete, legible copy of the entire DO DAM as a part of or concurrent with the Annual Radioactive Material Release Report for the period of the report in which any change to the DO DAM was made. Each change shall be identified by markings in the margin of the affected pages, clearly indicating the area of the page that was changed and shall indicate the date the change was implemented.
DAEC DODAM Page 120 of 196 Rev.000
Appendix A APPENDIX A: DOSE TRANSFER FACTORS FOR AIRBORNE PATHWAYS Environmental pathway models have been solved on the bases of unit radionuclide release in effluent (1 Ci/yr) and unit atmospheric dispersion (1 sec/m3) or deposition (1/m2) to derive dose transfer factors for airborne effluent. The dose transfer factors in this appendix were computed with the GASPAR II computer programa, using default values of parameters applicable to the most exposed members of the public as recommended in Regulatory Guide 1.109, revision 1, with the following exceptions.
Significant revisions of data since publication of the Regulatory Guide 1.109, revision 1 and incorporated into GASPAR II were employed. Data differing from those in the Regulatory Guide 1.109 are identified in GASPAR II documentation. b After publishing Reg. Guide 1.109, the NRG recommended that soil-to-plant bioaccumulation factors, Biv, of cesium and strontium be changed. c The revised values were used to derive dose transfer factors tabulated for Sr89, Sr90, and Cs137.
Values of environmental transit time recommended in Reg. Guide 1.109, d namely 1440 hr from harvest of stored vegetables to ingestion, were retained in lieu of default values in GASPAR II. 0 These factors affected dose transfer factors more than 10% only for H3, Sr89, Sr90, Cs137, Ce141, and Ce144.
Dose transfer factors from C14 via inhalation and from Kr90 via irradiation by an airborne cloud are the same as in the previous MIDAS library since GASPAR II does not produce them. Skin dose transfer factors are assumed to be the same as total body dose transfer factors for H3 and C14 in exposure pathways involving inhalation or ingestion also because GASPAR II does not calculate them.
a b
c Strenge, D.L., et. al., GASPAR II - Technical Reference and User Guide, NUREG/CR-4653, March 1987 Ibid., 3.3.1.1, 3.3.2.3 USNRC, SECY-79-653A, January 30, 1980.
ct Regulatory Guide 1.109, rev. 1, Table E-15 e
Strenge, et. al., p. C.3.
DAEC DODAM Page 121 of 196 Rev. 000
Appendix A Dose transfer factors are included hereafter for the following parameters.
Pathway Age Group Organ Inhalation Adult Total Body Ground irradiation Teenager GI tract Grass-cow-meat Kidney Vegetables, leafy + produce Thyroid Plume irradiation Lung Skin DAEC DODAM Page 122 of 196 Rev. 000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= ADULT PATHWAY = INHALATION TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN mrem m2 /Ci H 3 2.28E+01 2.28E+01 O.OOE-01 2.28E+01 2.28E+01 2.28E+01 2.28E+01 2.28E+01 c 14 1.08E+02 1.08E+02 5.76E+02 1.08E+02 1.08E+02 1.08E+02 1.08E+02 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR 88 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 3.17E+OO 1.05E+02 O.OOE-01 O.OOE-01 7.23E-01 1.89E+OO 4.56E+02 O.OOE-01 MN 54 2.00E+02 2.45E+03 O.OOE-01 1.25E+03 3.12E+02 O.OOE-01 4.44E+04 O.OOE-01 FE 55 1.25E+02 1.91E+02 7.81E+02 5.38E+02 O.OOE-01 O.OOE-01 2.29E+03 O.OOE-01 FE 59 3.36E+02 5.96E+03 3.74E+02 8.81E+02 O.OOE-01 O.OOE-01 3.23E+04 O.OOE-01 C058 6.56E+01 3.36E+03 O.OOE-01 5.01E+01 O.OOE-01 O.OOE-01 2.94E+04 O.OOE-01 C060 4.69E+02 9.03E+03 O.OOE-01 3.64E+02 O.OOE-01 O.OOE-01 1.89E+05 O.OOE-01 ZN 65 1.48E+03 1.70E+03 1.03E+03 3.26E+03 2.19E+03 O.OOE-01 2.74E+04 O.OOE-01 SR89 2.76E+02 1.11E+04 9.63E+03 O.OOE-01 O.OOE-01 O.OOE-01 4.44E+04 O.OOE-01 SR90 1.83E+04 2.29E+04 9.10E+05 O.OOE-01 O.OOE-01 O.OOE-01 3.04E+05 O.OOE-01 ZR95 7.38E+02 4.75E+03 3.39E+03 1.09E+03 1.72E+03 O.OOE-01 5.61E+04 O.OOE-01 SB124 3.93E+02 1.29E+04 9.89E+02 1.87E+01 O.OOE-01 2.40E+OO 7.86E+04 O.OOE-01 CS134 2.31E+04 3.30E+02 1.18E+04 2.69E+04 9.10E+03 O.OOE-01 3.09E+03 O.OOE-01 CS136 3.49E+03 3.71E+02 1.24E+03 4.63E+03 2.71E+03 O.OOE-01 3.80E+02 O.OOE-01 CS137 1.36E+04 2.66E+02 1.52E+04 1.97E+04 7.07E+03 O.OOE-01 2.38E+03 O.OOE-01 BA140 8.14E+01 6.91E+03 1.24E+03 1.56E+OO 5.29E-01 O.OOE-01 4.02E+04 O.OOE-01 CE141 4.85E+01 3.80E+03 6.31E+02 4.28E+02 1.99E+02 O.OOE-01 1.15E+04 O.OOE-01 CE144 5.83E+03 2.59E+04 1.09E+05 4.53E+04 2.69E+04 O.OOE-01 2.47E+05 O.OOE-01 1131 6.50E+02 1.99E+02 7.99E+02 1.13E+03 1.94E+03 3.77E+05 O.OOE-01 O.OOE-01 I 133 1.43E+02 2.81E+02 2.74E+02 4.69E+02 8.21E+02 6.81E+04 O.OOE-01 O.OOE-01 DAEC ODAM Page 123of196 Rev.ODO
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= ADULT PATHWAY = GROUND PLANE TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m2~/Ci H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.74E+05 MN54 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 5.13E+07 FE 55 9.80E+05 2.77E+05 5.48E+06 1.61E+06 O.OOE-01 O.OOE-01 3.22E+06 O.OOE-01 FE 59 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 1.01E+07 C058 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.41E+07 C060 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 8.02E+08 ZN 65 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.72E+07 SR89 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 7.95E+02 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 9.03E+06 SB124 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 2.19E+07 CS134 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.53E+08 CS136 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 5.39E+06 CS137 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.80E+08 BA140 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 7.45E+05 CE141 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.88E+05 CE144 2.21E+06 2.21E+06 2.21E+06 2.21E+06 2.21E+06 2.21E+06 2.21 E+06 2.55E+06 1131 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 3.33E+05 1133 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 4.72E+04 DAEC ODAM Page 124of196 Rev. 000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
=
ADULT PATHWAY
=
ANIMAL MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN mrem m2 /Ci H 3 5.93E+OO 5.93E+OO O.OOE-01 5.93E+OO 5.93E+OO 5.93E+OO 5.93E+OO 5.93E+OO c 14 2.13E+03 2.13E+03 1.06E+04 2.13E+03 2.13E+03 2.13E+03 2.13E+03 2.13E+03 AR41 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 1.99E+02 5.01E+04 O.OOE-01 O.OOE-01 4.40E+01 1.19E+02 2.65E+02 O.OOE-01 MN 54 4.44E+04 7.10E+05 O.OOE-01 2.32E+05 6.91E+04 O.OOE-01 O.OOE-01 O.OOE-01 FE55 7.36E+05 1.81E+06 4.58E+06 3.17E+06 O.OOE-01 O.OOE-01 1.77E+06 O.OOE-01 FE59 6.50E+06 5.64E+07 7.23E+06 1.70E+07 O.OOE-01 O.OOE-01 4.75E+06 O.OOE-01 C058 1.08E+06 9.76E+06 O.OOE-01 4.82E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 4.15E+06 3.55E+07 O.OOE-01 1.89E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 1.46E+07 2.03E+07 1.01E+07 3.23E+07 2.16E+07 O.OOE-01 O.OOE-01 O.OOE-01 SR89 2.51E+05 1.40E+06 8.75E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 3.74E+07 4.66E+07 1.85E+09 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 1.08E+04 5.04E+07 4.98E+04 1.59E+04 2.50E+04 O.OOE-01 O.OOE-01 O.OOE-01 SB124 2.09E+05 1.50E+07 5.26E+05 9.98E+03 O.OOE-01 1.28E+03 4.12E+05 O.OOE-01 CS134 3.23E+07 6.91E+05 1.66E+07 3.93E+07 1.28E+07 O.OOE-01 4.25E+06 O.OOE-01 CS136 1.03E+06 1.63E+05 3.61E+05 1.43E+06 7.95E+05 O.OOE-01 1.09E+05 O.OOE-01 CS137 2.08E+07 6.15E+05 2.33E+07 3.17E+07 1.08E+07 O.OOE-01 3.58E+06 O.OOE-01 BA140 5.70E+04 1.79E+06 8.71E+05 1.09E+03 3.71E+02 O.OOE-01 6.27E+02 O.OOE-01 CE141 3.01E+01 1.01E+06 3.93E+02 2.65E+02 1.23E+02 O.OOE-01 O.OOE-01 O.OOE-01 CE144 1.96E+03 1.24E+07 3.64E+04 1.53E+04 9.06E+03 O.OOE-01 O.OOE-01 O.OOE-01 1131 1.37E+05 6.31E+04 1.67E+05 2.39E+05 4.09E+05 7.83E+07 O.OOE-01 O.OOE-01 1133 3.11E-03 9.16E-03 5.86E-03 1.02E-02 1.78E-02 1.50E+OO O.OOE-01 O.OOE-01 DAECODAM Page 125of196 Rev.ODO
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= ADULT PATHWAY = VEGETABLES TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
{mrem m2}/Ci H 3 4.12E+01 4.12E+01 O.OOE-01 4.12E+01 4.12E+01 4.12E+01 4.12E+01 4.12E+01 c 14 5.74E+03 5.74E+03 2.87E+04 5.74E+03 5.74E+03 5.74E+03 5.74E+03 5.74E+03 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 1.45E+03 3.64E+05 O.OOE-01 O.OOE-01 3.20E+02 8.68E+02 1.93E+03 O.OOE-01 MN54 1.86E+06 2.99E+07 O.OOE-01 9.76E+06 2.90E+06 O.OOE-01 O.OOE-01 O.OOE-01 FE55 3.99E+05 9.84E+05 2.49E+06 1.71E+06 O.OOE-01 O.OOE-01 9.56E+05 O.OOE-01 FE 59 3.52E+06 3.07E+07 3.93E+06 9.19E+06 O.OOE-01 O.OOE-01 2.57E+06 O.OOE-01 C058 2.13E+06 1.93E+07 O.OOE-01 9.51E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 1.16E+07 9.92E+07 O.OOE-01 5.29E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 1.83E+07 2.55E+07 1.27E+07 4.06E+07 2.70E+07 O.OOE-01 O.OOE-01 O.OOE-01 SR89 9.19E+06 5.13E+07 3.20E+08 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 1.26E+09 1.57E+09 6.27E+10 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR 95 7.89E+03 3.68E+07 3.64E+04 1.16E+04 1.83E+04 O.OOE-01 O.OOE-01 O.OOE-01 SB124 1.27E+06 9.13E+07 3.20E+06 6.08E+04 O.OOE-01 7.80E+03 2.50E+06 O.OOE-01 CS134 2.87E+08 6.15E+06 1.47E+08 3.52E+08 1.13E+08 O.OOE-01 3.77E+07 O.OOE-01 CS136 3.83E+06 6.02E+05 1.35E+06 5.32E+06 2.96E+06 O.OOE-01 4.06E+05 O.OOE-01 CS137 2.06E+08 6.08E+06 2.30E+08 3.14E+08 1.07E+08 O.OOE-01 3.55E+07 O.OOE-01 BA140 2.67E+05 8.37E+06 4.06E+06 5.10E+03 1.74E+03 O.OOE-01 2.92E+03 O.OOE-01 CE141 4.72E+02 1.59E+07 6.15E+03 4.15E+03 1.93E+03 O.OOE-01 O.OOE-01 O.OOE-01 CE144 5.36E+04 3.39E+08 9.98E+05 4.18E+05 2.48E+05 O.OOE-01 O.OOE-01 O.OOE-01 1131 1.05E+06 4.82E+05 1.28E+06 1.83E+06 3.14E+06 5.99E+08 O.OOE-01 O.OOE-01 I 133 1.75E+04 5.17E+04 3.30E+04 5.74E+04 1.00E+05 8.43E+06 O.OOE-01 O.OOE-01 DAEC ODAM Page 126of196 Rev.ODO
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
=
ADULT PATHWAY =
PLUME TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 3~/~Ci sec~
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 3.14E+02 KR83m 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.38E-02 4.75E-01 KR85m 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.67E+01 KR85 3.58E-01 3.58E-01 3.58E-01 3.58E-01 3.58E-01 3.58E-01 9.51E-01 4.28E+01 KR87 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.35E+02 4.60E+02 KR88 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 4.50E+02 KR89 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.71E+02 7.48E+02 KR90 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 XE131m 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.38E+OO 1.89E+01 XE133m 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 6.02E+OO 3.96E+01 XE133 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.85E+OO 1.84E+01 XE135m 6.91E+01 6.91E+01 6.91 E+01 6.91 E+01 6.91E+01 6.91E+01 6.94E+01 1.05E+02 XE135 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 XE137 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.55E+01 4.25E+02 XE138 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.97E+02 3.58E+02 CR51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR 95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SB124 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC ODAM Page 127of196 Rev. 000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= TEENAGER PATHWAY = INHALATION TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 3~/~Ci sec~
H 3 2.30E+01 2.30E+01 O.OOE-01 2.30E+01 2.30E+01 2.30E+01 2.30E+01 2.30E+01 c 14 1.54E+02 1.54E+02 8.24E+02 1.54E+02 1.54E+02 1.54E+02 1.54E+02 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 4.28E+OO 9.51 E+01 O.OOE-01 O.OOE-01 9.73E-01 2.38E+OO 6.65E+02 O.OOE-01 MN54 2.66E+02 2.12E+03 O.OOE-01 1.62E+03 4.02E+02 O.OOE-01 6.27E+04 O.OOE-01 FE55 1.75E+02 2.02E+02 1.06E+03 7.55E+02 O.OOE-01 O.OOE-01 3.94E+03 O.OOE-01 FE59 4.53E+02 5.64E+03 5.04E+02 1.17E+03 O.OOE-01 O.OOE-01 4.85E+04 O.OOE-01 C058 8.81E+01 3.02E+03 O.OOE-01 6.56E+01 O.OOE-01 O.OOE-01 4.25E+04 O.OOE-01 C060 6.27E+02 8.21E+03 O.OOE-01 4.79E+02 O.OOE-01 O.OOE-01 2.76E+05 O.OOE-01 ZN 65 1.98E+03 1.48E+03 1.22E+03 4.25E+03 2.74E+03 O.OOE-01 3.93E+04 O.OOE-01 SR89 3.96E+02 1.18E+04 1.38E+04 O.OOE-01 O.OOE-01 O.OOE-01 7.67E+04 O.OOE-01 SR90 2.11E+04 2.42E+04 1.05E+06 O.OOE-01 O.OOE-01 O.OOE-01 5.23E+05 O.OOE-01 ZR95 9.98E+02 4.72E+03 4.63E+03 1.45E+03 2.14E+03 O.OOE-01 8.52E+04 O.OOE-01 SB124 5.32E+02 1.26E+04 1.37E+03 2.52E+01 O.OOE-01 3.09E+OO 1.22E+05 O.OOE-01 CS134 1.74E+04 3.09E+02 1.59E+04 3.58E+04 1.19E+04 O.OOE-01 4.63E+03 O.OOE-01 CS136 4.34E+03 3.45E+02 1.63E+03 6.15E+03 3.49E+03 O.OOE-01 5.64E+02 O.OOE-01 CS137 9.86E+03 2.69E+02 2.13E+04 2.69E+04 9.63E+03 O.OOE-01 3.83E+03 O.OOE-01 BA140 1.12E+02 7.26E+03 1.73E+03 2.13E+OO 7.23E-01 O.OOE-01 6.43E+04 O.OOE-01 CE141 6.88E+01 3.99E+03 9.00E+02 6.02E+02 2.81E+02 O.OOE-01 1.95E+04 O.OOE-01 CE144 8.33E+03 2.74E+04 1.55E+05 6.40E+04 3.83E+04 O.OOE-01 4.25E+05 O.OOE-01 1131 8.37E+02 2.06E+02 1.12E+03 1.56E+03 2.66E+03 4.63E+05 O.OOE-01 O.OOE-01 I 133 1.97E+02 3.26E+02 3.87E+02 6.50E+02 1.14E+03 9.25E+04 O.OOE-01 O.OOE-01 DAEC ODAM Page 128of196 Rev. 000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
=
TEENAGER PATHWAY
=
GROUND PLANE TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN mrem m2 /Ci H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.74E+05 MN 54 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 5.13E+07 FE 55 1.06E+06 3.10E+05 5.57E+06 1.69E+06 O.OOE-01 O.OOE-01 O.OOE-01 3.22E+06 FE59 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 1.01E+07 C058 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.41E+07 C060 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 8.02E+08 ZN 65 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.72E+07 SR89 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 7.95E+02 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 9.03E+06 SB124 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 2.19E+07 CS134 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.53E+08 CS136 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 5.39E+06 CS137 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.80E+08 BA140 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 7.45E+05 CE141 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.88E+05 CE144 2.21E+06 2.21E+06 2.21E+06 2.21 E+06 2.21E+06 2.21 E+06 2.21E+06 2.55E+06 1131 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 3.33E+05 I 133 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 4.72E+04 DAEC ODAM Page 129of196 Rev.ODO
AGE
= TEENAGER DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II PATHWAY = ANIMAL MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID mrem m2 /Ci H 3 3.55E+OO 3.55E+OO O.OOE-01 3.55E+OO 3.55E+OO 3.55E+OO c 14 1.80E+03 1.80E+03 9.00E+03 1.80E+03 1.80E+03 1.80E+03 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 1.59E+02 2.68E+04 O.OOE-01 O.OOE-01 3.49E+01 8.84E+01 MN 54 3.52E+04 3.64E+05 O.OOE-01 1.77E+05 5.29E+04 O.OOE-01 FE 55 6.14E+05 1.13E+06 3.72E+06 2.64E+06 O.OOE-01 O.OOE-01 FE 59 5.20E+06 3.17E+07 5.77E+06 1.35E+07 O.OOE-01 O.OOE-01 C058 8.56E+05 5.10E+06 O.OOE-01 3.71E+05 O.OOE-01 O.OOE-01 C060 3.30E+06 1.91 E+07 O.OOE-01 1.46E+06 O.OOE-01 O.OOE-01 ZN 65 1.16E+07 1.05E+07 7.13E+06 2.47E+07 1.58E+07 O.OOE-01 SR89 2.12E+05 8.81E+05 7.38E+06 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 2.57E+07 2.93E+07 1.28E+09 O.OOE-01 O.OOE-01 O.OOE-01 ZR 95 8.62E+03 2.90E+07 3.99E+04 1.25E+04 1.84E+04 O.OOE-01 SB124 1.68E+05 8.68E+06 4.31E+05 7.95E+03 O.OOE-01 9.76E+02 CS134 1.44E+07 3.87E+05 1.32E+07 3.10E+07 9.86E+06 O.OOE-01 CS136 7.48E+05 8.94E+04 2.83E+05 1.11E+06 6.05E+05 O.OOE-01 CS137 8.94E+06 3.64E+05 1.93E+07 2.57E+07 8.75E+06 O.OOE-01 BA140 4.63E+04 1.11E+06 7.19E+05 8.81E+02 2.99E+02 O.OOE-01 CE141 2.52E+01 6.27E+05 3.30E+02 2.20E+02 1.03E+02 O.OOE-01 CE144 1.65E+03 7.73E+06 3.08E+04 1.27E+04 7.61E+03 O.OOE-01 1131 1.05E+05 3.83E+04 1.39E+05 1.95E+05 3.36E+05 5.67E+07 I 133 2.54E-03 6.31 E-03 4.91E-03 8.30E-03 1.46E-02 1.16E+OO DAECODAM Page 130of196 Appendix A LUNG SKIN 3.55E+OO 3.55E+OO 1.80E+03 1.80E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 2.28E+02 O.OOE-01 O.OOE-01 O.OOE-01 1.67E+06 O.OOE-01 4.25E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 3.77E+05 O.OOE-01 3.77E+06 O.OOE-01 9.54E+04 O.OOE-01 3.39E+06 O.OOE-01 5.93E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Rev.ODO
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= TEENAGER PATHWAY = VEGETABLES TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN mrem m2 /Ci H 3 4.72E+01 4.72E+01 O.OOE-01 4.72E+01 4.72E+01 4.72E+01 4.72E+01 4.72E+01 c 14 9.32E+03 9.32E+03 4.66E+04 9.32E+03 9.32E+03 9.32E+03 9.32E+03 9.32E+03 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 1.93E+03 3.23E+05 O.OOE-01 O.OOE-01 4.21E+02 1.07E+03 2.75E+03 O.OOE-01 MN 54 2.81E+06 2.91E+07 O.OOE-01 1.42E+07 4.21 E+06 O.OOE-01 O.OOE-01 O.OOE-01 FE55 5.92+05 1.10E+06 3.59E+06 2.54E+06 O.OOE-01 O.OOE-01 1.61E+06 O.OOE-01 FE59 5.01E+06 3.07E+07 5.58E+06 1.30E+07 O.OOE-01 O.OOE-01 4.09E+06 O.OOE-01 C058 3.11E+06 1.86E+07 O.OOE-01 1.35E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 1.77E+07 1.02E+08 O.OOE-01 7.86E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 2.75E+07 2.50E+07 1.70E+07 5.89E+07 3.77E+07 O.OOE-01 O.OOE-01 O.OOE-01 SR89 1.39E+07 5.80E+07 4.88E+08 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 1.66E+09 1.90E+09 8.33E+10 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR 95 1.15E+04 3.87E+07 5.32E+04 1.68E+04 2.47E+04 O.OOE-01 O.OOE-01 O.OOE-01 SB124 1.87E+06 9.63E+07 4.79E+06 8.81E+04 O.OOE-01 1.09E+04 4.18E+06 O.OOE-01 CS134 2.45E+08 6.56E+06 2.24E+08 5.29E+08 1.68E+08 O.OOE-01 6.40E+07 O.OOE-01 CS136 3.64E+06 4.37E+05 1.38E+06 5.42E+06 2.95E+06 O.OOE-01 4.66E+05 O.OOE-01 CS137 1.70E+08 6.94E+06 3.68E+08 4.88E+08 1.66E+08 O.OOE-01 6.43E+07 O.OOE-01 BA140 2.82E+05 6.75E+06 4.37E+06 5.36E+03 1.82E+03 O.OOE-01 3.61E+03 O.OOE-01 CE141 6.78E+02 1.69E+07 8.84E+03 5.89E+03 2.78E+03 O.OOE-01 O.OOE-01 O.OOE-01 CE144 8.62E+04 4.02E+08 1.60E+06 6.62E+05 3.96E+05 O.OOE-01 O.OOE-01 O.OOE-01 1131 9.16E+05 3.36E+05 1.22E+06 1.70E+06 2.93E+06 4.98E+08 O.OOE-01 O.OOE-01 1133 1.58E+04 3.93E+04 3.06E+04 5.20E+04 9.13E+04 7.26E+06 O.OOE-01 O.OOE-01 DAECODAM Page 131of196 Rev.ODO
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
=
TEENAGER PATHWAY =
PLUME TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 3~/~Ci sec~
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 3.14E+02 KR83m 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.38E-02 4.75E-01 KR85m 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.67E+01 KR85 3.58E-01 3.58E-01 3.58E-01 3.58E-01 3.58E-01 3.58E-01 9.51E-01 4.28E+01 KR87 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.35E+02 4.60E+02 KR88 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 4.50E+02 KR89 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.71E+02 7.48E+02 KR90 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 XE131m 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.38E+OO 1.89E+01 XE133m 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 6.02E+OO 3.96E+01 XE133 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.85E+OO 1.84E+01 XE135m 6.91E+01 6.91E+01 6.91E+01 6.91E+01 6.91E+01 6.91E+01 6.94E+01 1.05E+02 XE135 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 XE137 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.55E+01 4.25E+02 XE138 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.97E+02 3.58E+02 CR51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SB124 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC ODAM Page 132 of 196 Rev.000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= CHILD PATHWAY = INHALATION TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 3~/~Ci sec~
H 3 2.03E+01 2.03E+01 O.OOE-01 2.03E+01 2.03E+01 2.03E+01 2.03E+01 2.03E+01 c 14 2.13E+02 2.13E+02 1.14E+03 2.13E+02 2.13E+02 2.13E+02 2.13E+02 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 4.88E+OO 3.42E+01 O.OOE-01 O.OOE-01 7.70E-01 2.71E+OO 5.39E+02 O.OOE-01 MN54 3.01E+02 7.26E+02 O.OOE-01 1.36E+03 3.17E+02 O.OOE-01 5.01E+04 O.OOE-01 FE 55 2.46E+02 9.09E+02 1.50E+03 7.97E+02 O.OOE-01 O.OOE-01 3.52E+03 O.OOE-01 FE 59 5.29E+02 2.24E+03 6.56E+02 1.06E+03 O.OOE-01 O.OOE-01 4.02E+04 O.OOE-01 C058 1.00E+02 1.09E+03 O.OOE-01 5.61E+01 O.OOE-01 O.OOE-01 3.52E+04 O.OOE-01 C060 7.19E+02 3.05E+03 O.OOE-01 4.15E+02 O.OOE-01 O.OOE-01 2.24E+05 O.OOE-01 ZN 65 2.23E+03 5.17E+02 1.35E+03 3.58E+03 2.26E+03 O.OOE-01 3.16E+04 O.OOE-01 SR89 5.45E+02 5.29E+03 1.90E+04 O.OOE-01 O.OOE-01 O.OOE-01 6.85E+04 O.OOE-01 SR 90 2.43E+04 1.09E+04 1.22E+06 O.OOE-01 O.OOE-01 O.OOE-01 4.69E+05 O.OOE-01 ZR95 1.17E+03 1.94E+03 6.02E+03 1.32E+03 1.89E+03 O.OOE-01 7.07E+04 O.OOE-01 SB124 6.34E+02 5.20E+03 1.82E+03 2.35E+01 O.OOE-01 3.99E+OO 1.03E+05 O.OOE-01 CS134 7.13E+03 1.22E+02 2.06E+04 3.20E+04 1.05E+04 O.OOE-01 3.83E+03 O.OOE-01 CS136 3.68E+03 1.32E+02 2.06E+03 5.42E+03 3.03E+03 O.OOE-01 4.60E+02 O.OOE-01 CS137 4.06E+03 1.15E+02 2.87E+04 2.61E+04 8.94E+03 O.OOE-01 3.30E+03 O.OOE-01 BA140 1.37E+02 3.23E+03 2.35E+03 2.05E+OO 6.69E-01 O.OOE-01 5.51E+04 O.OOE-01 CE141 9.19E+01 1.79E+03 1.24E+03 6.18E+02 2.71E+02 O.OOE-01 1.72E+04 O.OOE-01 CE144 1.15E+04 1.23E+04 2.15E+05 6.72E+04 3.71E+04 O.OOE-01 3.80E+05 O.OOE-01 I 131 8.65E+02 9.00E+01 1.52E+03 1.52E+03 2.50E+03 5.17E+05 O.OOE-01 O.OOE-01 I 133 2.44E+02 1.74E+02 5.26E+02 6.43E+02 1.07E+03 1.22E+05 O.OOE-01 O.OOE-01 DAEC ODAM Page 133of196 Rev.ODO
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= CHILD PATHWAY = GROUND PLANE TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN mrem m2 /Ci H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.74E+05 MN 54 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 5.13E+07 FE 55 1.23E+06 3.52E+05 6.03E+06 1.98E+06 O.OOE-01 O.OOE-01 3.86E+06 O.OOE-01 FE 59 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 1.01E+07 C058 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.41E+07 C060 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 8.02E+08 ZN 65 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.72E+07 SR 89 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 7.95E+02 SR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 9.03E+06 SB124 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 2.19E+07 CS134 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.53E+08 CS136 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 5.39E+06 CS137 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.80E+08 BA140 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 7.45E+05 CE141 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.88E+05 CE144 2.21E+06 2.21E+06 2.21E+06 2.21E+06 2.21E+06 2.21E+06 2.21E+06 2.55E+06 1131 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 3.33E+05 I 133 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 4.72E+04 DAEC ODAM Page 134of196 Rev. 000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
=
CHILD PATHWAY =
ANIMAL MEAT TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN mrem m2 /Ci H 3 4.28E+OO 4.28E+OO O.OOE-01 4.28E+OO 4.28E+OO 4.28E+OO 4.28E+OO 4.28E+OO c 14 3.39E+03 3.39E+03 1.69E+04 3.39E+03 3.39E+03 3.39E+03 3.39E+03 3.39E+03 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 2.48E+02 1.32E+04 O.OOE-01 O.OOE-01 3.77E+01 1.38E+02 2.52E+02 O.OOE-01 MN54 5.39E+04 1.70E+05 O.OOE-01 2.02E+05 5.67E+04 O.OOE-01 O.OOE-01 O.OOE-01 FE55 1.17E+06 6.99E+05 7.11E+06 3.77E+06 O.OOE-01 O.OOE-01 2.14E+06 O.OOE-01 FE59 8.24E+06 1.72E+07 1.02E+07 1.65E+07 O.OOE-01 O.OOE-01 4.79E+06 O.OOE-01 C058 1.32E+06 2.53E+06 O.OOE-01 4.34E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 5.13E+06 9.63E+06 O.OOE-01 1.74E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN65 1.77E+07 5.01E+06 1.07E+07 2.85E+07 1.80E+07 O.OOE-01 O.OOE-01 O.OOE-01 SR89 3.99E+05 5.42E+05 1.40E+07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 4.09E+07 1.82E+07 2.03E+09 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 1.38E+04 1.62E+07 7.07E+04 1.55E+04 2.22E+04 O.OOE-01 O.OOE-01 O.OOE-01 SB124 2.73E+05 4.88E+06 7.80E+05 1.01E+04 O.OOE-01 1.72E+03 4.34E+05 O.OOE-01 CS134 8.05E+06 2.06E+05 2.33E+07 3.80E+07 1.18E+07 O.OOE-01 4.25E+06 O.OOE-01 CS136 8.68E+05 4.72E+04 4.88E+05 1.34E+06 7.13E+05 O.OOE-01 1.06E+05 O.OOE-01 CS137 5.01E+06 2.13E+05 3.55E+07 3.39E+07 1.11E+07 O.OOE-01 3.99E+06 O.OOE-01 BA140 7.76E+04 6.72E+05 1.33E+06 1.16E+03 3.80E+02 O.OOE-01 6.94E+02 O.OOE-01 CE141 4.60E+01 3.87E+05 6.21E+02 3.09E+02 1.36E+02 O.OOE-01 O.OOE-01 O.OOE-01 CE144 3.10E+03 4.75E+06 5.80E+04 1.82E+04 1.01E+04 O.OOE-01 O.OOE-01 O.OOE-01 1131 1.47E+05 2.31E+04 2.58E+05 2.59E+05 4.25E+05 8.56E+07 O.OOE-01 O.OOE-01 I 133 4.25E-03 4.53E-03 9.10E-03 1.12E-02 1.88E-02 2.09E+OO O.OOE-01 O.OOE-01 DAEC ODAM Page 135of196 Rev.000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= CHILD PATHWAY = VEGETABLES TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 2~/Ci H 3 7.32E+01 7.32E+01 O.OOE-01 7.32E+01 7.32E+01 7.32E+01 7.32E+01 7.32E+01 c 14 2.24E+04 2.24E+04 1.12E+05 2.24E+04 2.24E+04 2.24E+04 2.24E+04 2.24E+04 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR 87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 3.68E+03 1.94E+05 O.OOE-01 O.OOE-01 5.55E+02 2.03E+03 3.71E+03 O.OOE-01 MN54 5.51E+06 1.74E+07 O.OOE-01 2.07E+07 5.80E+06 O.OOE-01 O.OOE-01 O.OOE-01 FE55 1.41E+06 8.45E+05 8.57E+06 4.57E+06 O.OOE-01 O.OOE-01 2.59E+06 O.OOE-01 FE 59 9.95E+06 2.08E+07 1.23E+07 2.00E+07 O.OOE-01 O.OOE-01 5.80E+06 O.OOE-01 C058 6.08E+06 1.16E+07 O.OOE-01 1.99E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 3.52E+07 6.62E+07 O.OOE-01 1.19E+07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 5.39E+07 1.52E+07 3.26E+07 8.68E+07 5.45E+07 O.OOE-01 O.OOE-01 O.OOE-01 SR89 3.30E+07 4.47E+07 1.16E+09 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 3.39E+09 1.51E+09 1.69E+11 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 2.33E+04 2.73E+07 1.19E+05 2.62E+04 3.74E+04 O.OOE-01 O.OOE-01 O.OOE-01 SB124 3.83E+06 6.81E+07 1.09E+07 1.42E+05 O.OOE-01 2.41E+04 6.05E+06 O.OOE-01 CS134 1.75E+08 4.47E+06 5.07E+08 8.30E+08 2.58E+08 O.OOE-01 9.25E+07 O.OOE-01 CS136 4.63E+06 2.50E+05 2.59E+06 7.13E+06 3.80E+06 O.OOE-01 5.67E+05 O.OOE-01 CS137 1.22E+08 5.20E+06 8.65E+08 8.27E+08 2.70E+08 O.OOE-01 9.70E+07 O.OOE-01 BA140 5.10E+05 4.44E+06 8.78E+06 7.67E+03 2.50E+03 O.OOE-01 4.56E+03 O.OOE-01 CE141 1.52E+03 1.27E+07 2.05E+04 1.02E+04 4.47E+03 O.OOE-01 O.OOE-01 O.OOE-01 CE144 2.06E+05 3.16E+08 3.87E+06 1.21E+06 6.69E+05 O.OOE-01 O.OOE-01 O.OOE-01 I 131 1.29E+06 2.03E+05 2.27E+06 2.28E+06 3.74E+06 7.54E+08 O.OOE-01 O.OOE-01 I 133 2.61E+04 2.78E+04 5.58E+04 6.91E+04 1.15E+05 1.28E+07 O.OOE-01 O.OOE-01 DAEC ODAM Page 136of196 Rev.ODO
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= CHILD PATHWAY = PLUME TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 3~/~Ci sec~
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 3.14E+02 KR83m 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.38E-02 4.75E-01 KR85m 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.67E+01 KR85 3.58E-01 3.58E-01 3.58E-01 3.58E-01 3.58E-01 3.58E-01 9.51E-01 4.28E+01 KR 87 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.35E+02 4.60E+02 KR 88 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 4.50E+02 KR89 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.71E+02 7.48E+02 KR90 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 XE131m 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.38E+OO 1.89E+01 XE133m 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 6.02E+OO 3.96E+01 XE133 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.85E+OO 1.84E+01 XE135m 6.91E+01 6.91E+01 6.91E+01 6.91E+01 6.91E+01 6.91E+01 6.94E+01 1.05E+02 XE135 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 XE137 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.55E+01 4.25E+02 XE138 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.97E+02 3.58E+02 CR51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SB124 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 0.00E-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1131 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC ODAM Page 137of196 Rev.000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= INFANT PATHWAY = INHALATION TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 3~/~Ci sec~
H 3 1.17E+01 1.17E+01 O.OOE-01 1.17E+01 1.17E+01 1.17E+01 1.17E+01 1.17E+01 c 14 1.68E+02 1.68E+02 8.39E+02 1.68E+02 1.68E+02 1.68E+02 1.68E+02 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 2.84E+OO 1.13E+01 0.00E-01 O.OOE-01 4.18E-01 1.83E+OO 4.06E+02 O.OOE-01 MN 54 1.58E+02 2.24E+02 O.OOE-01 8.05E+02 1.58E+02 O.OOE-01 3.17E+04 O.OOE-01 FE 55 1.05E+02 3.47E+01 6.27E+02 3.72E+02 O.OOE-01 O.OOE-01 2.77E+03 0.00E-01 FE59 3.00E+02 7.86E+02 4.31E+02 7.45E+02 O.OOE-01 O.OOE-01 3.23E+04 O.OOE-01 C058 5.77E+01 3.52E+02 O.OOE-01 3.87E+01 O.OOE-01 O.OOE-01 2.46E+04 O.OOE-01 C060 3.74E+02 1.01E+03 O.OOE-01 2.54E+02 O.OOE-01 O.OOE-01 1.43E+05 O.OOE-01 ZN 65 9.86E+02 1.63E+03 6.12E+02 1.98E+03 1.03E+03 O.OOE-01 2.05E+04 O.OOE-01 SR89 3.61 E+02 2.03E+03 1.26E+04 O.OOE-01 O.OOE-01 O.OOE-01 6.43E+04 O.OOE-01 SR90 9.89E+03 4.15E+03 4.91E+05 O.OOE-01 O.OOE-01 O.OOE-01 3.55E+05 O.OOE-01 ZR95 6.43E+02 6.88E+02 3.64E+03 8.84E+02 9.86E+02 O.OOE-01 5.55E+04 O.OOE-01 SB124 3.80E+02 1.87E+03 1.20E+03 1.76E+01 O.OOE-01 3.20E+OO 8.40E+04 O.OOE-01 CS134 2.36E+03 4.21E+01 1.25E+04 2.23E+04 6.02E+03 O.OOE-01 2.53E+03 O.OOE-01 CS136 1.68E+03 4.53E+01 1.53E+03 4.28E+03 1.79E+03 O.OOE-01 3.74E+02 O.OOE-01 CS137 1.44E+03 4.21 E+01 1.74E+04 1.94E+04 5.45E+03 O.OOE-01 2.26E+03 O.OOE-01 BA140 9.19E+01 1.22E+03 1.77E+03 1.77E+OO 4.25E-01 O.OOE-01 5.07E+04 O.OOE-01 CE141 6.31E+01 6.85E+02 8.78E+02 5.29E+02 1.66E+02 O.OOE-01 1.64E+04 O.OOE-01 CE144 5.58E+03 4.69E+03 1.01 E+05 3.83E+04 1.70E+04 O.OOE-01 3.12E+05 O.OOE-01 1131 6.21E+02 3.36E+01 1.20E+03 1.41E+03 1.64E+03 4.69E+05 O.OOE-01 O.OOE-01 I 133 1.77E+02 6.85E+01 4.18E+02 6.08E+02 7.10E+02 1.13E+05 O.OOE-01 O.OOE-01 DAEC ODAM Page 138of196 Rev.000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= INFANT PATHWAY = GROUND PLANE TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 2~/Ci H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.47E+05 1.74E+05 MN54 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 4.37E+07 5.13E+07 FE55 9.79E+05 3.84E+05 3.90E+06 1.44E+06 O.OOE-01 O.OOE-01 2.39E+06 O.OOE-01 FE59 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 8.65E+06 1.01E+07 C058 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.41E+07 C060 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 6.81E+08 8.02E+08 ZN 65 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.36E+07 2.72E+07 SR89 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 6.85E+02 7.95E+02 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR 95 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 7.76E+06 9.03E+06 SB124 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 1.90E+07 2.19E+07 CS134 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.17E+08 2.53E+08 CS136 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 4.75E+06 5.39E+06 CS137 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.26E+08 3.80E+08 BA140 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 6.50E+05 7.45E+05 CE141 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.34E+05 4.88E+05 CE144 2.21E+06 2.21E+06 2.21E+06 2.21 E+06 2.21E+06 2.21E+06 2.21E+06 2.55E+06 1131 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 2.73E+05 3.33E+05 1133 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 3.90E+04 4.72E+04 DAEC ODAM Page 139of196 Rev.ODO
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= INFANT PATHWAY = ANIMAL MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN mrem m2 /Ci H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR 87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 MN 54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SB124 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC ODAM Page 140of196 Rev. 000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= INFANT PATHWAY = VEGETABLES TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 2~/Ci H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR83m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR87 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 KR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE131m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135m O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 XE138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 CR51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 FE55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 ZR95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SB124 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC ODAM Page 141of196 Rev.000
Appendix A DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT AIR Computed by GASPAR II AGE
= INFANT PATHWAY = PLUME TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN
~mrem m 3~/~Ci sec~
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AR41 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 3.14E+02 KR83m 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.38E-02 4.75E-01 KR85m 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.67E+01 KR85 3.58E-01 3.58E-01 3.58E-01 3.58E-01 3.58E-01 3.58E-01 9.51E-01 4.28E+01 KR87 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.35E+02 4.60E+02 KR88 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 4.50E+02 KR89 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.71E+02 7.48E+02 KR90 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 XE131m 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.03E+OO 2.38E+OO 1.89E+01 XE133m 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 5.58E+OO 6.02E+OO 3.96E+01 XE133 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.53E+OO 6.85E+OO 1.84E+01 XE135m 6.91E+01 6.91E+01 6.91E+01 6.91E+01 6.91E+01 6.91E+01 6.94E+01 1.05E+02 XE135 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 XE137 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.55E+01 4.25E+02 XE138 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.97E+02 3.58E+02 CR51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SB124 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAECODAM Page 142of196 Rev.ODO
Appendix B APPENDIX B: TECHNICAL BASES FOR EFFECTIVE DOSE FACTORS Overview The evaluation of doses due to releases of radioactive material to the atmosphere can be simplified by the use of effective dose transfer factors instead of using dose factors which are radionuclide specific.
These effective factors, which are based on the total radioactivity released to approximate the dose in the environment, i.e., instead of having to sum the isotopic distribution multiplied by the isotope specific dose factor only a single multiplication times the total quantity of radioactive material released would be needed. This approach provides a reasonable estimate of the actual dose while eliminating the need for a detailed calculational technique.
Determination of Effective Dose Factors The effective dose transfer factors are based on past operating data. The radioactive effluent distribution for the past years can be used to derive single effective factors by the following equations:
where f
=
i where Arveff =
DAEC ODAM the effective gamma-air dose factor due to stack releases of noble gases (mrad/µCi) the gamma-air dose factor due to stack releases of each noble gas radionuclide i (mrad/µCi) the fraction of noble gas radioactivity constituted by radionuclide i Ayveff the effective gamma-air dose factor due to vent releases of all noble gases
(
mrad
)
µCi sec/ m3 the gamma-air dose factor due to vent releases of each noble gas
(
mrad
)
radionuclide i 3
µCi sec/ m Page 143 of 196 Rev.000
Appendix B where A /Jeff =
the effective beta-air dose factor due to either vent or stack releases of all noble
(
mrad
)
gases 3
µCi sec/ m A/3; =
the beta air dose factor due to either vent or stack releases of each noble gas
(
mrad
)
radionuclide i 3
µCi sec/ m To determine the appropriate effective factors to be used and to evaluate the degree of variability, the atmospheric radioactive effluents for the past 3 years have been evaluated.
Table B-1 presents the radionuclide distribution for stack and vent releases as measured by isotopic analysis of periodic grab samples from the respective effluent release points. Table B-2 presents the effective dose factors (gamma-air and beta-air) derived on the basis of the radionuclide distribution.
Except for the year 1981, the variability of the effective factors is minor. For 1981, Xe-138 contributes significantly to the derivation of the effective factors for stack releases. The Xe-138 contribution for the years 1979 and 1980 is not so significant. This increase in Xe-138 from 1981 results in a larger variability of the yearly values from the average than what is considered typical. Therefore, in order to assure adequate conservatism, the effective dose factors for stack releases will be based on the radionuclide distribution for the year 1981. Because this is considered an atypical distribution resulting in higher doses, use of the data will provide dose estimates which are conservative. As more data become available to further establish a typical radionuclide distribution, the effective dose factors for stack releases may be reevaluated.
To provide an additional degree of conservatism, a factor of 0.8 is introduced into the dose calculational process when the effective dose transfer factor is used. This added conservatism provides additional assurance that the evaluation of doses by the use of a single effective factor will not significantly underestimate any actual doses in the environment.
By evaluating doses using these effective dose factors, maximum allowable releases of noble gases for any calendar quarter may be determined. As discussed in Section 3.6.1, the maximum allowable releases based on the gamma-air effective dose factor have been determined to be 250,000 Ci/quarter for stack releases and 12,700 Ci/quarter for vent releases.
For the beta air effective dose factors, the releases of noble gases corresponding to the quarterly limit of 1 O mrads corresponds to 307,000 Ci/quarter for stack releases and 29,600 Ci/quarter for vent releases. Comparing these values for allowable releases with the values based on the gamma-air effective dose factors, it is demonstrated that the gamma-air doses are more restrictive than the beta-air doses. In other words, the doses calculated by using the gamma-air effective dose factors represent a larger fraction of the allowable dose than does the dose calculated by using the beta-air effective dose factors. Therefore, when using the effective dose factors for evaluating compliance with the quarterly dose limits of Section 6.2.3, only the gamma-air dose need be evaluated; compliance with the gamma-air dose limit represents a de facto compliance with the beta-air dose limit.
DAECODAM Page 144of196 Rev. 000
Appendix B Reevaluation The doses due to the gaseous effluents are evaluated by the more detailed calculational methods (i.e.,
use of nuclide specific dose factors) on a yearly basis. At that time, a comparison can be made between the simplified method and the detailed method to assure the overall reasonableness of this limited analysis approach. If the comparison indicates that the radionuclide distribution has changed significantly, thereby causing the simplified method to underestimate the doses, the value of the effective factors will need to be reexamined to assure the overall acceptability of this approach.
However, this reexamination will only be needed if the doses as calculated by the detailed analysis exceed 50% of the design bases doses (i.e., greater than 50% of the 1 O mrad gamma air dose or 20 mrad beta air dose).
DAEC ODAM Page 145 of 196 Rev.000
Appendix B Table B-1 RADIONUCLIDE DISTRIBUTION OF STACK AND VENT RELEASES Radionuclide Fraction of Total Releases Stack Vent 1979 1980 1981 1979 1980 1981 Kr-8!?m
.11
.05
.09
.02 Kr-87
.01
.02
.01 Kr-88
.07
.04
.08 Xe-133
.76
.82
.45
.24
.24
.14 Xe-135
.01
.02
.03
.72
.50
.59 Xe-135m
.02
.08
.02
.22
.21 Xe-138
.02
.06
.25
.03
.05 Table B-2 EFFECTIVE DOSE FACTORS NOBLE GASES - AIR DOSES Year Stack Releases Vent Releases Gamma-Air Beta-Air Gamma-Air Beta-Air Effective Dose Effective Dose Effective Dose Effective Dose Factor Factor Factor Factor Arseff A/Js~ff Arveff A/Jveff
( mra~)
(
mrad
)
(
mrad
)
µCi sec/ m3
(
mrad
)
µCl
µCi sec/ m3
µCi sec/ m3 1979 7.0x10*12 5.9x10*5 5.0x10*5 6.5x10*5 1980 6.7x10*12 5.3x10*5 6.7x10*5 6.0x10*5 1981 1.6x10*11 9.3x10*12 6.4x10"5 6.3x10*5 Average 9.9x10*12 6.8x10"5 6.4x10*5 6.3x10"5 DAEC ODAM Page 146 of 196 Rev. 000
Appendix C APPENDIX C: DOSE TRANSFER FACTORS FOR WATERBORNE PATHWAYS Dose transfer factors for waterborne effluent have been derived by solving environmental pathway models on the bases of unit radionuclide release in effluent (1 Ci/yr) discharged in 1 gallon/minute of water. The dose transfer factors in this appendix were computed with the LADTAP II computer program, using default values of parameters applicable to the most exposed members of the public as recommended in Regulatory 1.109, revision 1, with the following exceptions:
In order to account for significant revisions of data since publication of the Regulatory Guide, data differing from those in Regulatory Guide 1.109, revision 1 are identified in LADTAP II documentation. 15 After publishing Reg. Guide 1.109, the NRC recommended that soil-to-plant bioaccumulation factors, Biv, of cesium and strontium be changed. 16 The revised values were used to derive dose transfer factors tabulated for Sr89, Sr90, and Cs137 in irrigated vegetation.
Values of environmental transit time recommended in Reg. Guide 1.10917, namely 1440 hr from harvest of stored vegetables to ingestion, were retained.
LADT AP 11 divergence from Reg. Guide 1.109 is reflected in tritium dose transfer factors that are typically 43% lower than those described in the Reg. Guide.
Dose transfer factors are included hereafter for the following parameters. Only those pathways applicable at the time of a radioactive liquid effluent release will be used for dose calculations.
Likely pathways would include potable water, freshwater fish and irrigated fresh leafy vegetables (including strawberries).
15 16 17 Strenge, D.L., et. al., LADTAP II - Technical Reference and User guide, NUREG/CR-4013, April 1986.
NRC, SECY-79-653A, January 30, 1980.
Regulatory Guide 1.109, rev. 1, Table E-15.
DAEC ODAM Page 147of196 Rev. 000
Appendix C Pathway Age Group Organ Potable water Adult Total Body Freshwater fish Teenager GI tract Animal drinks river water-milk Animal drinks river water-meat River shoreline deposits-irradiation Swimming Boating DAEC ODAM Page 148of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
ADULT PATHWAY
=
POTABLE WATER TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 2.19E+01 2.19E+01 O.OOE-01 2.19E+01 2.19E+01 2.19E+01 2.19E+01 O.OOE-01 c 14 2.08E+02 2.08E+02 1.04E+03 2.08E+02 2.08E+02 2.08E+02 2.08E+02 O.OOE-01 NA24 2.06E+02 2.06E+02 2.06E+02 2.06E+02 2.06E+02 2.06E+02 2.06E+02 O.OOE-01 p 32 2.60E+03 7.57E+03 6.73E+04 4.19E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 9.50E-01 2.39E+02 O.OOE-01 O.OOE-01 2.09E-01 5.68E-01 1.26E+OO O.OOE-01 MN54 3.19E+02 5.12E+03 O.OOE-01 1.67E+03 4.97E+02 O.OOE-01 O.OOE-01 O.OOE-01 MN56 1.15E-02 2.06E+OO O.OOE-01 6.46E-02 8.20E-02 O.OOE-01 0.00E-01 O.OOE-01 FE55 1.62E+02 3.99E+02 1.01E+03 6.95E+02 O.OOE-01 O.OOE-01 3.88E+02 O.OOE-01 FE59 1.41E+03 1.23E+04 1.56E+03 3.68E+03 O.OOE-01 O.OOE-01 1.03E+03 O.OOE-01 C058 6.06E+02 5.48E+03 O.OOE-01 2.70E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 1.73E+03 1.47E+04 O.OOE-01 7.84E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 1.60E+03 6.89E+02 4.76E+04 3.30E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 N165 1.56E-02 8.66E-01 2.63E-01 3.42E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CU64 3.85E+OO 6.99E+02 O.OOE-01 8.21E+OO 2.07E+01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 2.54E+03 3.54E+03 1.77E+03 5.62E+03 3.76E+03 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 1.21E-08 2.62E-08 9.11 E-08 1.74E-07 1.13E-07 O.OOE-01 O.OOE-01 O.OOE-01 BR83 1.40E-02 2.02E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 3.47E+03 1.47E+03 O.OOE-01 7.45E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 89 3.19E+03 1.78E+04 1.11E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 6.41E+04 8.02E+04 3.19E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 1.45E+01 1.71E+03 3.59E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 7.38E-02 3.38E+01 1.71E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 7.29E-02 2.88E+04 2.72E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 1.37E+OO 2.81E+04 5.10E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 8.37E-05 5.02E+01 2.86E-03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 5.20E-03 5.98E+03 1.89E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 2.39E+OO 1.12E+04 1.10E+01 3.53E+OO 5.54E+OO O.OOE-01 O.OOE-01 O.OOE-01 ZR97 2.12E-02 1.44E+04 2.30E-01 4.64E-02 7.00E-02 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 6.68E-01 7.54E+03 2.23E+OO 1.24E+OO 1.23E+OO O.OOE-01 O.OOE-01 O.OOE-01 M099 2.33E+02 2.84E+03 O.OOE-01 1.23E+03 2.78E+03 O.OOE-01 O.OOE-01 O.OOE-01 TC99M 2.05E-01 9.53E+OO 5.70E-03 1.61E-02 2.45E-01 O.OOE-01 7.89E-03 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 149of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
ADULT PATHWAY
=
POTABLE WATER TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 2.87E+01 7.77E+03 6.66E+01 O.OOE-01 2.54E+02 O.OOE-01 O.OOE-01 O.OOE-01 RU105 5.24E-02 8.12E+01 1.33E-01 O.OOE-01 1.72E+OO O.OOE-01 O.OOE-01 O.OOE-01 RU106 1.27E+02 6.51E+04 1.00E+03 O.OOE-01 1.94E+03 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 3.21E+01 2.21E+04 5.85E+01 5.41E+01 1.06E+02 O.OOE-01 O.OOE-01 O.OOE-01 TE125M 1.30E+02 3.87E+03 9.70E+02 3.51E+02 3.94E+03 2.92E+02 O.OOE-01 O.OOE-01 TE127M 3.00E+02 8.26E+03 2.46E+03 8.81E+02 1.00E+04 6.30E+02 O.OOE-01 O.OOE-01 TE127 1.47E+OO 5.36E+02 6.80E+OO 2.44E+OO 2.77E+01 5.03E+OO O.OOE-01 O.OOE-01 TE129M 6.53E+02 2.08E+04 4.13E+03 1.54E+03 1.72E+04 1.42E+03 O.OOE-01 O.OOE-01 TE129 1.66E-06 5.13E-06 6.79E-06 2.55E-06 2.85E-05 5.21E-06 O.OOE-01 O.OOE-01 TE131M 1.48E+02 1.77E+04 3.64E+02 1.78E+02 1.80E+03 2.82E+02 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 4.53E+02 2.28E+04 7.46E+02 4.83E+02 4.65E+03 5.33E+02 O.OOE-01 O.OOE-01 1130 8.37E+01 1.83E+02 7.19E+01 2.12E+02 3.31E+02 1.80E+04 O.OOE-01 O.OOE-01 1131 1.15E+03 5.28E+02 1.40E+03 2.00E+03 3.43E+03 6.55E+05 O.OOE-01 O.OOE-01 I 132 5.03E-02 2.?0E-02 5.38E-02 1.44E-01 2.29E-01 5.03E+OO O.OOE-01 O.OOE-01 I 133 1.24E+02 3.66E+02 2.34E+02 4.07E+02 7.10E+02 5.98E+04 O.OOE-01 O.OOE-01 1134 2.10E-07 5.11E-10 2.16E-07 5.86E-07 9.32E-07 1.02E-05 O.OOE-01 O.OOE-01 I 135 1.26E+01 3.85E+01 1.30E+01 3.41E+01 5.47E+01 2.25E+03 O.OOE-01 O.OOE-01 CS134 4.43E+04 9.48E+02 2.28E+04 5.42E+04 1.75E+04 O.OOE-01 5.82E+03 O.OOE-01 CS136 6.43E+03 1.01E+03 2.26E+03 8.93E+03 4.97E+03 O.OOE-01 6.81E+02 O.OOE-01 CS137 2.61E+04 7.73E+02 2.92E+04 3.99E+04 1.35E+04 O.OOE-01 4.50E+03 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 BA139 5.81E-06 3.52E-04 1.98E-04 1.41 E-07 1.32E-07 O.OOE-01 8.02E-08 O.OOE-01 BA140 4.61E+02 1.45E+04 7.04E+03 8.85E+OO 3.01E+OO O.OOE-01 5.0?E+OO O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 8.0?E-02 2.24E+04 6.06E-01 3.05E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 1.08E-07 3.18E-03 9.57E-07 4.35E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 2.57E-01 8.68E+03 3.36E+OO 2.27E+OO 1.05E+OO O.OOE-01 O.OOE-01 O.OOE-01 CE143 2.99E-02 1.01E+04 3.66E-01 2.70E+02 1.19E-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 9.57E+OO 6.03E+04 1.78E+02 7.46E+01 4.42E+01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 1.59E-01 1.40E+04 3.20E+OO 1.28E+OO 7.42E-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 1.50E-01 1.20E+04 2.16E+OO 2.50E+OO 1.46E+OO O.OOE-01 O.OOE-01 O.OOE-01 W187 5.50E+OO 5.15E+03 1.88E+01 1.57E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 1.76E-02 6.55E+03 3.25E-01 3.20E-02 9.97E-02 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 150of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
= ADULT PATHWAY
= FRESH WATER FISH TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 5.68E-01 5.68E-01 O.OOE-01 5.68E-01 5.68E-01 5.68E-01 5.68E-01 O.OOE-01 c 14 2.75E+04 2.75E+04 1.38E+05 2.75E+04 2.75E+04 2.75E+04 2.75E+04 O.OOE-01 NA24 5.90E+02 5.90E+02 5.90E+02 5.90E+02 5.90E+02 5.90E+02 5.90E+02 O.OOE-01 p 32 7.49E+06 2.18E+07 1.94E+08 1.20E+07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 5.47E+OO 1.37E+03 O.OOE-01 O.OOE-01 1.20E+OO 3.27E+OO 7.26E+OO O.OOE-01 MN54 3.67E+03 5.89E+04 O.OOE-01 1.92E+04 5.72E+03 O.OOE-01 O.OOE-01 O.OOE-01 MN56 1.28E-01 2.31E+01 O.OOE-01 7.24E-01 9.19E-01 O.OOE-01 O.OOE-01 O.OOE-01 FE55 4.66E+02 1.15E+03 2.90E+03 2.00E+03 O.OOE-01 O.OOE-01 1.12E+03 O.OOE-01 FE 59 4.06E+03 3.53E+04 4.50E+03 1.06E+04 O.OOE-01 O.OOE-01 2.96E+03 O.OOE-01 C058 8.71E+02 7.88E+03 O.OOE-01 3.89E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 2.49E+03 2.12E+04 O.OOE-01 1.13E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 4.59E+03 1.98E+03 1.37E+05 9.49E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 4.36E-02 2.42E+OO 7.36E-01 9.56E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 cu 64 5.51E+OO 1.00E+03 O.OOE-01 1.17E+01 2.96E+01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 1.46E+05 2.04E+05 1.02E+05 3.24E+05 2.16E+05 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 6.48E-07 1.40E-06 4.87E-06 9.32E-06 6.05E-06 O.OOE-01 O.OOE-01 O.OOE-01 BR 83 1.65E-01 2.37E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 2.00E+05 8.45E+04 O.OOE-01 4.28E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 2.76E+03 1.54E+04 9.60E+04 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 5.53E+04 6.92E+04 2.75E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 1.24E+01 1.47E+03 3.08E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 6.21E-02 2.85E+01 1.44E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 5.24E-02 2.07E+04 1.95E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 9.81E-01 2.02E+04 3.67E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 5.90E-05 3.54E+01 2.02E-03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 3.72E-03 4.27E+03 1.35E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR 95 2.27E-01 1.06E+03 1.05E+OO 3.35E-01 5.26E-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR97 2.00E-03 1.36E+03 2.17E-02 4.38E-03 6.62E-03 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 5.76E+02 6.51E+06 1.93E+03 1.07E+03 1.06E+03 O.OOE-01 O.OOE-01 O.OOE-01 M099 6.71E+01 8.17E+02 O.OOE-01 3.52E+02 7.98E+02 O.OOE-01 O.OOE-01 O.OOE-01 TC99M 8.75E-02 4.07E+OO 2.43E-03 6.87E-03 1.04E-01 O.OOE-01 3.37E-03 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 151of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
ADULT PATHWAY
=
FRESH WATER FISH TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 8.25E+OO 2.24E+03 1.91E+01 O.OOE-01 7.31 E+01 O.OOE-01 O.OOE-01 O.OOE-01 RU105 1.48E-02 2.30E+01 3.76E-02 O.OOE-01 4.86E-01 O.OOE-01 O.OOE-01 O.OOE-01 RU106 3.66E+01 1.87E+04 2.89E+02 O.OOE-01 5.58E+02 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 2.12E+OO 1.46E+03 3.87E+OO 3.58E+OO 7.03E+OO O.OOE-01 O.OOE-01 O.OOE-01 TE125M 1.49E+03 4.46E+04 1.12E+04 4.04E+03 4.54E+04 3.36E+03 O.OOE-01 O.OOE-01 TE127M 3.45E+03 9.51E+04 2.83E+04 1.01E+04 1.15E+05 7.25E+03 O.OOE-01 O.OOE-01 TE127 1.68E+01 6.12E+03 7.76E+01 2.79E+01 3.16E+02 5.75E+01 O.OOE-01 O.OOE-01 TE129M 7.51E+03 2.39E+05 4.75E+04 1.77E+04 1.98E+05 1.63E+04 O.OOE-01 O.OOE-01 TE129 1.79E-05 5.56E-05 7.36E-05 2.77E-05 3.09E-04 5.65E-05 O.OOE-01 O.OOE-01 TE131M 1.70E+03 2.03E+05 4.18E+03 2.04E+03 2.07E+04 3.24E+03 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 5.21E+03 2.62E+05 8.58E+03 5.55E+03 5.35E+04 6.13E+03 O.OOE-01 O.OOE-01 I 130 3.59E+01 7.84E+01 3.09E+01 9.11 E+01 1.42E+02 7.72E+03 O.OOE-01 O.OOE-01 1131 4.94E+02 2.28E+02 6.03E+02 8.62E+02 1.48E+03 2.83E+05 O.OOE-01 O.OOE-01 I 132 2.11E-02 1.13E-02 2.25E-02 6.02E-02 9.60E-02 2.11E+OO O.OOE-01 O.OOE-01 I 133 5.33E+01 1.57E+02 1.01E+02 1.75E+02 3.05E+02 2.57E+04 O.OOE-01 O.OOE-01 1134 8.36E-08 2.04E-10 8.60E-08 2.34E-07 3.72E-07 4.05E-06 O.OOE-01 O.OOE-01 1135 5.37E+OO 1.64E+01 5.56E+OO 1.46E+01 2.33E+01 9.60E+02 O.OOE-01 O.OOE-01 CS134 2.55E+06 5.45E+04 1.31E+06 3.12E+06 1.01E+06 O.OOE-01 3.35E+05 O.OOE-01 CS136 3.70E+05 5.84E+04 1.30E+05 5.14E+05 2.86E+05 O.OOE-01 3.92E+04 O.OOE-01 CS137 1.50E+06 4.45E+04 1.68E+06 2.30E+06 7.80E+05 O.OOE-01 2.59E+05 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 6.35E-07 3.85E-05 2.17E-05 1.55E-08 1.45E-08 O.OOE-01 8.77E-09 O.OOE-01 BA140 5.31E+01 1.67E+03 8.10E+02 1.02E+OO 3.46E-01 O.OOE-01 5.83E-01 O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 5.80E-02 1.61E+04 4.35E-01 2.19E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 7.45E-08 2.18E-03 6.58E-07 2.99E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 7.41E-03 2.50E+02 9.65E-02 6.53E-02 3.03E-02 O.OOE-01 O.OOE-01 O.OOE-01 CE143 8.59E-04 2.90E+02 1.05E-02 7.77E+OO 3.42E-03 O.OOE-01 O.OOE-01 O.OOE-01 CE144 2.75E-01 1.73E+03 5.13E+OO 2.14E+OO 1.27E+OO O.OOE-01 O.OOE-01 O.OOE-01 PR143 1.14E-01 1.01E+04 2.30E+OO 9.24E-01 5.33E-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 1.08E-01 8.63E+03 1.56E+OO 1.80E+OO 1.05E+OO O.OOE-01 O.OOE-01 O.OOE-01 W187 1.89E+02 1.77E+05 6.48E+02 5.41E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 5.06E-03 1.88E+03 9.34E-02 9.18E-03 2.86E-02 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 152of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
= ADULT PATHWAY
= ANIMAL DRINKING WATER-MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 1.65E+OO 1.65E+OO O.OOE-01 1.65E+OO 1.65E+OO 1.65E+OO 1.65E+OO O.OOE-01 c 14 4.86E+01 4.86E+01 2.43E+02 4.86E+01 4.86E+01 4.86E+01 4.86E+01 O.OOE-01 NA24 3.33E-08 3.33E-08 3.33E-08 3.33E-08 3.33E-08 3.33E-08 3.33E-08 O.OOE-01 p 32 3.58E+02 1.04E+03 9.27E+03 5.77E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 1.07E-02 2.68E+OO O.OOE-01 O.OOE-01 2.35E-03 6.37E-03 1.42E-02 O.OOE-01 MN54 1.84E+OO 2.96E+01 O.OOE-01 9.65E+OO 2.87E+OO O.OOE-01 O.OOE-01 O.OOE-01 MN 56 3.01E-28 5.42E-26 O.OOE-01 1.70E-27 2.16E-27 O.OOE-01 O.OOE-01 O.OOE-01 FE55 4.82E+01 1.19E+02 2.99E+02 2.07E+02 O.OOE-01 O.OOE-01 1.15E+02 O.OOE-01 FE59 3.16E+02 2.75E+03 3.51E+02 8.24E+02 O.OOE-01 O.OOE-01 2.30E+02 O.OOE-01 C058 4.93E+01 4.45E+02 O.OOE-01 2.20E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 1.68E+02 1.43E+03 O.OOE-01 7.62E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 6.37E+02 2.75E+02 1.90E+04 1.32E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 3.05E-26 1.69E-24 5.14E-25 6.67E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 cu 64 3.20E-12 5.81E-10 O.OOE-01 6.82E-12 1.72E-11 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 5.44E+02 7.59E+02 3.78E+02 1.20E+03 8.06E+02 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 4.78E-28 1.03E-27 3.60E-27 6.88E-27 4.47E-27 O.OOE-01 O.OOE-01 O.OOE-01 BR 83 1.89E-26 2.72E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 84 8.86E-27 6.96E-32 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 85 6.73E-34 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 4.00E+02 1.69E+02 O.OOE-01 8.59E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 2.34E-27 6.10E-38 O.OOE-01 4.41E-27 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 1.38E-27 1.14E-40 O.OOE-01 1.97E-27 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 1.11E+01 6.21E+01 3.87E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 2.89E+02 3.62E+02 1.44E+04 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 2.06E-16 2.42E-14 5.09E-15 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 1.04E-27 4.78E-25 2.41E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 1.82E-05 7.18E+OO 6.77E-04 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M 1.69E-31 1.28E-29 4.37E-30 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 3.77E-02 7.77E+02 1.41E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 2.26E-30 1.35E-24 7.73E-29 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 4.07E-18 4.67E-12 1.47E-16 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 4.99E-01 2.33E+03 2.30E+OO 7.37E-01 1.16E+OO O.OOE-01 O.OOE-01 O.OOE-01 ZR97 3.89E-11 2.63E-05 4.21E-10 8.50E-11 1.28E-10 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 9.69E-01 1.09E+04 3.24E+OO 1.80E+OO 1.78E+OO O.OOE-01 O.OOE-01 O.OOE-01 M099 1.15E-01 1.40E+OO O.OOE-01 6.06E-01 1.37E+OO O.OOE-01 O.OOE-01 O.OOE-01 TC99M 8.45E-24 3.93E-22 2.35E-25 6.64E-25 1.01E-23 O.OOE-01 3.25E-25 O.OOE-01 TC101 1.85E-27 5.68E-40 1.31E-28 1.89E-28 3.40E-27 O.OOE-01 9.65E-29 O.OOE-01 DAEC DODAM Page 153 of 196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDE$ IN EFFLUENT WATER AGE
=
ADULT PATHWAY
=
ANIMAL DRINKING WATER-MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 6.18E+01 1.67E+04 1.43E+02 O.OOE-01 5.47E+02 O.OOE-01 O.OOE-01 O.OOE-01 RU105 5.03E-26 7.79E-23 1.27E-25 O.OOE-01 1.65E-24 O.OOE-01 O.OOE-01 O.OOE-01 RU106 3.70E+02 1.89E+05 2.92E+03 O.OOE-01 5.64E+03 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 3.90E+OO 2.68E+03 7.10E+OO 6.57E+OO 1.29E+01 O.OOE-01 O.OOE-01 O.OOE-01 TE125M 6.01E+01 1.79E+03 4.48E+02 1.62E+02 1.82E+03 1.35E+02 O.OOE-01 O.OOE-01 TE127M 1.54E+02 4.25E+03 1.27E+03 4.53E+02 5.14E+03 3.24E+02 O.OOE-01 O.OOE-01 TE127 1.63E-15 5.95E-13 7.54E-15 2.71E-15 3.07E-14 5.58E-15 O.OOE-01 O.OOE-01 TE129M 2.56E+02 8.13E+03 1.62E+03 6.03E+02 6.74E+03 5.55E+02 O.OOE-01 O.OOE-01 TE129 7.83E-27 2.43E-26 3.21E-26 1.21E-26 1.35E-25 2.47E-26 O.OOE-01 O.OOE-01 TE131M 2.23E-03 2.65E-01 5.46E-03 2.67E-03 2.71 E-02 4.23E-03 O.OOE-01 O.OOE-01 TE131 2.20E-27 9.87E-28 6.97E-27 2.91 E-27 3.06E-26 5.73E-27 O.OOE-01 O.OOE-01 TE132 4.59E+OO 2.31E+02 7.57E+OO 4.89E+OO 4.71E+01 5.40E+OO O.OOE-01 O.OOE-01 I 130 1.31E-11 2.85E-11 1.12E-11 3.31 E-11 5.17E-11 2.81E-09 O.OOE-01 O.OOE-01 1131 4.85E+OO 2.23E+OO 5.91E+OO 8.46E+OO 1.45E+01 2.77E+03 O.OOE-01 O.OOE-01 I 132 9.85E-27 5.29E-27 1.05E-26 2.81 E-26 4.48E-26 9.85E-25 O.OOE-01 O.OOE-01 I 133 6.67E-07 1.96E-06 1.26E-06 2.19E-06 3.82E-06 3.21 E-04 O.OOE-01 O.OOE-01 1134 3.27E-27 7.97E-30 3.36E-27 9.14E-27 1.45E-26 1.58E-25 O.OOE-01 O.OOE-01 1135 3.76E-22 1.15E-21 3.90E-22 1.02E-21 1.64E-21 6.73E-20 O.OOE-01 O.OOE-01 CS134 1.31E+03 2.81E+01 6.74E+02 1.60E+03 5.19E+02 O.OOE-01 1.72E+02 O.OOE-01 CS136 7.08E+01 1.12E+01 2.49E+01 9.83E+01 5.47E+01 O.OOE-01 7.50E+OO O.OOE-01 CS137 7.87E+02 2.33E+01 8.79E+02 1.20E+03 4.08E+02 O.OOE-01 1.36E+02 O.OOE-01 CS138 1.44E-27 1.24E-32 1.47E-27 2.90E-27 2.13E-27 O.OOE-01 2.11E-28 O.OOE-01 BA139 1.33E-28 8.04E-27 4.53E-27 3.23E-30 3.02E-30 O.OOE-01 1.83E-30 O.OOE-01 BA140 3.97E+OO 1.25E+02 6.05E+01 7.60E-02 2.58E-02 O.OOE-01 4.35E-02 O.OOE-01 BA141 1.26E-29 1.76E-37 3.74E-28 2.83E-31 2.63E-31 O.OOE-01 1.61E-31 O.OOE-01 BA142 2.12E-30 O.OOE-01 3.37E-29 3.47E-32 2.93E-32 O.OOE-01 1.96E-32 O.OOE-01 LA140 4.67E-08 1.30E-02 3.51E-07 1.77E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 4.47E-32 1.31E-27 3.94E-31 1.79E-31 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 1.55E-03 5.23E+01 2.02E-02 1.37E-02 6.35E-03 O.OOE-01 O.OOE-01 O.OOE-01 CE143 1.91 E-08 6.45E-03 2.34E-07 1.73E-04 7.60E-08 O.OOE-01 O.OOE-01 O.OOE-01 CE144 8.26E-02 5.20E+02 1.54E+OO 6.43E-01 3.82E-01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 2.13E-03 1.88E+02 4.30E-02 1.72E-02 9.95E-03 O.OOE-01 O.OOE-01 O.OOE-01 PR144 1.56E-32 4.42E-38 3.08E-31 1.28E-31 7.20E-32 O.OOE-01 O.OOE-01 O.OOE-01 ND147 1.13E-03 9.09E+01 1.64E-02 1.89E-02 1.11 E-02 O.OOE-01 O.OOE-01 O.OOE-01 W187 9.54E-08 8.94E-05 3.26E-07 2.73E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 9.88E-08 3.67E-02 1.82E-06 1.79E-07 5.59E-07 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 154of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
ADULT PATHWAY
=
RIVER SHORELINE DEPOSITS TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 1.88E+OO 1.88E+OO 1.88E+OO 1.88E+OO 1.88E+OO 1.88E+OO 1.88E+OO 2.18E+OO p 32 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 7.33E-01 7.33E-01 7.33E-01 7.33E-01 7.33E-01 7.33E-01 7.33E-01 8.66E-01 MN 54 2.18E+02 2.18E+02 2.18E+02 2.18E+02 2.18E+02 2.18E+02 2.18E+02 2.56E+02 MN 56 1.38E-01 1.38E-01 1.38E-01 1.38E-01 1.38E-01 1.38E-01 1.38E-01 1.63E-01 FE 55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 59 4.29E+01 4.29E+01 4.29E+01 4.29E+01 4.29E+01 4.29E+01 4.29E+01 5.04E+01 C058 5.98E+01 5.98E+01 5.98E+01 5.98E+01 5.98E+01 5.98E+01 5.98E+01 7.01E+01 C060 3.38E+03 3.38E+03 3.38E+03 3.38E+03 3.38E+03 3.38E+03 3.38E+03 3.98E+03 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 4.55E-02 4.55E-02 4.55E-02 4.55E-02 4.55E-02 4.55E-02 4.55E-02 5.29E-02 cu 64 9.48E-02 9.48E-02 9.48E-02 9.48E-02 9.48E-02 9.48E-02 9.48E-02 1.07E-01 ZN 65 1.17E+02 1.17E+02 1.17E+02 1.17E+02 1.17E+02 1.17E+02 1.17E+02 1.35E+02 ZN 69 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 83 7.46E-04 7.46E-04 7.46E-04 7.46E-04 7.46E-04 7.46E-04 7.46E-04 1.08E-03 BR 84 2.80E-02 2.80E-02 2.80E-02 2.80E-02 2.80E-02 2.80E-02 2.80E-02 3.27E-02 BR 85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 1.42E+OO 1.42E+OO 1.42E+OO 1.42E+OO 1.42E+OO 1.42E+OO 1.42E+OO 1.62E+OO RB 88 4.14E-03 4.14E-03 4.14E-03 4.14E-03 4.14E-03 4.14E-03 4.14E-03 4.73E-03 RB 89 1.46E-02 1.46E-02 1.46E-02 1.46E-02 1.46E-02 1.46E-02 1.46E-02 1.75E-02 SR 89 3.40E-03 3.40E-03 3.40E-03 3.40E-03 3.40E-03 3.40E-03 3.40E-03 3.95E-03 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 3.35E-01 3.35E-01 3.35E-01 3.35E-01 3.35E-01 3.35E-01 3.35E-01 3.92E-01 SR 92 1.19E-01 1.19E-01 1.19E-01 1.19E-01 1.19E-01 1.19E-01 1.19E-01 1.33E-01 y 90 7.08E-04 7.08E-04 7.08E-04 7.08E-04 7.08E-04 7.08E-04 7.08E-04 8.36E-04 Y 91M 1.45E-02 1.45E-02 1.45E-02 1.45E-02 1.45E-02 1.45E-02 1.45E-02 1.68E-02 y 91 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.90E-01 y 92 2.80E-02 2.80E-02 2.80E-02 2.80E-02 2.80E-02 2.80E-02 2.80E-02 3.32E-02 y 93 2.86E-02 2.86E-02 2.86E-02 2.86E-02 2.86E-02 2.86E-02 2.86E-02 3.92E-02 ZR95 3.86E+01 3.86E+01 3.86E+01 3.86E+01 3.86E+01 3.86E+01 3.86E+01 4.48E+01 ZR97 4.64E-01 4.64E-01 4.64E-01 4.64E-01 4.64E-01 4.64E-01 4.64E-01 5.40E-01 NB95 2.16E+01 2.16E+01 2.16E+01 2.16E+01 2.16E+01 2.16E+01 2.16E+01 2.54E+01 M099 6.28E-01 6.28E-01 6.28E-01 6.28E-01 6.28E-01 6.28E-01 6.28E-01 7.27E-01 TC99M 2.87E-02 2.87E-02 2.87E-02 2.87E-02 2.87E-02 2.87E-02 2.87E-02 3.28E-02 TC101 2.39E-03 2.39E-03 2.39E-03 2.39E-03 2.39E-03 2.39E-03 2.39E-03 2.66E-03 DAEC DODAM Page 155of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
ADULT PATHWAY
=
RIVER SHORELINE DEPOSITS TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 1.70E+01 1.70E+01 1.70E+01 1.70E+01 1.70E+01 1.70E+01 1.70E+01 1.99E+01 RU105 9.86E-02 9.86E-02 9.86E-02 9.86E-02 9.86E-02 9.86E-02 9.86E-02 1.12E-01 RU106 6.65E+01 6.65E+01 6.65E+01 6.65E+01 6.65E+01 6.65E+01 6.65E+01 7.97E+01 AG110M 5.43E+02 5.43E+02 5.43E+02 5.43E+02 5.43E+02 5.43E+02 5.43E+02 6.34E+02 TE125M 2.45E-01 2.45E-01 2.45E-01 2.45E-01 2.45E-01 2.45E-01 2.45E-01 3.36E-01 TE127M 1.44E-02 1.44E-02 1.44E-02 1.44E-02 1.44E-02 1.44E-02 1.44E-02 1.71E-02 TE127 4.65E-04 4.65E-04 4.65E-04 4.65E-04 4.65E-04 4.65E-04 4.65E-04 5.12E-04 TE129M 3.11E+OO 3.11E+OO 3.11 E+OO 3.11 E+OO 3.11 E+OO 3.11E+OO 3.11E+OO 3.64E+OO TE129 3.89E-03 3.89E-03 3.89E-03 3.89E-03 3.89E-03 3.89E-03 3.89E-03 4.60E-03 TE131M 1.26E+OO 1.26E+OO 1.26E+OO 1.26E+OO 1.26E+OO 1.26E+OO 1.26E+OO 1.49E+OO TE131 3.90E-03 3.90E-03 3.90E-03 3.90E-03 3.90E-03 3.90E-03 3.90E-03 4.61E+OO TE132 6.67E-01 6.67E-01 6.67E-01 6.67E-01 6.67E-01 6.67E-01 6.67E-01 7.85E-01 I 130 8.62E-01 8.62E-01 8.62E-01 8.62E-01 8.62E-01 8.62E-01 8.62E-01 1.05E+OO I 131 2.71E+OO 2.71E+OO 2.71E+OO 2.71E+OO 2.71E+OO 2.71E+OO 2.71E+OO 3.29E+OO I 132 1.90E-01 1.90E-01 1.90E-01 1.90E-01 1.90E-01 1.90E-01 1.90E-01 2.24E-01 I 133 3.85E-01 3.85E-01 3.85E-01 3.85E-01 3.85E-01 3.85E-01 3.85E-01 4.68E-01 1134 6.49E-02 6.49E-02 6.49E-02 6.49E-02 6.49E-02 6.49E-02 6.49E-02 7.71E-02 I 135 3.93E-01 3.93E-01 3.93E-01 3.93E-01 3.93E-01 3.93E-01 3.93E-01 4.58E-01 CS134 1.08E+03 1.08E+03 1.08E+03 1.08E+03 1.08E+03 1.08E+03 1.08E+03 1.26E+03 CS136 2.37E+01 2.37E+01 2.37E+01 2.37E+01 2.37E+01 2.37E+01 2.37E+01 2.68E+01 CS137 1.62E+03 1.62E+03 1.62E+03 1.62E+03 1.62E+03 1.62E+03 1.62E+03 1.89E+03 CS138 4.98E-02 4.98E-02 4.98E-02 4.98E-02 4.98E-02 4.98E-02 4.98E-02 5.69E-02 BA139 1.58E-02 1.58E-02 1.58E-02 1.58E-02 1.58E-02 1.58E-02 1.58E-02 1.77E-02 BA140 3.23E+OO 3.23E+OO 3.23E+OO 3.23E+OO 3.23E+OO 3.23E+OO 3.23E+OO 3.70E+OO BA141 5.24E-03 5.24E-03 5.24E-03 5.24E-03 5.24E-03 5.24E-03 5.24E-03 5.97E-03 BA142 4.79E-03 4.79E-03 4.79E-03 4.79E-03 4.79E-03 4.79E-03 4.79E-03 5.46E-03 LA140 3.03E+OO 3.03E+OO 3.03E+OO 3.03E+OO 3.03E+OO 3.03E+OO 3.03E+OO 3.43E+OO LA142 1.11E-01 1.11E-01 1.11 E-01 1.11 E-01 1.11 E-01 1.11 E-01 1.11E-01 1.33E-01 CE141 2.15E+OO 2.15E+OO 2.15E+OO 2.15E+OO 2.15E+OO 2.15E+OO 2.15E+OO 2.42E+OO CE143 3.65E-01 3.65E-01 3.65E-01 3.65E-01 3.65E-01 3.65E-01 3.65E-01 4.15E-01 CE144 1.10E+01 1.10E+01 1.10E+01 1.10E+01 1.10E+01 1.10E+01 1.10E+01 1.27E+01 PR143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 2.27E-04 2.27E-04 2.27E-04 2.27E-04 2.27E-04 2.27E-04 2.27E-04 2.61 E-04 ND147 1.34E+OO 1.34E+OO 1.34E+OO 1.34E+OO 1.34E+OO 1.34E+OO 1.34E+OO 1.60E+OO W187 3.71E-01 3.71E-01 3.71E-01 3.71E-01 3.71E-01 3.71E-01 3.71E-01 4.31E-01 NP239 2.70E-01 2.70E-01 2.70E-01 2.70E-01 2.70E-01 2.70E-01 2.70E-01 3.12E-01 DAEC DODAM Page 156of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
ADULT PATHWAY
=
SWIMMING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 3.12E+01 3.12E+01 3.12E+01 3.12E+01 3.12E+01 3.12E+01 3.12E+01 O.OOE-01 p 32 2.57E-02 2.57E-02 2.57E-02 2.57E-02 2.57E-02 2.57E-02 2.57E-02 O.OOE-01 CR 51 2.09E-01 2.09E-01 2.09E-01 2.09E-01 2.09E-01 2.09E-01 2.09E-01 O.OOE-01 MN 54 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO O.OOE-01 MN 56 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 O.OOE-01 FE55 2.57E-04 2.57E-04 2.57E-04 2.57E-04 2.57E-04 2.57E-04 2.57E-04 O.OOE-01 FE59 8.83E+OO 8.83E+OO 8.83E+OO 8.83E+OO 8.83E+OO 8.83E+OO 8.83E+OO O.OOE-01 C058 7.23E+OO 7.23E+OO 7.23E+OO 7.23E+OO 7.23E+OO 7.23E+OO 7.23E+OO O.OOE-01 C060 1.85E+01 1.85E+01 1.85E+01 1.85E+01 1.85E+01 1.85E+01 1.85E+01 O.OOE-01 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 3.90E+OO 3.90E+OO 3.90E+OO 3.90E+OO 3.90E+OO 3.90E+OO 3.90E+OO O.OOE-01 cu 64 1.48E+OO 1.48E+OO 1.48E+OO 1.48E+OO 1.48E+OO 1.48E+OO 1.48E+OO O.OOE-01 ZN 65 4.42E+OO 4.42E+OO 4.42E+OO 4.42E+OO 4.42E+OO 4.42E+OO 4.42E+OO O.OOE-01 ZN 69 5.97E-03 5.97E-03 5.97E-03 5.97E-03 5.97E-03 5.97E-03 5.97E-03 O.OOE-01 BR 83 6.63E-02 6.63E-02 6.63E-02 6.63E-02 6.63E-02 6.63E-02 6.63E-02 O.OOE-01 BR 84 1.23E+01 1.23E+01 1.23E+01 1.23E+01 1.23E+01 1.23E+01 1.23E+01 O.OOE-01 BR 85 1.32E-02 1.32E-02 1.32E-02 1.32E-02 1.32E-02 1.32E-02 1.32E-02 O.OOE-01 RB 86 6.82E-01 6.82E-01 6.82E-01 6.82E-01 6.82E-01 6.82E-01 6.82E-01 O.OOE-01 RB 88 3.82E+OO 3.82E+OO 3.82E+OO 3.82E+OO 3.82E+OO 3.82E+OO 3.82E+OO O.OOE-01 RB 89 1.38E+01 1.38E+01 1.38E+01 1.38E+01 1.38E+01 1.38E+01 1.38E+01 O.OOE-01 SR89 1.85E-02 1.85E-02 1.85E-02 1.85E-02 1.85E-02 1.85E-02 1.85E-02 O.OOE-01 SR90 2.17E-03 2.17E-03 2.17E-03 2.17E-03 2.17E-03 2.17E-03 2.17E-03 O.OOE-01 SR 91 7.57E+OO 7.57E+OO 7.57E+OO 7.57E+OO 7.57E+OO 7.57E+OO 7.57E+OO O.OOE-01 SR 92 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 O.OOE-01 y 90 5.21 E-02 5.21E-02 5.21 E-02 5.21E-02 5.21E-02 5.21E-02 5.21 E-02 O.OOE-01 Y 91M 3.69E+OO 3.69E+OO 3.69E+OO 3.69E+OO 3.69E+OO 3.69E+OO 3.69E+OO O.OOE-01 y 91 2.69E-02 2.69E-02 2.69E-02 2.69E-02 2.69E-02 2.69E-02 2.69E-02 O.OOE-01 y 92 1.81E+OO 1.81E+OO 1.81E+OO 1.81E+OO 1.81E+OO 1.81E+OO 1.81E+OO O.OOE-01 y 93 7.57E-01 7.57E-01 7.57E-01 7.57E-01 7.57E-01 7.57E-01 7.57E-01 O.OOE-01 ZR 95 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO O.OOE-01 ZR97 6.00E+OO 6.00E+OO 6.00E+OO 6.00E+OO 6.00E+OO 6.00E+OO 6.00E+OO O.OOE-01 NB 95 5.62E+OO 5.62E+OO 5.62E+OO 5.62E+OO 5.62E+OO 5.62E+OO 5.62E+OO O.OOE-01 M099 1.88E+OO 1.88E+OO 1.88E+OO 1.88E+OO 1.88E+OO 1.88E+OO 1.88E+OO O.OOE-01 TC99M 9.52E-01 9.52E-01 9.52E-01 9.52E-01 9.52E-01 9.52E-01 9.52E-01 O.OOE-01 TC101 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO O.OOE-01 DAEC DODAM Page 157of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
ADULT PATHWAY
=
SWIMMING TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 3.57E+OO 3.57E+OO 3.57E+OO 3.57E+OO 3.57E+OO 3.57E+OO 3.57E+OO O.OOE-01 RU105 4.74E+OO 4.74E+OO 4.74E+OO 4.74E+OO 4.74E+OO 4.74E+OO 4.74E+OO O.OOE-01 RU106 1.52E+OO 1.52E+OO 1.52E+OO 1.52E+OO 1.52E+OO 1.52E+OO 1.52E+OO O.OOE-01 AG110M 1.97E+01 1.97E+01 1.97E+01 1.97E+01 1.97E+01 1.97E+01 1.97E+01 O.OOE-01 TE125M 1.48E-02 1.48E-02 1.48E-02 1.48E-02 1.48E-02 1.48E-02 1.48E-02 O.OOE-01 TE127M 1.04E-03 1.04E-03 1.04E-03 1.04E-03 1.04E-03 1.04E-03 1.04E-03 O.OOE-01 TE127 1.12E-02 1.12E-02 1.12E-02 1.12E-02 1.12E-02 1.12E-02 1.12E-02 O.OOE-01 TE129M 8.43E-01 8.43E-01 8.43E-01 8.43E-01 8.43E-01 8.43E-01 8.43E-01 O.OOE-01 TE129 7.19E-01 7.19E-01 7.19E-01 7.19E-01 7.19E-01 7.19E-01 7.19E-01 O.OOE-01 TE131M 8.81E+OO 8.81E+OO 8.81E+OO 8.81E+OO 8.81E+OO 8.81E+OO 8.81E+OO O.OOE-01 TE131 2.52E+OO 2.52E+OO 2.52E+OO 2.52E+OO 2.52E+OO 2.52E+OO 2.52E+OO O.OOE-01 TE132 1.60E+OO 1.60E+OO 1.60E+OO 1.60E+OO 1.60E+OO 1.60E+OO 1.60E+OO O.OOE-01 I 130 1.56E+01 1.56E+01 1.56E+01 1.56E+01 1.56E+01 1.56E+01 1.56E+01 O.OOE-01 I 131 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO O.OOE-01 I 132 1.71E+01 1.71E+01 1.71E+01 1.71E+01 1.71E+01 1.71E+01 1.71E+01 O.OOE-01 I 133 3.84E+OO 3.84E+OO 3.84E+OO 3.84E+OO 3.84E+OO 3.84E+OO 3.84E+OO O.OOE-01 1134 1.56E+01 1.56E+01 1.56E+01 1.56E+01 1.56E+01 1.56E+01 1.56E+01 O.OOE-01 I 135 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 O.OOE-01 CS134 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 O.OOE-01 CS136 1.65E+01 1.65E+01 1.65E+01 1.65E+01 1.65E+01 1.65E+01 1.65E+01 O.OOE-01 CS137 4.01E+OO 4.01E+OO 4.01E+OO 4.01E+OO 4.01E+OO 4.01E+OO 4.01E+OO O.OOE-01 CS138 1.41E+01 1.41 E+01 1.41E+01 1.41 E+01 1.41 E+01 1.41E+01 1.41 E+01 O.OOE-01 BA139 2.94E-01 2.94E-01 2.94E-01 2.94E-01 2.94E-01 2.94E-01 2.94E-01 O.OOE-01 BA140 1.97E+OO 1.97E+OO 1.97E+OO 1.97E+OO 1.97E+OO 1.97E+OO 1.97E+OO O.OOE-01 BA141 3.52E+OO 3.52E+OO 3.52E+OO 3.52E+OO 3.52E+OO 3.52E+OO 3.52E+OO O.OOE-01 BA142 5.99E+OO 5.99E+OO 5.99E+OO 5.99E+OO 5.99E+OO 5.99E+OO 5.99E+OO O.OOE-01 LA140 1.64E+01 1.64E+01 1.64E+01 1.64E+01 1.64E+01 1.64E+01 1.64E+01 O.OOE-01 LA142 1.73E+01 1.73E+01 1.73E+01 1.73E+01 1.73E+01 1.73E+01 1.73E+01 O.OOE-01 CE141 5.22E-01 5.22E-01 5.22E-01 5.22E-01 5.22E-01 5.22E-01 5.22E-01 O.OOE-01 CE143 2.28E+OO 2.28E+OO 2.28E+OO 2.28E+OO 2.28E+OO 2.28E+OO 2.28E+OO O.OOE-01 CE144 3.45E-01 3.45E-01 3.45E-01 3.45E-01 3.45E-01 3.45E-01 3.45E-01 O.OOE-01 PR143 6.42E-03 6.42E-03 6.42E-03 6.42E-03 6.42E-03 6.42E-03 6.42E-03 O.OOE-01 PR144 1.77E-01 1.77E-01 1.77E-01 1.77E-01 1.77E-01 1.77E-01 1.77E-01 O.OOE-01 ND147 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO O.OOE-01 W187 3.32E+OO 3.32E+OO 3.32E+OO 3.32E+OO 3.32E+OO 3.32E+OO 3.32E+OO O.OOE-01 NP239 9.62E-01 9.62E-01 9.62E-01 9.62E-01 9.62E-01 9.62E-01 9.62E-01 O.OOE-01 DAEC DODAM Page 158of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
ADULT PATHWAY
=
BOATING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 5.65E+01 5.65E+01 5.65E+01 5.65E+01 5.65E+01 5.65E+01 5.65E+01 O.OOE-01 p 32 4.66E-02 4.66E-02 4.66E-02 4.66E-02 4.66E-02 4.66E-02 4.66E-02 O.OOE-01 CR51 3.78E-01 3.78E-01 3.78E-01 3.78E-01 3.78E-01 3.78E-01 3.78E-01 O.OOE-01 MN54 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 O.OOE-01 MN 56 2.27E+01 2.27E+01 2.27E+01 2.27E+01 2.27E+01 2.27E+01 2.27E+01 O.OOE-01 FE 55 4.66E-04 4.66E-04 4.66E-04 4.66E-04 4.66E-04 4.66E-04 4.66E-04 O.OOE-01 FE 59 1.60E+01 1.60E+01 1.60E+01 1.60E+01 1.60E+01 1.60E+01 1.60E+01 O.OOE-01 C058 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 O.OOE-01 C060 3.35E+01 3.35E+01 3.35E+01 3.35E+01 3.35E+01 3.35E+01 3.35E+01 O.OOE-01 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 7.08E+OO 7.08E+OO 7.08E+OO 7.08E+OO 7.08E+OO 7.08E+OO 7.08E+OO O.OOE-01 cu 64 2.68E+OO 2.68E+OO 2.68E+OO 2.68E+OO 2.68E+OO 2.68E+OO 2.68E+OO O.OOE-01 ZN 65 8.00E+OO 8.00E+OO 8.00E+OO 8.00E+OO 8.00E+OO 8.00E+OO 8.00E+OO O.OOE-01 ZN 69 1.08E-02 1.08E-02 1.08E-02 1.08E-02 1.08E-02 1.08E-02 1.08E-02 O.OOE-01 BR83 1.20E-01 1.20E-01 1.20E-01 1.20E-01 1.20E-01 1.20E-01 1.20E-01 O.OOE-01 BR84 2.24E+01 2.24E+01 2.24E+01 2.24E+01 2.24E+01 2.24E+01 2.24E+01 O.OOE-01 BR 85 2.39E-02 2.39E-02 2.39E-02 2.39E-02 2.39E-02 2.39E-02 2.39E-02 O.OOE-01 RB 86 1.24E+OO 1.24E+OO 1.24E+OO 1.24E+OO 1.24E+OO 1.24E+OO 1.24E+OO O.OOE-01 RB 88 6.92E+OO 6.92E+OO 6.92E+OO 6.92E+OO 6.92E+OO 6.92E+OO 6.92E+OO O.OOE-01 RB89 2.49E+01 2.49E+01 2.49E+01 2.49E+01 2.49E+01 2.49E+01 2.49E+01 O.OOE-01 SR89 3.35E-02 3.35E-02 3.35E-02 3.35E-02 3.35E-02 3.35E-02 3.35E-02 O.OOE-01 SR 90 3.93E-03 3.93E-03 3.93E-03 3.93E-03 3.93E-03 3.93E-03 3.93E-03 O.OOE-01 SR91 1.37E+01 1.37E+01 1.37E+01 1.37E+01 1.37E+01 1.37E+01 1.37E+01 O.OOE-01 SR92 1.84E+01 1.84E+01 1.84E+01 1.84E+01 1.84E+01 1.84E+01 1.84E+01 O.OOE-01 y 90 9.45E-02 9.45E-02 9.45E-02 9.45E-02 9.45E-02 9.45E-02 9.45E-02 O.OOE-01 Y 91M 6.69E+OO 6.69E+OO 6.69E+OO 6.69E+OO 6.69E+OO 6.69E+OO 6.69E+OO O.OOE-01 y 91 4.87E-02 4.87E-02 4.87E-02 4.87E-02 4.87E-02 4.87E-02 4.87E-02 O.OOE-01 y 92 3.28E+OO 3.28E+OO 3.28E+OO 3.28E+OO 3.28E+OO 3.28E+OO 3.28E+OO O.OOE-01 y 93 1.37E+OO 1.37E+OO 1.37E+OO 1.37E+OO 1.37E+OO 1.37E+OO 1.37E+OO O.OOE-01 ZR95 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 O.OOE-01 ZR97 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 O.OOE-01 NB 95 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 O.OOE-01 M099 3.42E+OO 3.42E+OO 3.42E+OO 3.42E+OO 3.42E+OO 3.42E+OO 3.42E+OO O.OOE-01 TC99M 1.73E+OO 1.73E+OO 1.73E+OO 1.73E+OO 1.73E+OO 1.73E+OO 1.73E+OO O.OOE-01 TC101 3.69E+OO 3.69E+OO 3.69E+OO 3.69E+OO 3.69E+OO 3.69E+OO 3.69E+OO O.OOE-01 DAEC DODAM Page 159of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
= ADULT PATHWAY
=
BOATING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 6.47E+OO 6.47E+OO 6.47E+OO 6.47E+OO 6.47E+OO 6.47E+OO 6.47E+OO O.OOE-01 RU105 8.60E+OO 8.60E+OO 8.60E+OO 8.60E+OO 8.60E+OO 8.60E+OO 8.60E+OO O.OOE-01 RU106 2.77E+OO 2.77E+OO 2.77E+OO 2.77E+OO 2.77E+OO 2.77E+OO 2.77E+OO O.OOE-01 AG110M 3.57E+01 3.57E+01 3.57E+01 3.57E+01 3.57E+01 3.57E+01 3.57E+01 O.OOE-01 TE125M 2.69E-02 2.69E-02 2.69E-02 2.69E-02 2.69E-02 2.69E-02 2.69E-02 O.OOE-01 TE127M 1.89E-03 1.89E-03 1.89E-03 1.89E-03 1.89E-03 1.89E-03 1.89E-03 O.OOE-01 TE127 2.02E-02 2.02E-02 2.02E-02 2.02E-02 2.02E-02 2.02E-02 2.02E-02 O.OOE-01 TE129M 1.53E+OO 1.53E+OO 1.53E+OO 1.53E+OO 1.53E+OO 1.53E+OO 1.53E+OO O.OOE-01 TE129 1.30E+OO 1.30E+OO 1.30E+OO 1.30E+OO 1.30E+OO 1.30E+OO 1.30E+OO O.OOE-01 TE131M 1.60E+01 1.60E+01 1.60E+01 1.60E+01 1.60E+01 1.60E+01 1.60E+01 O.OOE-01 TE131 4.56E+OO 4.56E+OO 4.56E+OO 4.56E+OO 4.56E+OO 4.56E+OO 4.56E+OO O.OOE-01 TE132 2.91E+OO 2.91E+OO 2.91E+OO 2.91E+OO 2.91E+OO 2.91E+OO 2.91E+OO O.OOE-01 I 130 2.82E+01 2.82E+01 2.82E+01 2.82E+01 2.82E+01 2.82E+01 2.82E+01 O.OOE-01 1131 5.67E+OO 5.67E+OO 5.67E+OO 5.67E+OO 5.67E+OO 5.67E+OO 5.67E+OO O.OOE-01 I 132 3.11E+01 3.11E+01 3.11 E+01 3.11 E+01 3.11 E+01 3.11E+01 3.11E+01 O.OOE-01 I 133 6.96E+OO 6.96E+OO 6.96E+OO 6.96E+OO 6.96E+OO 6.96E+OO 6.96E+OO O.OOE-01 I 134 2.82E+01 2.82E+01 2.82E+01 2.82E+01 2.82E+01 2.82E+01 2.82E+01 O.OOE-01 I 135 2.38E+01 2.38E+01 2.38E+01 2.38E+01 2.38E+01 2.38E+01 2.38E+01 O.OOE-01 CS134 2.11E+01 2.11E+01 2.11E+01 2.11E+01 2.11 E+01 2.11E+01 2.11E+01 O.OOE-01 CS136 2.98E+01 2.98E+01 2.98E+01 2.98E+01 2.98E+01 2.98E+01 2.98E+01 O.OOE-01 CS137 7.28E+OO 7.28E+OO 7.28E+OO 7.28E+OO 7.28E+OO 7.28E+OO 7.28E+OO O.OOE-01 CS138 2.56E+01 2.56E+01 2.56E+01 2.56E+01 2.56E+01 2.56E+01 2.56E+01 O.OOE-01 BA139 5.33E-01 5.33E-01 5.33E-01 5.33E-01 5.33E-01 5.33E-01 5.33E-01 O.OOE-01 BA140 3.56E+OO 3.56E+OO 3.56E+OO 3.56E+OO 3.56E+OO 3.56E+OO 3.56E+OO O.OOE-01 BA141 6.37E+OO 6.37E+OO 6.37E+OO 6.37E+OO 6.37E+OO 6.37E+OO 6.37E+OO O.OOE-01 BA142 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 1.09E+01 O.OOE-01 LA140 2.98E+01 2.98E+01 2.98E+01 2.98E+01 2.98E+01 2.98E+01 2.98E+01 O.OOE-01 LA142 3.13E+01 3.13E+01 3.13E+01 3.13E+01 3.13E+01 3.13E+01 3.13E+01 O.OOE-01 CE141 9.46E-01 9.46E-01 9.46E-01 9.46E-01 9.46E-01 9.46E-01 9.46E-01 O.OOE-01 CE143 4.14E+OO 4.14E+OO 4.14E+OO 4.14E+OO 4.14E+OO 4.14E+OO 4.14E+OO O.OOE-01 CE144 6.26E-01 6.26E-01 6.26E-01 6.26E-01 6.26E-01 6.26E-01 6.26E-01 O.OOE-01 PR143 1.16E-02 1.16E-02 1.16E-02 1.16E-02 1.16E-02 1.16E-02 1.16E-02 O.OOE-01 PR144 3.20E-01 3.20E-01 3.20E-01 3.20E-01 3.20E-01 3.20E-01 3.20E-01 O.OOE-01 ND147 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO O.OOE-01 W187 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO 6.02E+OO O.OOE-01 NP239 1.74E+OO 1.74E+OO 1.74E+OO 1.74E+OO 1.74E+OO 1.74E+OO 1.74E+OO O.OOE-01 DAEC DODAM Page 160 of 196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE TEENAGER PATHWAY POTABLE WATER TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 1.54E+01 1.54E+01 O.OOE-01 1.54E+01 1.54E+01 1.54E+01 1.54E+01 O.OOE-01 c 14 2.08E+02 2.08E+02 1.04E+03 2.08E+02 2.08E+02 2.08E+02 2.08E+02 O.OOE-01 NA24 1.95E+02 1.95E+02 1.95E+02 1.95E+02 1.95E+02 1.95E+02 1.95E+02 O.OOE-01 p 32 2.61E+03 5.66E+03 6.73E+04 4.17E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 8.99E-01 1.51E+02 O.OOE-01 O.OOE-01 1.97E-01 4.99E-01 1.28E+OO O.OOE-01 MN54 2.99E+02 3.09E+03 O.OOE-01 1.51E+03 4.49E+02 O.OOE-01 O.OOE-01 O.OOE-01 MN56 1.10E-02 4.08E+OO O.OOE-01 6.20E-02 7.85E-02 O.OOE-01 O.OOE-01 O.OOE-01 FE55 1.60E+02 2.97E+02 9.67E+02 6.85E+02 O.OOE-01 O.OOE-01 4.35E+02 O.OOE-01 FE59 1.33E+03 8.16E+03 1.48E+03 3.45E+03 O.OOE-01 O.OOE-01 1.09E+03 O.OOE-01 C058 5.68E+02 3.40E+03 O.OOE-01 2.46E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 1.62E+03 9.36E+03 O.OOE-01 7.19E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 1.53E+03 5.09E+02 4.53E+04 3.20E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 1.52E-02 1.80E+OO 2.61E-01 3.33E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 cu 64 3.72E+OO 6.14E+02 O.OOE-01 7.91E+OO 2.00E+01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 2.38E+03 2.16E+03 1.47E+03 5.10E+03 3.27E+03 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 1.21E-08 3.19E-07 9.08E-08 1.73E-07 1.13E-07 O.OOE-01 O.OOE-01 O.OOE-01 BR 83 1.40E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 3.45E+03 1.09E+03 O.OOE-01 7.35E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 89 3.18E+03 1.32E+04 1.11E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 5.22E+04 5.96E+04 2.61E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR91 1.42E+01 1.62E+03 3.57E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR92 7.21E-02 4.31E+01 1.69E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 7.29E-02 2.23E+04 2.70E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 1.36E+OO 2.08E+04 5.08E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 8.29E-05 7.86E+01 2.86E-03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 5.16E-03 5.75E+03 1.88E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 2.26E+OO 7.59E+03 1.04E+01 3.29E+OO 4.84E+OO O.OOE-01 O.OOE-01 O.OOE-01 ZR97 2.06E-02 1.21E+04 2.27E-01 4.48E-02 6.80E-02 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 6.30E-01 4.89E+03 2.06E+OO 1.14E+OO 1.11E+OO O.OOE-01 O.OOE-01 O.OOE-01 M099 2.29E+02 2.15E+03 O.OOE-01 1.20E+03 2.74E+03 O.OOE-01 O.OOE-01 O.OOE-01 TC99M 1.93E-01 9.80E+OO 5.35E-03 1.49E-02 2.22E-01 O.OOE-01 8.29E-03 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page161 of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
TEENAGER PATHWAY
=
POTABLE WATER TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 2.74E+01 5.36E+03 6.41E+01 O.OOE-01 2.26E+02 O.OOE-01 O.OOE-01 O.OOE-01 RU105 5.09E-02 1.06E+02 1.31 E-01 O.OOE-01 1.65E+OO O.OOE-01 O.OOE-01 O.OOE-01 RU106 1.26E+02 4.80E+04 1.00E+03 O.OOE-01 1.93E+03 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 3.01E+01 1.39E+04 5.23E+01 4.95E+01 9.44E+01 O.OOE-01 O.OOE-01 O.OOE-01 TE125M 1.29E+02 2.86E+03 9.68E+02 3.49E+02 O.OOE-01 2.71E+02 O.OOE-01 O.OOE-01 TE127M 2.92E+02 6.13E+03 2.46E+03 8.72E+02 9.97E+03 5.85E+02 O.OOE-01 O.OOE-01 TE127 1.47E+OO 5.27E+02 6.82E+OO 2.42E+OO 2.76E+01 4.70E+OO O.OOE-01 O.OOE-01 TE129M 6.47E+02 1.53E+04 4.09E+03 1.52E+03 1.71E+04 1.32E+03 O.OOE-01 O.OOE-01 TE129 1.65E-06 3.70E-05 6.77E-06 2.52E-06 2.84E-05 4.83E-06 O.OOE-01 O.OOE-01 TE131M 1.43E+02 1.38E+04 3.59E+02 1.72E+02 1.79E+03 2.59E+02 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 4.30E+02 1.45E+04 7.22E+02 4.57E+02 4.39E+03 4.82E+02 O.OOE-01 O.OOE-01 I 130 7.91E+01 1.52E+02 6.85E+01 1.98E+02 3.05E+02 1.62E+04 O.OOE-01 O.OOE-01 1131 1.03E+03 3.80E+02 1.37E+03 1.92E+03 3.31E+03 5.61E+05 O.OOE-01 O.OOE-01 I 132 4.85E-02 5.89E-02 5.16E-02 1.35E-01 2.13E-01 4.55E+OO O.OOE-01 O.OOE-01 I 133 1.20E+02 2.97E+02 2.31E+02 3.92E+02 6.88E+02 5.48E+04 O.OOE-01 O.OOE-01 1134 1.98E-07 7.25E-09 2.08E-07 5.50E-07 8.68E-07 9.17E-06 O.OOE-01 O.OOE-01 I 135 1.19E+01 3.57E+01 1.25E+01 3.22E+01 5.09E+01 2.07E+03 O.OOE-01 O.OOE-01 CS134 2.34E+04 6.26E+02 2.14E+04 5.04E+04 1.60E+04 O.OOE-01 6.11E+03 O.OOE-01 CS136 5.51E+03 6.60E+02 2.08E+03 8.20E+03 4.47E+03 O.OOE-01 7.04E+02 O.OOE-01 CS137 1.33E+04 5.42E+02 2.87E+04 3.81E+04 1.30E+04 O.OOE-01 5.04E+03 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 5.79E-06 1.77E-03 1.99E-04 1.40E-07 1.32E-07 O.OOE-01 9.63E-08 O.OOE-01 BA140 4.44E+02 1.06E+04 6.88E+03 8.44E+OO 2.86E+OO O.OOE-01 5.67E+OO O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 7.71E-02 1.66E+04 5.89E-01 2.90E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 1.03E-07 1.26E-02 9.35E-07 4.15E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 2.55E-01 6.36E+03 3.33E+OO 2.22E+OO 1.05E+OO O.OOE-01 O.OOE-01 O.OOE-01 CE143 2.96E-02 7.96E+03 3.64E-01 2.65E+02 1.19E-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 9.55E+OO 4.47E+04 1.78E+02 7.35E+01 4.39E+01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 1.59E-01 1.05E+04 3.19E+OO 1.27E+OO 7.39E-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 1.47E-01 8.85E+03 2.26E+OO 2.45E+OO 1.44E+OO O.OOE-01 O.OOE-01 O.OOE-01 W187 5.32E+OO 4.11E+03 1.86E+01 1.52E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 1.76E-02 5.09E+03 3.36E-01 3.17E-02 9.94E-02 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 162 of 196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE TEENAGER PATHWAY FRESH WATER FISH TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 4.36E-01 4.36E-01 O.OOE-01 4.36E-01 4.36E-01 4.36E-01 4.36E-01 O.OOE-01 c 14 3.00E+04 3.00E+04 1.50E+05 3.00E+04 3.00E+04 3.00E+04 3.00E+04 O.OOE-01 NA24 6.08E+02 6.08E+02 6.08E+02 6.08E+02 6.08E+02 6.08E+02 6.08E+02 O.OOE-01 p 32 8.18E+06 1.77E+07 2.11 E+08 1.31E+07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 5.64E+OO 9.47E+02 O.OOE-01 O.OOE-01 1.24E+OO 3.13E+OO 8.05E+OO O.OOE-01 MN 54 3.75E+03 3.88E+04 O.OOE-01 1.89E+04 5.64E+03 O.OOE-01 O.OOE-01 O.OOE-01 MN 56 1.35E-01 4.99E+01 O.OOE-01 7.57E-01 9.59E-01 O.OOE-01 O.OOE-01 O.OOE-01 FE55 5.01E+02 9.31E+02 3.03E+03 2.15E+03 O.OOE-01 O.OOE-01 1.36E+03 O.OOE-01 FE 59 4.18E+03 2.56E+04 4.64E+03 1.08E+04 O.OOE-01 O.OOE-01 3.41E+03 O.OOE-01 C058 8.90E+02 5.33E+03 O.OOE-01 3.86E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 2.54E+03 1.47E+04 O.OOE-01 1.13E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 4.82E+03 1.60E+03 1.42E+05 1.00E+04 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 4.63E-02 5.51E+OO 7.95E-01 1.02E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 cu 64 5.81E+OO 9.58E+02 O.OOE-01 1.24E+01 3.12E+01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 1.49E+05 1.36E+05 9.22E+04 3.20E+05 2.05E+05 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 7.06E-07 1.86E-05 5.30E-06 1.01E-05 6.59E-06 O.OOE-01 O.OOE-01 O.OOE-01 BR83 1.79E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 2.17E+05 6.82E+04 O.OOE-01 4.61E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 89 2.99E+03 1.24E+04 1.04E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 4.91E+04 5.61E+04 2.46E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR91 1.33E+01 1.51E+03 3.34E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR92 6.61E-02 3.95E+01 1.55E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 5.71E-02 1.75E+04 2.12E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 1.07E+OO 1.63E+04 3.99E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 6.37E-05 6.05E+01 2.20E-03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 4.02E-03 4.48E+03 1.47E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 2.34E-01 7.86E+02 1.08E+OO 3.41 E-01 5.01E-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR97 2.13E-03 1.25E+03 2.34E-02 4.62E-03 7.01 E-03 O.OOE-01 O.OOE-01 O.OOE-01 NB95 5.93E+02 4.60E+06 1.94E+03 1.08E+03 1.04E+03 O.OOE-01 O.OOE-01 O.OOE-01 M099 7.17E+01 6.73E+02 O.OOE-01 3.76E+02 8.60E+02 O.OOE-01 O.OOE-01 O.OOE-01 TC99M 9.00E-02 4.56E+OO 2.49E-03 6.94E-03 1.04E-01 O.OOE-01 3.85E-03 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 163of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
TEENAGER PATHWAY
=
FRESH WATER FISH TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 8.60E+OO 1.68E+03 2.01E+01 O.OOE-01 7.09E+01 O.OOE-01 O.OOE-01 O.OOE-01 RU105 1.57E-02 3.27E+01 4.05E-02 O.OOE-01 5.11 E-01 O.OOE-01 O.OOE-01 O.OOE-01 RU106 3.96E+01 1.51E+04 3.14E+02 O.OOE-01 6.06E+02 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 2.17E+OO 1.00E+03 3.78E+OO 3.57E+OO 6.81E+OO O.OOE-01 O.OOE-01 O.OOE-01 TE125M 1.62E+03 3.59E+04 1.21 E+04 4.38E+03 O.OOE-01 3.39E+03 O.OOE-01 O.OOE-01 TE127M 3.67E+03 7.69E+04 3.09E+04 1.09E+04 1.25E+05 7.34E+03 O.OOE-01 O.OOE-01 TE127 1.83E+01 6.56E+03 8.49E+01 3.01E+01 3.44E+02 5.86E+01 O.OOE-01 O.OOE-01 TE129M 8.12E+03 1.92E+05 5.13E+04 1.90E+04 2.14E+05 1.65E+04 O.OOE-01 O.OOE-01 TE129 1.95E-05 4.38E-04 8.00E-05 2.98E-05 3.36E-04 5.72E-05 O.OOE-01 O.OOE-01 TE131M 1.80E+03 1.73E+05 4.49E+03 2.15E+03 2.24E+04 3.24E+03 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 5.40E+03 1.82E+05 9.05E+03 5.73E+03 5.50E+04 6.04E+03 O.OOE-01 O.OOE-01 1130 3.70E+01 7.12E+01 3.20E+01 9.27E+01 1.43E+02 7.56E+03 O.OOE-01 O.OOE-01 I 131 4.86E+02 1.79E+02 6.46E+02 9.04E+02 1.56E+03 2.64E+05 O.OOE-01 O.OOE-01 I 132 2.21E-02 2.69E-02 2.36E-02 6.17E-02 9.72E-02 2.08E+OO O.OOE-01 O.OOE-01 I 133 5.61E+01 1.39E+02 1.08E+02 1.84E+02 3.23E+02 2.57E+04 O.OOE-01 O.OOE-01 1134 8.60E-08 3.15E-09 9.03E-08 2.39E-07 3.77E-07 3.99E-06 O.OOE-01 O.OOE-01 I 135 5.56E+OO 1.66E+01 5.83E+OO 1.50E+01 2.37E+01 9.66E+02 O.OOE-01 O.OOE-01 CS134 1.47E+06 3.93E+04 1.34E+06 3.16E+06 1.00E+06 O.OOE-01 3.83E+05 O.OOE-01 CS136 3.46E+05 4.14E+04 1.31E+05 5.15E+05 2.80E+05 O.OOE-01 4.42E+04 O.OOE-01 CS137 8.33E+05 3.40E+04 1.80E+06 2.39E+06 8.14E+05 O.OOE-01 3.16E+05 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 6.90E-07 2.11E-04 2.37E-05 1.67E-08 1.57E-08 O.OOE-01 1.15E-08 O.OOE-01 BA140 5.57E+01 1.33E+03 8.64E+02 1.06E+OO 3.59E-01 O.OOE-01 7.12E-01 O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 6.03E-02 1.30E+04 4.61E-01 2.27E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 7.75E-08 9.47E-03 7.01 E-07 3.11E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 8.02E-03 2.00E+02 1.05E-01 6.98E-02 3.29E-02 O.OOE-01 O.OOE-01 O.OOE-01 CE143 9.26E-04 2.49E+02 1.14E-02 8.29E+OO 3.72E-03 O.OOE-01 O.OOE-01 O.OOE-01 CE144 2.99E-01 1.40E+03 5.57E+OO 2.31E+OO 1.38E+OO O.OOE-01 O.OOE-01 O.OOE-01 PR143 1.24E-01 8.22E+03 2.50E+OO 9.97E-01 5.80E-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 1.15E-01 6.94E+03 1.77E+OO 1.92E+OO 1.13E+OO O.OOE-01 O.OOE-01 O.OOE-01 W187 2.00E+02 1.54E+05 7.00E+02 5.70E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 5.51E-03 1.60E+03 1.05E-01 9.92E-03 3.11E-02 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 164of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
TEENAGER PATHWAY
=
ANIMAL DRINKING WATER-MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 9.85E-01 9.85E-01 O.OOE-01 9.85E-01 9.85E-01 9.85E-01 9.85E-01 O.OOE-01 c 14 4.10E+01 4.10E+01 2.05E+02 4.10E+01 4.10E+01 4.10E+01 4.10E+01 O.OOE-01 NA24 2.66E-08 2.66E-08 2.66E-08 2.66E-08 2.66E-08 2.66E-08 2.66E-08 O.OOE-01 p 32 3.04E+02 6.59E+02 7.84E+03 4.86E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 8.53E-03 1.43E+OO O.OOE-01 O.OOE-01 1.87E-03 4.74E-03 1.22E-02 O.OOE-01 MN 54 1.46E+OO 1.51E+01 O.OOE-01 7.36E+OO 2.20E+OO O.OOE-01 O.OOE-01 O.OOE-01 MN 56 2.45E-28 9.07E-26 O.OOE-01 1.38E-27 1.74E-27 O.OOE-01 O.OOE-01 O.OOE-01 FE 55 4.02E+01 7.46E+01 2.43E+02 1.72E+02 O.OOE-01 O.OOE-01 1.09E+02 O.OOE-01 FE59 2.53E+02 1.55E+03 2.80E+02 6.54E+02 O.OOE-01 O.OOE-01 2.06E+02 O.OOE-01 C058 3.90E+01 2.34E+02 O.OOE-01 1.69E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 1.33E+02 7.70E+02 O.OOE-01 5.91E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 5.18E+02 1.72E+02 1.53E+04 1.08E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NI 65 2.51 E-26 2.98E-24 4.31 E-25 5.50E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 cu 64 2.62E-12 4.32E-10 O.OOE-01 5.56E-12 1.41 E-11 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 4.31E+02 3.91E+02 2.66E+02 9.24E+02 5.92E+02 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 4.04E-28 1.06E-26 3.03E-27 5.78E-27 3.77E-27 O.OOE-01 O.OOE-01 O.OOE-01 BR 83 1.60E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 84 7.26E-27 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 85 5.67E-34 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 3.37E+02 1.06E+02 O.OOE-01 7.17E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 1.96E-27 3.15E-34 O.OOE-01 3.67E-27 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 1.13E-27 2.45E-36 O.OOE-01 1.60E-27 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 9.36E+OO 3.89E+01 3.27E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 1.99E+02 2.28E+02 9.97E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 1.70E-16 1.94E-14 4.28E-15 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR92 8.63E-28 5.16E-25 2.02E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 1.54E-05 4.70E+OO 5.70E-04 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M 1.40E-31 1.73E-28 3.66E-30 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 3.19E-02 4.88E+02 1.19E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 1.89E-30 1.79E-24 6.54E-29 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 3.41E-18 3.80E-12 1.24E-16 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 3.99E-01 1.34E+03 1.84E+OO 5.81E-01 8.53E-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR97 3.20E-11 1.88E-05 3.51E-10 6.95E-11 1.05E-10 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 7.72E-01 6.00E+03 2.53E+OO 1.40E+OO 1.36E+OO O.OOE-01 O.OOE-01 O.OOE-01 M099 9.56E-02 8.97E-01 O.OOE-01 5.01E-01 1.15E+OO O.OOE-01 O.OOE-01 O.OOE-01 TC99M 6.74E-24 3.42E-22 1.87E-25 5.20E-25 7.75E-24 O.OOE-01 2.89E-25 O.OOE-01 TC101 1.53E-27 2.67E-35 1.10E-28 1.56E-28 2.82E-27 O.OOE-01 9.51E-29 O.OOE-01 DAEC DODAM Page 165of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
= TEENAGER PATHWAY
= ANIMAL DRINKING WATER-MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 4.99E+01 9.76E+03 1.17E+02 O.OOE-01 4.12E+02 O.OOE-01 O.OOE-01 O.OOE-01 RU105 4.13E-26 8.60E-23 1.06E-25 O.OOE-01 1.34E-24 O.OOE-01 O.OOE-01 O.OOE-01 RU106 3.10E+02 1.18E+05 2.46E+03 O.OOE-01 4.75E+03 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 3.10E+OO 1.43E+03 5.38E+OO 5.09E+OO 9.70E+OO O.OOE-01 O.OOE-01 O.OOE-01 TE125M 5.06E+01 1.12E+03 3.79E+02 1.36E+02 O.OOE-01 1.06E+02 O.OOE-01 O.OOE-01 TE127M 1.27E+02 2.66E+03 1.07E+03 3.79E+02 4.33E+03 2.54E+02 O.OOE-01 O.OOE-01 TE127 1.38E-15 4.94E-13 6.40E-15 2.27E-15 2.59E-14 4.41E-15 O.OOE-01 O.OOE-01 TE129M 2.14E+02 5.08E+03 1.35E+03 5.02E+02 5.66E+03 4.37E+02 O.OOE-01 O.OOE-01 TE129 6.59E-27 1.48E-25 2.71 E-26 1.01E-26 1.14E-25 1.94E-26 O.OOE-01 O.OOE-01 TE131M 1.82E-03 1.75E-01 4.55E-03 2.18E-03 2.28E-02 3.28E-03 O.OOE-01 O.OOE-01 TE131 1.82E-27 4.79E-28 5.84E-27 2.41E-27 2.55E-26 4.50E-27 O.OOE-01 O.OOE-01 TE132 3.69E+OO 1.24E+02 6.19E+OO 3.92E+OO 3.76E+01 4.13E+OO O.OOE-01 O.OOE-01 I 130 1.04E-11 2.01 E-11 9.04E-12 2.62E-11 4.03E-11 2.13E-09 O.OOE-01 O.OOE-01 1131 3.70E+OO 1.36E+OO 4.91E+OO 6.88E+OO 1.18E+01 2.01E+03 O.OOE-01 O.OOE-01 I 132 8.03E-27 9.74E-27 8.55E-27 2.24E-26 3.52E-26 7.54E-25 O.OOE-01 O.OOE-01 I 133 5.44E-07 1.35E-06 1.05E-06 1.78E-06 3.13E-06 2.49E-04 O.OOE-01 O.OOE-01 1134 2.61E-27 9.57E-29 2.74E-27 7.26E-27 1.14E-26 1.21E-25 O.OOE-01 O.OOE-01 I 135 3.02E-22 9.04E-22 3.17E-22 8.16E-22 1.29E-21 5.25E-20 O.OOE-01 O.OOE-01 CS134 5.85E+02 1.57E+01 5.36E+02 1.26E+03 4.01E+02 O.OOE-01 1.53E+02 O.OOE-01 CS136 5.13E+01 6.15E+OO 1.94E+01 7.64E+01 4.16E+01 O.OOE-01 6.56E+OO O.OOE-01 CS137 3.38E+02 1.38E+01 7.30E+02 9.71E+02 3.30E+02 O.OOE-01 1.28E+02 O.OOE-01 CS138 1.17E-27 1.06E-30 1.22E-27 2.35E-27 1.73E-27 O.OOE-01 2.01E-28 O.OOE-01 BA139 1.12E-28 3.42E-26 3.84E-27 2.70E-30 2.55E-30 O.OOE-01 1.86E-30 O.OOE-01 BA140 3.22E+OO 7.72E+01 5.00E+01 6.13E-02 2.08E-02 O.OOE-01 4.12E-02 O.OOE-01 BA141 1.05E-29 6.72E-34 3.15E-28 2.35E-31 2.18E-31 O.OOE-01 1.61E-31 O.OOE-01 BA142 1.72E-30 8.59E-41 2.80E-29 2.80E-32 2.37E-32 O.OOE-01 1.86E-32 O.OOE-01 LA140 3.77E-08 8.14E-03 2.89E-07 1.42E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 3.61E-32 4.41E-27 3.26E-31 1.45E-31 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 1.30E-03 3.24E+01 1.?0E-02 1.13E-02 5.33E-03 O.OOE-01 O.OOE-01 O.OOE-01 CE143 1.60E-08 4.30E-03 1.96E-07 1.43E-04 6.41E-08 O.OOE-01 O.OOE-01 O.OOE-01 CE144 6.97E-02 3.26E+02 1.30E+OO 5.37E-01 3.21E-01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 1.80E-03 1.19E+02 3.62E-02 1.44E-02 8.39E-03 O.OOE-01 O.OOE-01 O.OOE-01 PR144 1.32E-32 2.86E-34 2.60E-31 1.06E-31 6.10E-32 O.OOE-01 O.OOE-01 O.OOE-01 ND147 9.40E-04 5.66E+01 1.44E-02 1.57E-02 9.22E-03 O.OOE-01 O.OOE-01 O.OOE-01 W187 7.81E-08 6.03E-05 2.74E-07 2.23E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 8.34E-08 2.42E-02 1.59E-06 1.50E-07 4.71E-07 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 166of196 Rev.000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
TEENAGER PATHWAY
=
RIVER SHORELINE DEPOSITS TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 1.05E+01 1.05E+01 1.05E+01 1.05E+01 1.05E+01 1.05E+01 1.05E+01 1.22E+01 p 32 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 4.09E+OO 4.09E+OO 4.09E+OO 4.09E+OO 4.09E+OO 4.09E+OO 4.09E+OO 4.84E+OO MN 54 1.22E+03 1.22E+03 1.22E+03 1.22E+03 1.22E+03 1.22E+03 1.22E+03 1.43E+03 MN 56 7.70E-01 7.70E-01 7.70E-01 7.70E-01 7.70E-01 7.70E-01 7.70E-01 9.10E-01 FE 55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE59 2.40E+02 2.40E+02 2.40E+02 2.40E+02 2.40E+02 2.40E+02 2.40E+02 2.82E+02 C058 3.34E+02 3.34E+02 3.34E+02 3.34E+02 3.34E+02 3.34E+02 3.34E+02 3.91E+02 C060 1.89E+04 1.89E+04 1.89E+04 1.89E+04 1.89E+04 1.89E+04 1.89E+04 2.22E+04 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 2.54E-01 2.54E-01 2.54E-01 2.54E-01 2.54E-01 2.54E-01 2.54E-01 2.95E-01 CU64 5.29E-01 5.29E-01 5.29E-01 5.29E-01 5.29E-01 5.29E-01 5.29E-01 6.00E-01 ZN65 6.56E+02 6.56E+02 6.56E+02 6.56E+02 6.56E+02 6.56E+02 6.56E+02 7.54E+02 ZN 69 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR83 4.16E-03 4.16E-03 4.16E-03 4.16E-03 4.16E-03 4.16E-03 4.16E-03 6.05E-03 BR84 1.56E-01 1.56E-01 1.56E-01 1.56E-01 1.56E-01 1.56E-01 1.56E-01 1.83E-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 7.92E+OO 7.92E+OO 7.92E+OO 7.92E+OO 7.92E+OO 7.92E+OO 7.92E+OO 9.05E+OO RB 88 2.31 E-02 2.31E-02 2.31E-02 2.31 E-02 2.31E-02 2.31E-02 2.31 E-02 2.64E-02 RB 89 8.14E-02 8.14E-02 8.14E-02 8.14E-02 8.14E-02 8.14E-02 8.14E-02 9.76E-02 SR89 1.90E-02 1.90E-02 1.90E-02 1.90E-02 1.90E-02 1.90E-02 1.90E-02 2.21E-02 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 1.87E+OO 1.87E+OO 1.87E+OO 1.87E+OO 1.87E+OO 1.87E+OO 1.87E+OO 2.19E+OO SR 92 6.66E-01 6.66E-01 6.66E-01 6.66E-01 6.66E-01 6.66E-01 6.66E-01 7.40E-01 y 90 3.95E-03 3.95E-03 3.95E-03 3.95E-03 3.95E-03 3.95E-03 3.95E-03 4.67E-03 Y 91M 8.09E-02 8.09E-02 8.09E-02 8.09E-02 8.09E-02 8.09E-02 8.09E-02 9.36E-02 y 91 9.45E-01 9.45E-01 9.45E-01 9.45E-01 9.45E-01 9.45E-01 9.45E-01 1.06E+OO y 92 1.56E-01 1.56E-01 1.56E-01 1.56E-01 1.56E-01 1.56E-01 1.56E-01 1.85E-01 y 93 1.60E-01 1.60E-01 1.60E-01 1.60E-01 1.60E-01 1.60E-01 1.60E-01 2.19E-01 ZR95 2.16E+02 2.16E+02 2.16E+02 2.16E+02 2.16E+02 2.16E+02 2.16E+02 2.50E+02 ZR97 2.59E+OO 2.59E+OO 2.59E+OO 2.59E+OO 2.59E+OO 2.59E+OO 2.59E+OO 3.02E+OO NB 95 1.21E+02 1.21E+02 1.21E+02 1.21E+02 1.21E+02 1.21E+02 1.21E+02 1.42E+02 M099 3.51E+OO 3.51E+OO 3.51E+OO 3.51E+OO 3.51E+OO 3.51E+OO 3.51E+OO 4.06E+OO TC 99M 1.60E-01 1.60E-01 1.60E-01 1.60E-01 1.60E-01 1.60E-01 1.60E-01 1.83E-01 TC101 1.33E-02 1.33E-02 1.33E-02 1.33E-02 1.33E-02 1.33E-02 1.33E-02 1.48E-02 DAEC DODAM Page 167of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
TEENAGER PATHWAY
=
RIVER SHORELINE DEOSITS TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 9.52E+01 9.52E+01 9.52E+01 9.52E+01 9.52E+01 9.52E+01 9.52E+01 1.11E+02 RU105 5.50E-01 5.50E-01 5.50E-01 5.50E-01 5.50E-01 5.50E-01 5.50E-01 6.24E-01 RU106 3.71E+02 3.71E+02 3.71E+02 3.71E+02 3.71E+02 3.71E+02 3.71E+02 4.45E+02 AG110M 3.03E+03 3.03E+03 3.03E+03 3.03E+03 3.03E+03 3.03E+03 3.03E+03 3.54E+03 TE125M 1.37E+OO 1.37E+OO 1.37E+OO 1.37E+OO 1.37E+OO 1.37E+OO 1.37E+OO 1.88E+OO TE127M 8.06E-02 8.06E-02 8.06E-02 8.06E-02 8.06E-02 8.06E-02 8.06E-02 9.53E-02 TE127 2.60E-03 2.60E-03 2.60E-03 2.60E-03 2.60E-03 2.60E-03 2.60E-03 2.86E-03 TE129M 1.74E+01 1.74E+01 1.74E+01 1.74E+01 1.74E+01 1.74E+01 1.74E+01 2.03E+01 TE129 2.17E-02 2.17E-02 2.17E-02 2.17E-02 2.17E-02 2.17E-02 2.17E-02 2.57E-02 TE131M 7.04E+OO 7.04E+OO 7.04E+OO 7.04E+OO 7.04E+OO 7.04E+OO 7.04E+OO 8.30E+OO TE131 2.18E-02 2.18E-02 2.18E-02 2.18E-02 2.18E-02 2.18E-02 2.18E-02 2.58E+01 TE132 3.72E+OO 3.72E+OO 3.72E+OO 3.72E+OO 3.72E+OO 3.72E+OO 3.72E+OO 4.38E+OO 1130 4.81E+OO 4.81E+OO 4.81E+OO 4.81E+OO 4.81E+OO 4.81E+OO 4.81E+OO 5.84E+OO 1131 1.51E+01 1.51E+01 1.51E+01 1.51E+01 1.51E+01 1.51E+01 1.51E+01 1.84E+01 1132 1.06E+OO 1.06E+OO 1.06E+OO 1.06E+OO 1.06E+OO 1.06E+OO 1.06E+OO 1.25E+OO I 133 2.15E+OO 2.15E+OO 2.15E+OO 2.15E+OO 2.15E+OO 2.15E+OO 2.15E+OO 2.62E+OO 1134 3.62E-01 3.62E-01 3.62E-01 3.62E-01 3.62E-01 3.62E-01 3.62E-01 4.30E-01 I 135 2.19E+OO 2.19E+OO 2.19E+OO 2.19E+OO 2.19E+OO 2.19E+OO 2.19E+OO 2.56E+OO CS134 6.01E+03 6.01E+03 6.01E+03 6.01E+03 6.01E+03 6.01E+03 6.01E+03 7.01E+03 CS136 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.32E+02 1.50E+02 CS137 9.06E+03 9.06E+03 9.06E+03 9.06E+03 9.06E+03 9.06E+03 9.06E+03 1.06E+04 CS138 2.78E-01 2.78E-01 2.78E-01 2.78E-01 2.78E-01 2.78E-01 2.78E-01 3.18E-01 BA139 8.79E-02 8.79E-02 8.79E-02 8.79E-02 8.79E-02 8.79E-02 8.79E-02 9.89E-02 BA140 1.81E+01 1.81E+01 1.81E+01 1.81E+01 1.81E+01 1.81E+01 1.81E+01 2.06E+01 BA141 2.92E-02 2.92E-02 2.92E-02 2.92E-02 2.92E-02 2.92E-02 2.92E-02 3.33E-02 BA142 2.67E-02 2.67E-02 2.67E-02 2.67E-02 2.67E-02 2.67E-02 2.67E-02 3.05E-02 LA140 1.69E+01 1.69E+01 1.69E+01 1.69E+01 1.69E+01 1.69E+01 1.69E+01 1.91E+01 LA142 6.19E-01 6.19E-01 6.19E-01 6.19E-01 6.19E-01 6.19E-01 6.19E-01 7.43E-01 CE141 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.35E+01 CE143 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.04E+OO 2.32E+OO CE144 6.12E+01 6.12E+01 6.12E+01 6.12E+01 6.12E+01 6.12E+01 6.12E+01 7.08E+01 PR143 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 1.27E-03 1.27E-03 1.27E-03 1.27E-03 1.27E-03 1.27E-03 1.27E-03 1.46E-03 ND147 7.46E+OO 7.46E+OO 7.46E+OO 7.46E+OO 7.46E+OO 7.46E+OO 7.46E+OO 8.95E+OO W187 2.07E+OO 2.07E+OO 2.07E+OO 2.07E+OO 2.07E+OO 2.07E+OO 2.07E+OO 2.40E+OO NP239 1.50E+OO 1.50E+OO 1.50E+OO 1.50E+OO 1.50E+OO 1.50E+OO 1.50E+OO 1.74E+OO DAEC DODAM Page 168of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
= TEENAGER PATHWAY
= SWIMMING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 1.75E+02 1.75E+02 1.75E+02 1.75E+02 1.75E+02 1.75E+02 1.75E+02 O.OOE-01 p 32 1.45E-01 1.45E-01 1.45E-01 1.45E-01 1.45E-01 1.45E-01 1.45E-01 O.OOE-01 CR 51 1.17E+OO 1.17E+OO 1.17E+OO 1.17E+OO 1.17E+OO 1.17E+OO 1.17E+OO O.OOE-01 MN 54 3.39E+01 3.39E+01 3.39E+01 3.39E+01 3.39E+01 3.39E+01 3.39E+01 O.OOE-01 MN 56 7.03E+01 7.03E+01 7.03E+01 7.03E+01 7.03E+01 7.03E+01 7.03E+01 O.OOE-01 FE 55 1.44E-03 1.44E-03 1.44E-03 1.44E-03 1.44E-03 1.44E-03 1.44E-03 O.OOE-01 FE 59 4.97E+01 4.97E+01 4.97E+01 4.97E+01 4.97E+01 4.97E+01 4.97E+01 O.OOE-01 C058 4.06E+01 4.06E+01 4.06E+01 4.06E+01 4.06E+01 4.06E+01 4.06E+01 O.OOE-01 C060 1.04E+02 1.04E+02 1.04E+02 1.04E+02 1.04E+02 1.04E+02 1.04E+02 O.OOE-01 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 2.20E+01 2.20E+01 2.20E+01 2.20E+01 2.20E+01 2.20E+01 2.20E+01 O.OOE-01 cu 64 8.31E+OO 8.31E+OO 8.31 E+OO 8.31E+OO 8.31E+OO 8.31E+OO 8.31E+OO O.OOE-01 ZN 65 2.48E+01 2.48E+01 2.48E+01 2.48E+01 2.48E+01 2.48E+01 2.48E+01 O.OOE-01 ZN 69 3.36E-02 3.36E-02 3.36E-02 3.36E-02 3.36E-02 3.36E-02 3.36E-02 O.OOE-01 BR83 3.73E-01 3.73E-01 3.73E-01 3.73E-01 3.73E-01 3.73E-01 3.73E-01 O.OOE-01 BR 84 6.93E+01 6.93E+01 6.93E+01 6.93E+01 6.93E+01 6.93E+01 6.93E+01 O.OOE-01 BR 85 7.41E-02 7.41E-02 7.41 E-02 7.41E-02 7.41E-02 7.41E-02 7.41E-02 O.OOE-01 RB 86 3.84E+OO 3.84E+OO 3.84E+OO 3.84E+OO 3.84E+OO 3.84E+OO 3.84E+OO O.OOE-01 RB 88 2.15E+01 2.15E+01 2.15E+01 2.15E+01 2.15E+01 2.15E+01 2.15E+01 O.OOE-01 RB 89 7.74E+01 7.74E+01 7.74E+01 7.74E+01 7.74E+01 7.74E+01 7.74E+01 O.OOE-01 SR 89 1.04E-01 1.04E-01 1.04E-01 1.04E-01 1.04E-01 1.04E-01 1.04E-01 O.OOE-01 SR90 1.22E-02 1.22E-02 1.22E-02 1.22E-02 1.22E-02 1.22E-02 1.22E-02 O.OOE-01 SR 91 4.26E+01 4.26E+01 4.26E+01 4.26E+01 4.26E+01 4.26E+01 4.26E+01 O.OOE-01 SR 92 5.72E+01 5.72E+01 5.72E+01 5.72E+01 5.72E+01 5.72E+01 5.72E+01 O.OOE-01 y 90 2.93E-01 2.93E-01 2.93E-01 2.93E-01 2.93E-01 2.93E-01 2.93E-01 O.OOE-01 Y 91M 2.08E+01 2.08E+01 2.08E+01 2.08E+01 2.08E+01 2.08E+01 2.08E+01 O.OOE-01 y 91 1.51E-01 1.51E-01 1.51E-01 1.51 E-01 1.51 E-01 1.51 E-01 1.51 E-01 O.OOE-01 y 92 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 O.OOE-01 y 93 4.26E+OO 4.26E+OO 4.26E+OO 4.26E+OO 4.26E+OO 4.26E+OO 4.26E+OO O.OOE-01 ZR95 3.39E+01 3.39E+01 3.39E+01 3.39E+01 3.39E+01 3.39E+01 3.39E+01 O.OOE-01 ZR97 3.37E+01 3.37E+01 3.37E+01 3.37E+01 3.37E+01 3.37E+01 3.37E+01 O.OOE-01 NB 95 3.16E+01 3.16E+01 3.16E+01 3.16E+01 3.16E+01 3.16E+01 3.16E+01 O.OOE-01 M099 1.06E+01 1.06E+01 1.06E+01 1.06E+01 1.06E+01 1.06E+01 1.06E+01 O.OOE-01 TC99M 5.36E+OO 5.36E+OO 5.36E+OO 5.36E+OO 5.36E+OO 5.36E+OO 5.36E+OO O.OOE-01 TC101 1.14E+01 1.14E+01 1.14E+01 1.14E+01 1.14E+01 1.14E+01 1.14E+01 O.OOE-01 DAEC DODAM Page 169of196 Rev.000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
TEENAGER PATHWAY
=
SWIMMING TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 2.01E+01 2.01E+01 2.01E+01 2.01E+01 2.01E+01 2.01E+01 2.01E+01 O.OOE-01 RU105 2.67E+01 2.67E+01 2.67E+01 2.67E+01 2.67E+01 2.67E+01 2.67E+01 O.OOE-01 RU106 8.58E+OO 8.58E+OO 8.58E+OO 8.58E+OO 8.58E+OO 8.58E+OO 8.58E+OO O.OOE-01 AG110M 1.11E+02 1.11E+02 1.11E+02 1.11E+02 1.11E+02 1.11E+02 1.11E+02 O.OOE-01 TE125M 8.33E-02 8.33E-02 8.33E-02 8.33E-02 8.33E-02 8.33E-02 8.33E-02 O.OOE-01 TE127M 5.87E-03 5.87E-03 5.87E-03 5.87E-03 5.87E-03 5.87E-03 5.87E-03 O.OOE-01 TE127 6.28E-02 6.28E-02 6.28E-02 6.28E-02 6.28E-02 6.28E-02 6.28E-02 O.OOE-01 TE129M 4.74E+OO 4.74E+OO 4.74E+OO 4.74E+OO 4.74E+OO 4.74E+OO 4.74E+OO O.OOE-01 TE129 4.04E+OO 4.04E+OO 4.04E+OO 4.04E+OO 4.04E+OO 4.04E+OO 4.04E+OO O.OOE-01 TE131M 4.96E+01 4.96E+01 4.96E+01 4.96E+01 4.96E+01 4.96E+01 4.96E+01 O.OOE-01 TE131 1.41E+01 1.41E+01 1.41 E+01 1.41E+01 1.41E+01 1.41 E+01 1.41 E+01 O.OOE-01 TE132 9.02E+OO 9.02E+OO 9.02E+OO 9.02E+OO 9.02E+OO 9.02E+OO 9.02E+OO O.OOE-01 I 130 8.76E+01 8.76E+01 8.76E+01 8.76E+01 8.76E+01 8.76E+01 8.76E+01 O.OOE-01 1131 1.76E+01 1.76E+01 1.76E+01 1.76E+01 1.76E+01 1.76E+01 1.76E+01 O.OOE-01 I 132 9.64E+01 9.64E+01 9.64E+01 9.64E+01 9.64E+01 9.64E+01 9.64E+01 O.OOE-01 I 133 2.16E+01 2.16E+01 2.16E+01 2.16E+01 2.16E+01 2.16E+01 2.16E+01 O.OOE-01 I 134 8.76E+01 8.76E+01 8.76E+01 8.76E+01 8.76E+01 8.76E+01 8.76E+01 O.OOE-01 I 135 7.37E+01 7.37E+01 7.37E+01 7.37E+01 7.37E+01 7.37E+01 7.37E+01 O.OOE-01 CS134 6.55E+01 6.55E+01 6.55E+01 6.55E+01 6.55E+01 6.55E+01 6.55E+01 O.OOE-01 CS136 9.26E+01 9.26E+01 9.26E+01 9.26E+01 9.26E+01 9.26E+01 9.26E+01 O.OOE-01 CS137 2.26E+01 2.26E+01 2.26E+01 2.26E+01 2.26E+01 2.26E+01 2.26E+01 O.OOE-01 CS138 7.94E+01 7.94E+01 7.94E+01 7.94E+01 7.94E+01 7.94E+01 7.94E+01 O.OOE-01 BA139 1.65E+OO 1.65E+OO 1.65E+OO 1.65E+OO 1.65E+OO 1.65E+OO 1.65E+OO O.OOE-01 BA140 1.11E+01 1.11E+01 1.11 E+01 1.11 E+01 1.11E+01 1.11E+01 1.11E+01 O.OOE-01 BA141 1.98E+01 1.98E+01 1.98E+01 1.98E+01 1.98E+01 1.98E+01 1.98E+01 O.OOE-01 BA142 3.37E+01 3.37E+01 3.37E+01 3.37E+01 3.37E+01 3.37E+01 3.37E+01 O.OOE-01 LA140 9.24E+01 9.24E+01 9.24E+01 9.24E+01 9.24E+01 9.24E+01 9.24E+01 O.OOE-01 LA142 9.71E+01 9.71E+01 9.71E+01 9.71 E+01 9.71E+01 9.71E+01 9.71E+01 O.OOE-01 CE141 2.93E+OO 2.93E+OO 2.93E+OO 2.93E+OO 2.93E+OO 2.93E+OO 2.93E+OO O.OOE-01 CE143 1.28E+01 1.28E+01 1.28E+01 1.28E+01 1.28E+01 1.28E+01 1.28E+01 O.OOE-01 CE144 1.94E+OO 1.94E+OO 1.94E+OO 1.94E+OO 1.94E+OO 1.94E+OO 1.94E+OO O.OOE-01 PR143 3.61E-02 3.61E-02 3.61E-02 3.61E-02 3.61E-02 3.61E-02 3.61E-02 O.OOE-01 PR144 9.94E-01 9.94E-01 9.94E-01 9.94E-01 9.94E-01 9.94E-01 9.94E-01 O.OOE-01 ND147 6.32E+OO 6.32E+OO 6.32E+OO 6.32E+OO 6.32E+OO 6.32E+OO 6.32E+OO O.OOE-01 W187 1.87E+01 1.87E+01 1.87E+01 1.87E+01 1.87E+01 1.87E+01 1.87E+01 O.OOE-01 NP239 5.41E+OO 5.41E+OO 5.41E+OO 5.41E+OO 5.41E+OO 5.41E+OO 5.41E+OO O.OOE-01 DAEC DODAM Page 170of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
TEENAGER PATHWAY
=
BOATING TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 1.01E+02 1.01E+02 1.01E+02 1.01E+02 1.01E+02 1.01E+02 1.01E+02 O.OOE-01 p 32 8.35E-02 8.35E-02 8.35E-02 8.35E-02 8.35E-02 8.35E-02 8.35E-02 O.OOE-01 CR51 6.78E-01 6.78E-01 6.78E-01 6.78E-01 6.78E-01 6.78E-01 6.78E-01 O.OOE-01 MN54 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 O.OOE-01 MN56 4.06E+01 4.06E+01 4.06E+01 4.06E+01 4.06E+01 4.06E+01 4.06E+01 O.OOE-01 FE55 8.35E-04 8.35E-04 8.35E-04 8.35E-04 8.35E-04 8.35E-04 8.35E-04 O.OOE-01 FE59 2.87E+01 2.87E+01 2.87E+01 2.87E+01 2.87E+01 2.87E+01 2.87E+01 O.OOE-01 C058 2.35E+01 2.35E+01 2.35E+01 2.35E+01 2.35E+01 2.35E+01 2.35E+01 O.OOE-01 C060 6.00E+01 6.00E+01 6.00E+01 6.00E+01 6.00E+01 6.00E+01 6.00E+01 O.OOE-01 Nl63 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 1.27E+01 1.27E+01 1.27E+01 1.27E+01 1.27E+01 1.27E+01 1.27E+01 O.OOE-01 cu 64 4.80E+OO 4.80E+OO 4.80E+OO 4.80E+OO 4.80E+OO 4.80E+OO 4.80E+OO O.OOE-01 ZN 65 1.44E+01 1.44E+01 1.44E+01 1.44E+01 1.44E+01 1.44E+01 1.44E+01 O.OOE-01 ZN 69 1.94E-02 1.94E-02 1.94E-02 1.94E-02 1.94E-02 1.94E-02 1.94E-02 O.OOE-01 BR 83 2.15E-01 2.15E-01 2.15E-01 2.15E-01 2.15E-01 2.15E-01 2.15E-01 O.OOE-01 BR84 4.01E+01 4.01E+01 4.01E+01 4.01E+01 4.01E+01 4.01E+01 4.01E+01 O.OOE-01 BR 85 4.28E-02 4.28E-02 4.28E-02 4.28E-02 4.28E-02 4.28E-02 4.28E-02 O.OOE-01 RB 86 2.22E+OO 2.22E+OO 2.22E+OO 2.22E+OO 2.22E+OO 2.22E+OO 2.22E+OO O.OOE-01 RB 88 1.24E+01 1.24E+01 1.24E+01 1.24E+01 1.24E+01 1.24E+01 1.24E+01 O.OOE-01 RB 89 4.47E+01 4.47E+01 4.47E+01 4.47E+01 4.47E+01 4.47E+01 4.47E+01 O.OOE-01 SR89 6.00E-02 6.00E-02 6.00E-02 6.00E-02 6.00E-02 6.00E-02 6.00E-02 O.OOE-01 SR 90 7.04E-03 7.04E-03 7.04E-03 7.04E-03 7.04E-03 7.04E-03 7.04E-03 O.OOE-01 SR 91 2.46E+01 2.46E+01 2.46E+01 2.46E+01 2.46E+01 2.46E+01 2.46E+01 O.OOE-01 SR 92 3.31E+01 3.31 E+01 3.31 E+01 3.31 E+01 3.31 E+01 3.31E+01 3.31E+01 O.OOE-01 y 90 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.69E-01 O.OOE-01 Y 91M 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.20E+01 O.OOE-01 y 91 8.74E-02 8.74E-02 8.74E-02 8.74E-02 8.74E-02 8.74E-02 8.74E-02 O.OOE-01 y 92 5.89E+OO 5.89E+OO 5.89E+OO 5.89E+OO 5.89E+OO 5.89E+OO 5.89E+OO O.OOE-01 y 93 2.46E+OO 2.46E+OO 2.46E+OO 2.46E+OO 2.46E+OO 2.46E+OO 2.46E+OO O.OOE-01 ZR95 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 O.OOE-01 ZR97 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 O.OOE-01 NB 95 1.83E+01 1.83E+01 1.83E+01 1.83E+01 1.83E+01 1.83E+01 1.83E+01 O.OOE-01 M099 6.12E+OO 6.12E+OO 6.12E+OO 6.12E+OO 6.12E+OO 6.12E+OO 6.12E+OO O.OOE-01 TC 99M 3.10E+OO 3.10E+OO 3.10E+OO 3.10E+OO 3.10E+OO 3.10E+OO 3.10E+OO O.OOE-01 TC101 6.62E+OO 6.62E+OO 6.62E+OO 6.62E+OO 6.62E+OO 6.62E+OO 6.62E+OO O.OOE-01 DAEC DODAM Page 171 of 196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE TEENAGER PATHWAY BOATING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 O.OOE-01 RU105 1.54E+01 1.54E+01 1.54E+01 1.54E+01 1.54E+01 1.54E+01 1.54E+01 O.OOE-01 RU106 4.96E+OO 4.96E+OO 4.96E+OO 4.96E+OO 4.96E+OO 4.96E+OO 4.96E+OO O.OOE-01 AG110M 6.39E+01 6.39E+01 6.39E+01 6.39E+01 6.39E+01 6.39E+01 6.39E+01 O.OOE-01 TE125M 4.81 E-02 4.81E-02 4.81 E-02 4.81 E-02 4.81E-02 4.81E-02 4.81E-02 O.OOE-01 TE127M 3.39E-03 3.39E-03 3.39E-03 3.39E-03 3.39E-03 3.39E-03 3.39E-03 O.OOE-01 TE127 3.63E-02 3.63E-02 3.63E-02 3.63E-02 3.63E-02 3.63E-02 3.63E-02 O.OOE-01 TE129M 2.74E+OO 2.74E+OO 2.74E+OO 2.74E+OO 2.74E+OO 2.74E+OO 2.74E+OO O.OOE-01 TE129 2.34E+OO 2.34E+OO 2.34E+OO 2.34E+OO 2.34E+OO 2.34E+OO 2.34E+OO O.OOE-01 TE131M 2.86E+01 2.86E+01 2.86E+01 2.86E+01 2.86E+01 2.86E+01 2.86E+01 O.OOE-01 TE131 8.18E+OO 8.18E+OO 8.18E+OO 8.18E+OO 8.18E+OO 8.18E+OO 8.18E+OO O.OOE-01 TE132 5.21E+OO 5.21E+OO 5.21E+OO 5.21E+OO 5.21E+OO 5.21E+OO 5.21E+OO O.OOE-01 I 130 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 O.OOE-01 1131 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 O.OOE-01 I 132 5.57E+01 5.57E+01 5.57E+01 5.57E+01 5.57E+01 5.57E+01 5.57E+01 O.OOE-01 I 133 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 O.OOE-01 1134 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 O.OOE-01 I 135 4.26E+01 4.26E+01 4.26E+01 4.26E+01 4.26E+01 4.26E+01 4.26E+01 O.OOE-01 CS134 3.78E+01 3.78E+01 3.78E+01 3.78E+01 3.78E+01 3.78E+01 3.78E+01 O.OOE-01 CS136 5.35E+01 5.35E+01 5.35E+01 5.35E+01 5.35E+01 5.35E+01 5.35E+01 O.OOE-01 CS137 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 O.OOE-01 CS138 4.59E+01 4.59E+01 4.59E+01 4.59E+01 4.59E+01 4.59E+01 4.59E+01 O.OOE-01 BA139 9.55E-01 9.55E-01 9.55E-01 9.55E-01 9.55E-01 9.55E-01 9.55E-01 O.OOE-01 BA140 6.39E+OO 6.39E+OO 6.39E+OO 6.39E+OO 6.39E+OO 6.39E+OO 6.39E+OO O.OOE-01 BA141 1.14E+01 1.14E+01 1.14E+01 1.14E+01 1.14E+01 1.14E+01 1.14E+01 O.OOE-01 BA142 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 O.OOE-01 LA140 5.34E+01 5.34E+01 5.34E+01 5.34E+01 5.34E+01 5.34E+01 5.34E+01 O.OOE-01 LA142 5.61E+01 5.61E+01 5.61E+01 5.61E+01 5.61E+01 5.61E+01 5.61E+01 O.OOE-01 CE141 1.70E+OO 1.70E+OO 1.70E+OO 1.70E+OO 1.70E+OO 1.70E+OO 1.70E+OO O.OOE-01 CE143 7.42E+OO 7.42E+OO 7.42E+OO 7.42E+OO 7.42E+OO 7.42E+OO 7.42E+OO O.OOE-01 CE144 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO O.OOE-01 PR143 2.09E-02 2.09E-02 2.09E-02 2.09E-02 2.09E-02 2.09E-02 2.09E-02 O.OOE-01 PR144 5.74E-01 5.74E-01 5.74E-01 5.74E-01 5.74E-01 5.74E-01 5.74E-01 O.OOE-01 ND147 3.65E+OO 3.65E+OO 3.65E+OO 3.65E+OO 3.65E+OO 3.65E+OO 3.65E+OO O.OOE-01 W187 1.08E+01 1.08E+01 1.08E+01 1.08E+01 1.08E+01 1.08E+01 1.08E+01 O.OOE-01 NP239 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO O.OOE-01 DAEC DODAM Page 172 of 196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
POTABLE WATER TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 2.97E+01 2.97E+01 O.OOE-01 2.97E+01 2.97E+01 2.97E+01 2.97E+01 O.OOE-01 c 14 6.19E+02 6.19E+02 3.10E+03 6.19E+02 6.19E+02 6.19E+02 6.19E+02 O.OOE-01 NA24 4.91E+02 4.91E+02 4.91E+02 4.91E+02 4.91E+02 4.91E+02 4.91E+02 O.OOE-01 p 32 7.75E+03 5.56E+03 2.01E+05 9.41E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 2.22E+OO 1.18E+02 O.OOE-01 O.OOE-01 3.37E-01 1.23E+OO 2.25E+OO O.OOE-01 MN 54 7.28E+02 2.29E+03 O.OOE-01 2.73E+03 7.66E+02 O.OOE-01 O.OOE-01 O.OOE-01 MN 56 2.96E-02 1.90E+01 O.OOE-01 1.31 E-01 1.59E-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 55 4.83E+02 2.89E+02 2.94E+03 1.56E+03 O.OOE-01 O.OOE-01 8.82E+02 O.OOE-01 FE 59 3.35E+03 7.00E+03 4.16E+03 6.73E+03 O.OOE-01 O.OOE-01 1.95E+03 O.OOE-01 C058 1.40E+03 2.66E+03 O.OOE-01 4.56E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 3.99E+03 7.50E+03 O.OOE-01 1.35E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 4.68E+03 4.96E+02 1.38E+05 7.37E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 4.24E-02 8.90E+OO 7.72E-01 7.27E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CU64 1.02E+01 7.91E+02 O.OOE-01 1.69E+01 4.07E+01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 5.79E+03 1.64E+03 3.50E+03 9.31E+03 5.87E+03 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 3.61E-08 2.47E-05 2.71E-07 3.91E-07 2.37E-07 O.OOE-01 O.OOE-01 O.OOE-01 BR 83 4.17E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 1.02E+04 1.06E+03 O.OOE-01 1.65E+04 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 9.52E+03 1.29E+04 3.33E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 1.32E+05 5.86E+04 6.55E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 4.01E+01 2.35E+03 1.06E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 2.01E-01 9.48E+01 5.01E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 2.17E-01 2.31E+04 8.12E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 4.07E+OO 2.03E+04 1.52E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 2.44E-04 2.46E+02 8.52E-03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 1.54E-02 8.35E+03 5.60E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 5.75E+OO 6.73E+03 2.94E+01 6.46E+OO 9.24E+OO O.OOE-01 O.OOE-01 O.OOE-01 ZR97 5.70E-02 1.46E+04 6.68E-01 9.65E-02 1.39E-01 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 1.57E+OO 4.06E+03 5.65E+OO 2.20E+OO 2.07E+OO O.OOE-01 O.OOE-01 O.OOE-01 M099 6.54E+02 2.19E+03 O.OOE-01 2.64E+03 5.65E+03 O.OOE-01 O.OOE-01 O.OOE-01 TC 99M 4.84E-01 1.66E+01 1.49E-02 2.92E-02 4.24E-01 O.OOE-01 1.48E-02 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 173 of 196 Rev.000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
POTABLE WATER TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 7.07E+01 4.75E+03 1.84E+02 O.OOE-01 4.63E+02 O.OOE-01 O.OOE-01 O.OOE-01 RU105 1.41E-01 2.53E+02 3.88E-01 O.OOE-01 3.41E+OO O.OOE-01 O.OOE-01 O.OOE-01 RU106 3.73E+02 4.65E+04 2.99E+03 O.OOE-01 4.04E+03 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 7.43E+01 1.10E+04 1.38E+02 9.29E+01 1.73E+02 O.OOE-01 O.OOE-01 O.OOE-01 TE125M 3.84E+02 2.78E+03 2.88E+03 7.81E+02 O.OOE-01 8.09E+02 O.OOE-01 O.OOE-01 TE127M 8.72E+02 5.95E+03 7.35E+03 1.98E+03 2.09E+04 1.76E+03 O.OOE-01 O.OOE-01 TE127 4.36E+OO 7.94E+02 2.03E+01 5.48E+OO 5.78E+01 1.41E+01 O.OOE-01 O.OOE-01 TE129M 1.89E+03 1.49E+04 1.22E+04 3.41E+03 3.58E+04 3.94E+03 O.OOE-01 O.OOE-01 TE129 4.81 E-06 1.26E-03 2.02E-05 5.65E-06 5.92E-05 1.44E-05 O.OOE-01 O.OOE-01 TE131M 3.89E+02 1.48E+04 1.06E+03 3.66E+02 3.54E+03 7.52E+02 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 1.12E+03 9.31E+03 2.09E+03 9.25E+02 8.59E+03 1.35E+03 O.OOE-01 O.OOE-01 I 130 2.02E+02 1.83E+02 1.94E+02 3.92E+02 5.86E+02 4.32E+04 O.OOE-01 O.OOE-01 1131 2.31E+03 3.61E+02 4.04E+03 4.06E+03 6.67E+03 1.34E+06 O.OOE-01 O.OOE-01 I 132 1.25E-01 3.20E-01 1.48E-01 2.72E-01 4.17E-01 1.26E+01 O.OOE-01 O.OOE-01 I 133 3.19E+02 3.39E+02 6.81E+02 8.42E+02 1.40E+03 1.56E+05 O.OOE-01 O.OOE-01 I 134 5.09E-07 7.34E-07 5.96E-07 1.11E-06 1.69E-06 2.55E-05 O.OOE-01 O.OOE-01 I 135 3.06E+01 4.93E+01 3.59E+01 6.47E+01 9.92E+01 5.73E+03 O.OOE-01 O.OOE-01 CS134 2.07E+04 5.29E+02 5.98E+04 9.82E+04 3.04E+04 O.OOE-01 1.09E+04 O.OOE-01 CS136 1.01E+04 5.51E+02 5.70E+03 1.57E+04 8.35E+03 O.OOE-01 1.24E+03 O.OOE-01 CS137 1.18E+04 5.02E+02 8.37E+04 8.01E+04 2.61E+04 O.OOE-01 9.39E+03 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 1.71E-05 3.41E-02 5.91E-04 3.16E-07 2.76E-07 O.OOE-01 1.86E-07 O.OOE-01 BA140 1.18E+03 1.02E+04 2.01E+04 1.76E+01 5.74E+OO O.OOE-01 1.05E+01 O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 2.01E-01 1.67E+04 1.71E+OO 5.98E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 2.73E-07 1.73E-01 2.74E-06 8.72E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 7.37E-01 6.19E+03 9.94E+OO 4.96E+OO 2.17E+OO O.OOE-01 O.OOE-01 O.OOE-01 CE143 8.51E-02 8.60E+03 1.08E+OO 5.87E+02 2.46E-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 2.83E+01 4.34E+04 5.31E+02 1.66E+02 9.22E+01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 4.74E-01 1.03E+04 9.56E+OO 2.87E+OO 1.55E+OO O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 4.21E-01 8.61E+03 6.71E+OO 5.43E+OO 2.98E+OO O.OOE-01 O.OOE-01 O.OOE-01 W187 1.46E+01 4.56E+03 5.48E+01 3.24E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 5.05E-02 5.32E+03 1.00E+OO 7.19E-02 2.0BE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 174 of 196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
FRESH WATER FISH TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 3.61E-01 3.61E-01 O.OOE-01 3.61E-01 3.61E-01 3.61E-01 3.61E-01 O.OOE-01 c 14 3.85E+04 3.85E+04 1.93E+05 3.85E+04 3.85E+04 3.85E+04 3.85E+04 O.OOE-01 NA24 6.61E+02 6.61E+02 6.61E+02 6.61E+02 6.61E+02 6.61E+02 6.61E+02 O.OOE-01 p 32 1.05E+07 7.52E+06 2.72E+08 1.27E+07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 6.01E+OO 3.19E+02 O.OOE-01 O.OOE-01 9.12E-01 3.34E+OO 6.09E+OO O.OOE-01 MN54 3.94E+03 1.24E+04 O.OOE-01 1.48E+04 4.15E+03 O.OOE-01 O.OOE-01 O.OOE-01 MN 56 1.56E-01 1.00E+02 O.OOE-01 6.91E-01 8.35E-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 55 6.54E+02 3.91E+02 3.98E+03 2.11E+03 O.OOE-01 O.OOE-01 1.19E+03 O.OOE-01 FE59 4.53E+03 9.48E+03 5.62E+03 9.10E+03 O.OOE-01 O.OOE-01 2.64E+03 O.OOE-01 C058 9.45E+02 1.80E+03 O.OOE-01 3.09E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 2.70E+03 5.07E+03 O.OOE-01 9.15E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 6.34E+03 6.72E+02 1.86E+05 9.97E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 5.58E-02 1.17E+01 1.02E+OO 9.57E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CU64 6.85E+OO 5.32E+02 O.OOE-01 1.13E+01 2.74E+01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 1.57E+05 4.43E+04 9.46E+04 2.52E+05 1.59E+05 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 9.09E-07 6.20E-04 6.81 E-06 9.84E-06 5.97E-06 O.OOE-01 O.OOE-01 O.OOE-01 BR83 2.30E-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 2.75E+05 2.88E+04 O.OOE-01 4.47E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 3.86E+03 5.23E+03 1.35E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 5.35E+04 2.38E+04 2.66E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 1.62E+01 9.46E+02 4.28E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 7.94E-02 3.75E+01 1.98E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 7.34E-02 7.81E+03 2.74E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 1.38E+OO 6.86E+03 5.15E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 8.09E-05 8.17E+01 2.83E-03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 5.17E-03 2.81E+03 1.88E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 2.57E-01 3.01E+02 1.31E+OO 2.88E-01 4.12E-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR97 2.53E-03 6.50E+02 2.97E-02 4.29E-03 6.16E-03 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 6.37E+02 1.65E+06 2.29E+03 8.92E+02 8.38E+02 O.OOE-01 O.OOE-01 O.OOE-01 M099 8.84E+01 2.96E+02 O.OOE-01 3.57E+02 7.63E+02 O.OOE-01 O.OOE-01 O.OOE-01 TC99M 9.70E-02 3.33E+OO 2.98E-03 5.85E-03 8.51E-02 O.OOE-01 2.97E-03 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 175of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
FRESH WATER FISH TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 9.56E+OO 6.43E+02 2.49E+01 O.OOE-01 6.26E+01 O.OOE-01 O.OOE-01 O.OOE-01 RU105 1.88E-02 3.38E+01 5.17E-02 O.OOE-01 4.55E-01 O.OOE-01 O.OOE-01 O.OOE-01 RU106 5.05E+01 6.29E+03 4.04E+02 O.OOE-01 5.46E+02 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 2.31E+OO 3.44E+02 4.28E+OO 2.89E+OO 5.38E+OO O.OOE-01 O.OOE-01 O.OOE-01 TE125M 2.08E+03 1.50E+04 1.56E+04 4.23E+03 O.OOE-01 4.38E+03 O.OOE-01 O.OOE-01 TE127M 4.72E+03 3.22E+04 3.98E+04 1.07E+04 1.13E+05 9.51E+03 O.OOE-01 O.OOE-01 TE127 2.34E+01 4.27E+03 1.09E+02 2.95E+01 3.11E+02 7.56E+01 O.OOE-01 O.OOE-01 TE129M 1.03E+04 8.06E+04 6.61E+04 1.84E+04 1.94E+05 2.13E+04 O.OOE-01 O.OOE-01 TE129 2.45E-05 6.42E-03 1.03E-04 2.88E-05 3.02E-04 7.36E-05 O.OOE-01 O.OOE-01 TE131M 2.10E+03 8.01E+04 5.71E+03 1.98E+03 1.91E+04 4.06E+03 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 6.04E+03 5.03E+04 1.13E+04 5.00E+03 4.64E+04 7.28E+03 O.OOE-01 O.OOE-01 1130 4.08E+01 3.70E+01 3.92E+01 7.92E+01 1.18E+02 8.72E+03 O.OOE-01 O.OOE-01 1131 4.68E+02 7.33E+01 8.19E+02 8.24E+02 1.35E+03 2.72E+05 O.OOE-01 O.OOE-01 I 132 2.46E-02 6.31 E-02 2.92E-02 5.36E-02 8.20E-02 2.49E+OO O.OOE-01 O.OOE-01 I 133 6.45E+01 6.87E+01 1.38E+02 1.70E+02 2.84E+02 3.17E+04 O.OOE-01 O.OOE-01 1134 9.55E-08 1.38E-07 1.12E-07 2.07E-07 3.17E-07 4.77E-06 O.OOE-01 O.OOE-01 I 135 6.14E+OO 9.90E+OO 7.22E+OO 1.30E+01 1.99E+01 1.15E+03 O.OOE-01 O.OOE-01 CS134 5.60E+05 1.43E+04 1.62E+06 2.66E+06 8.23E+05 O.OOE-01 2.95E+05 O.OOE-01 CS136 2.74E+05 1.49E+04 1.54E+05 4.24E+05 2.26E+05 O.OOE-01 3.37E+04 O.OOE-01 CS137 3.20E+05 1.36E+04 2.26E+06 2.17E+06 7.06E+05 O.OOE-01 2.54E+05 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 8.82E-07 1.76E-03 3.04E-05 1.62E-08 1.42E-08 O.OOE-01 9.56E-09 O.OOE-01 BA140 6.36E+01 5.52E+02 1.09E+03 9.55E-01 3.11 E-01 O.OOE-01 5.69E-01 O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 6.BOE-02 5.63E+03 5.77E-01 2.02E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 8.83E-08 5.59E-02 8.85E-07 2.82E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 9.96E-03 8.37E+01 1.34E-01 6.71E-02 2.94E-02 O.OOE-01 O.OOE-01 O.OOE-01 CE143 1.15E-03 1.16E+02 1.46E-02 7.93E+OO 3.32E-03 O.OOE-01 O.OOE-01 O.OOE-01 CE144 3.83E-01 5.87E+02 7.18E+OO 2.25E+OO 1.25E+OO O.OOE-01 O.OOE-01 O.OOE-01 PR143 1.60E-01 3.49E+03 3.23E+OO 9.70E-01 5.25E-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 1.42E-01 2.91E+03 2.27E+OO 1.84E+OO 1.01E+OO O.OOE-01 O.OOE-01 O.OOE-01 W187 2.36E+02 7.38E+04 8.86E+02 5.25E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 6.83E-03 7.19E+02 1.35E-01 9.72E-03 2.81 E-02 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 176 of 196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
ANIMAL DRINKING WATER-MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 1.19E+OO 1.19E+OO O.OOE-01 1.19E+OO 1.19E+OO 1.19E+OO 1.19E+OO O.OOE-01 c 14 7.72E+01 7.72E+01 3.86E+02 7.72E+01 7.72E+01 7.72E+01 7.72E+01 O.OOE-01 NA24 4.24E-08 4.24E-08 4.24E-08 4.24E-08 4.24E-08 4.24E-08 4.24E-08 O.OOE-01 p 32 5.70E+02 4.08E+02 1.48E+04 6.91E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 1.33E-02 7.05E-01 O.OOE-01 0.00E-01 2.02E-03 7.38E-03 1.35E-02 O.OOE-01 MN 54 2.24E+OO 7.07E+OO O.OOE-01 8.42E+OO 2.36E+OO O.OOE-01 O.OOE-01 O.OOE-01 MN 56 4.15E-28 2.66E-25 O.OOE-01 1.84E-27 2.22E-27 O.OOE-01 O.OOE-01 O.OOE-01 FE55 7.67E+01 4.58E+01 4.67E+02 2.47E+02 O.OOE-01 O.OOE-01 1.40E+02 O.OOE-01 FE59 4.01E+02 8.38E+02 4.97E+02 8.04E+02 O.OOE-01 O.OOE-01 2.33E+02 O.OOE-01 C058 6.06E+01 1.15E+02 O.OOE-01 1.98E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 2.07E+02 3.89E+02 O.OOE-01 7.02E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 9.97E+02 1.06E+02 2.93E+04 1.57E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 4.42E-26 9.28E-24 8.05E-25 7.58E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 cu 64 4.52E-12 3.51 E-10 O.OOE-01 7.48E-12 1.81E-11 O.OOE-01 O.OOE-01 O.OOE-01 ZN65 6.62E+02 1.87E+02 3.99E+02 1.06E+03 6.70E+02 O.OOE-01 O.OOE-01 O.OOE-01 ZN69 7.61E-28 5.19E-25 5.70E-27 8.24E-27 5.00E-27 O.OOE-01 O.OOE-01 O.OOE-01 BR83 3.00E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 1.25E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 1.07E-33 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 6.25E+02 6.54E+01 O.OOE-01 1.02E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 3.59E-27 2.53E-28 O.OOE-01 5.17E-27 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 1.90E-27 1.87E-29 O.OOE-01 2.14E-27 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 89 1.77E+01 2.40E+01 6.19E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 3.17E+02 1.41E+02 1.58E+04 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 3.03E-16 1.77E-14 8.03E-15 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 1.51E-27 7.16E-25 3.78E-26 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 2.89E-05 3.07E+OO 1.08E-03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M 2.49E-31 1.34E-26 6.84E-30 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 6.01E-02 2.99E+02 2.25E+OO O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 3.51E-30 3.55E-24 1.23E-28 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 6.41E-18 3.48E-12 2.34E-16 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 6.39E-01 7.49E+02 3.27E+OO 7.18E-01 1.03E+OO O.OOE-01 O.OOE-01 O.OOE-01 ZR97 5.57E-11 1.43E-05 6.53E-10 9.44E-11 1.36E-10 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 1.22E+OO 3.14E+03 4.37E+OO 1.70E+OO 1.60E+OO O.OOE-01 O.OOE-01 O.OOE-01 M099 1.72E-01 5.77E-01 O.OOE-01 6.97E-01 1.49E+OO O.OOE-01 O.OOE-01 O.OOE-01 TC99M 1.06E-23 3.65E-22 3.27E-25 6.42E-25 9.32E-24 O.OOE-01 3.26E-25 O.OOE-01 TC101 2.73E-27 6.85E-28 2.06E-28 2.15E-28 3.67E-27 O.OOE-01 1.14E-28 O.OOE-01 DAEC DODAM Page 177 of 196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDE$ IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
ANIMAL DRINKING WATER-MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 8.12E+01 5.46E+03 2.11 E+02 O.OOE-01 5.32E+02 O.OOE-01 O.OOE-01 O.OOE-01 RU105 7.21 E-26 1.30E-22 1.99E-25 O.OOE-01 1.75E-24 O.OOE-01 O.OOE-01 O.OOE-01 RU106 5.78E+02 7.21E+04 4.64E+03 O.OOE-01 6.26E+03 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 4.82E+OO 7.16E+02 8.92E+OO 6.02E+OO 1.12E+01 O.OOE-01 O.OOE-01 O.OOE-01 TE125M 9.48E+01 6.86E+02 7.11E+02 1.93E+02 O.OOE-01 2.00E+02 O.OOE-01 O.OOE-01 TE127M 2.39E+02 1.63E+03 2.01E+03 5.42E+02 5.75E+03 4.82E+02 O.OOE-01 O.OOE-01 TE127 2.58E-15 4.70E-13 1.20E-14 3.24E-15 3.42E-14 8.32E-15 O.OOE-01 O.OOE-01 TE129M 3.96E+02 3.11E+03 2.55E+03 7.12E+02 7.49E+03 8.22E+02 O.OOE-01 O.OOE-01 TE129 1.21E-26 3.18E-24 5.11 E-26 1.43E-26 1.50E-25 3.65E-26 O.OOE-01 O.OOE-01 TE131M 3.12E-03 1.19E-01 8.47E-03 2.93E-03 2.84E-02 6.03E-03 O.OOE-01 O.OOE-01 TE131 3.26E-27 5.75E-26 1.10E-26 3.34E-27 3.31 E-26 8.38E-27 O.OOE-01 O.OOE-01 TE132 6.04E+OO 5.03E+01 1.13E+01 5.00E+OO 4.64E+01 7.28E+OO O.OOE-01 O.OOE-01 I 130 1.68E-11 1.53E-11 1.62E-11 3.27E-11 4.88E-11 3.60E-09 O.OOE-01 O.OOE-01 1131 5.21E+OO 8.16E-01 9.11E+OO 9.17E+OO 1.51E+01 3.03E+03 O.OOE-01 O.OOE-01 I 132 1.31E-26 3.34E-26 1.55E-26 2.84E-26 4.35E-26 1.32E-24 O.OOE-01 O.OOE-01 I 133 9.14E-07 9.73E-07 1.95E-06 2.41E-06 4.03E-06 4.49E-04 O.OOE-01 O.OOE-01 I 134 4.24E-27 6.10E-27 4.96E-27 9.20E-27 1.41 E-26 2.12E-25 O.OOE-01 O.OOE-01 I 135 4.88E-22 7.87E-22 5.74E-22 1.03E-21 1.58E-21 9.14E-20 O.OOE-01 O.OOE-01 CS134 3.27E+02 8.36E+OO 9.45E+02 1.55E+03 4.81E+02 O.OOE-01 1.72E+02 O.OOE-01 CS136 5.96E+01 3.24E+OO 3.35E+01 9.21E+01 4.90E+01 O.OOE-01 7.32E+OO O.OOE-01 CS137 1.90E+02 8.06E+OO 1.34E+03 1.29E+03 4.19E+02 O.OOE-01 1.51E+02 O.OOE-01 CS138 2.00E-27 1.45E-27 2.26E-27 3.15E-27 2.21E-27 O.OOE-01 2.38E-28 O.OOE-01 BA139 2.09E-28 4.16E-25 7.21 E-27 3.85E-30 3.36E-30 O.OOE-01 2.26E-30 O.OOE-01 BA140 5.39E+OO 4.68E+01 9.24E+01 8.09E-02 2.63E-02 O.OOE-01 4.82E-02 O.OOE-01 BA141 1.93E-29 3.38E-28 5.93E-28 3.32E-31 2.87E-31 O.OOE-01 1.95E-30 O.OOE-01 BA142 2.88E-30 6.73E-31 5.16E-29 3.71E-32 3.01E-32 O.OOE-01 2.18E-32 O.OOE-01 LA140 6.23E-08 5.15E-03 5.28E-07 1.85E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 6.01E-32 3.80E-26 6.02E-31 1.92E-31 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 CE141 2.37E-03 1.99E+01 3.20E-02 1.59E-02 6.99E-03 O.OOE-01 O.OOE-01 O.OOE-01 CE143 2.90E-08 2.93E-03 3.69E-07 2.00E-04 8.39E-08 O.OOE-01 O.OOE-01 O.OOE-01 CE144 1.31E-01 2.00E+02 2.44E+OO 7.66E-01 4.24E-01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 3.39E-03 7.38E+01 6.84E-02 2.05E-02 1.11E-02 O.OOE-01 O.OOE-01 O.OOE-01 PR144 2.47E-32 3.27E-28 4.91E-31 1.52E-31 8.04E-32 O.OOE-01 O.OOE-01 O.OOE-01 ND147 1.70E-03 3.47E+01 2.71E-02 2.19E-02 1.20E-02 O.OOE-01 O.OOE-01 O.OOE-01 W187 1.35E-07 4.22E-05 5.07E-07 3.00E-07 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 1.51E-07 1.59E-02 3.00E-06 2.15E-07 6.22E-07 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 178 of 196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
RIVER SHORELINE DEPOSITS TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 2.19E+OO 2.19E+OO 2.19E+OO 2.19E+OO 2.19E+OO 2.19E+OO 2.19E+OO 2.54E+OO p 32 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 8.55E-01 8.55E-01 8.55E-01 8.55E-01 8.55E-01 8.55E-01 8.55E-01 1.01E+OO MN54 2.54E+02 2.54E+02 2.54E+02 2.54E+02 2.54E+02 2.54E+02 2.54E+02 2.98E+02 MN 56 1.61 E-01 1.61 E-01 1.61 E-01 1.61 E-01 1.61 E-01 1.61E-01 1.61 E-01 1.90E-01 FE55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 59 5.01E+01 5.01E+01 5.01E+01 5.01E+01 5.01E+01 5.01E+01 5.01E+01 5.88E+01 C058 6.98E+01 6.98E+01 6.98E+01 6.98E+01 6.98E+01 6.98E+01 6.98E+01 8.18E+01 C060 3.95E+03 3.95E+03 3.95E+03 3.95E+03 3.95E+03 3.95E+03 3.95E+03 4.65E+03 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 5.31E-02 5.31 E-02 5.31 E-02 5.31 E-02 5.31 E-02 5.31E-02 5.31 E-02 6.17E-02 cu 64 1.11E-01 1.11 E-01 1.11E-01 1.11 E-01 1.11 E-01 1.11 E-01 1.11 E-01 1.25E-01 ZN 65 1.37E+02 1.37E+02 1.37E+02 1.37E+02 1.37E+02 1.37E+02 1.37E+02 1.58E+02 ZN 69 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR83 8.70E-04 8.70E-04 8.70E-04 8.70E-04 8.70E-04 8.70E-04 8.70E-04 1.26E-03 BR84 3.27E-02 3.27E-02 3.27E-02 3.27E-02 3.27E-02 3.27E-02 3.27E-02 3.81E-02 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 1.65E+OO 1.65E+OO 1.65E+OO 1.65E+OO 1.65E+OO 1.65E+OO 1.65E+OO 1.89E+OO RB 88 4.83E-03 4.83E-03 4.83E-03 4.83E-03 4.83E-03 4.83E-03 4.83E-03 5.52E-03 RB 89 1.70E-02 1.70E-02 1.70E-02 1.70E-02 1.70E-02 1.70E-02 1.70E-02 2.04E-02 SR89 3.97E-03 3.97E-03 3.97E-03 3.97E-03 3.97E-03 3.97E-03 3.97E-03 4.61E-03 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 3.91E-01 3.91E-01 3.91E-01 3.91E-01 3.91E-01 3.91E-01 3.91E-01 4.57E-01 SR92 1.39E-01 1.39E-01 1.39E-01 1.39E-01 1.39E-01 1.39E-01 1.39E-01 1.55E-01 y 90 8.25E-04 8.25E-04 8.25E-04 8.25E-04 8.25E-04 8.25E-04 8.25E-04 9.76E-04 Y 91M 1.69E-02 1.69E-02 1.69E-02 1.69E-02 1.69E-02 1.69E-02 1.69E-02 1.96E-02 y 91 1.97E-01 1.97E-01 1.97E-01 1.97E-01 1.97E-01 1.97E-01 1.97E-01 2.22E-01 y 92 3.26E-02 3.26E-02 3.26E-02 3.26E-02 3.26E-02 3.26E-02 3.26E-02 3.87E-02 y 93 3.34E-02 3.34E-02 3.34E-02 3.34E-02 3.34E-02 3.34E-02 3.34E-02 4.57E-02 ZR95 4.51 E+01 4.51E+01 4.51E+01 4.51E+01 4.51E+01 4.51E+01 4.51E+01 5.23E+01 ZR97 5.41E-01 5.41E-01 5.41 E-01 5.41 E-01 5.41 E-01 5.41E-01 5.41 E-01 6.30E-01 NB 95 2.52E+01 2.52E+01 2.52E+01 2.52E+01 2.52E+01 2.52E+01 2.52E+01 2.96E+01 M099 7.33E-01 7.33E-01 7.33E-01 7.33E-01 7.33E-01 7.33E-01 7.33E-01 8.48E-01 TC 99M 3.34E-02 3.34E-02 3.34E-02 3.34E-02 3.34E-02 3.34E-02 3.34E-02 3.83E-02 TC101 2.79E-03 2.79E-03 2.79E-03 2.79E-03 2.79E-03 2.79E-03 2.79E-03 3.10E-03 DAEC DODAM Page 179 of 196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
RIVER SHORELINE DEPOSITS TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 1.99E+01 1.99E+01 1.99E+01 1.99E+01 1.99E+01 1.99E+01 1.99E+01 2.32E+01 RU105 1.15E-01 1.15E-01 1.15E-01 1.15E-01 1.15E-01 1.15E-01 1.15E-01 1.30E-01 RU106 7.75E+01 7.75E+01 7.75E+01 7.75E+01 7.75E+01 7.75E+01 7.75E+01 9.31E+01 AG110M 6.34E+02 6.34E+02 6.34E+02 6.34E+02 6.34E+02 6.34E+02 6.34E+02 7.39E+02 TE125M 2.86E-01 2.86E-01 2.86E-01 2.86E-01 2.86E-01 2.86E-01 2.86E-01 3.92E-01 TE127M 1.68E-02 1.68E-02 1.68E-02 1.68E-02 1.68E-02 1.68E-02 1.68E-02 1.99E-02 TE127 5.43E-04 5.43E-04 5.43E-04 5.43E-04 5.43E-04 5.43E-04 5.43E-04 5.97E-04 TE129M 3.63E+OO 3.63E+OO 3.63E+OO 3.63E+OO 3.63E+OO 3.63E+OO 3.63E+OO 4.24E+OO TE129 4.54E-03 4.54E-03 4.54E-03 4.54E-03 4.54E-03 4.54E-03 4.54E-03 5.37E-03 TE131M 1.47E+OO 1.47E+OO 1.47E+OO 1.47E+OO 1.47E+OO 1.47E+OO 1.47E+OO 1.73E+OO TE131 4.56E-03 4.56E-03 4.56E-03 4.56E-03 4.56E-03 4.56E-03 4.56E-03 5.38E+OO TE132 7.78E-01 7.78E-01 7.78E-01 7.78E-01 7.78E-01 7.78E-01 7.78E-01 9.15E-01 1130 1.01E+OO 1.01E+OO 1.01E+OO 1.01E+OO 1.01E+OO 1.01E+OO 1.01E+OO 1.22E+OO 1131 3.16E+OO 3.16E+OO 3.16E+OO 3.16E+OO 3.16E+OO 3.16E+OO 3.16E+OO 3.84E+OO 1132 2.22E-01 2.22E-01 2.22E-01 2.22E-01 2.22E-01 2.22E-01 2.22E-01 2.61E-01 1133 4.49E-01 4.49E-01 4.49E-01 4.49E-01 4.49E-01 4.49E-01 4.49E-01 5.46E-01 1134 7.57E-02 7.57E-02 7.57E-02 7.57E-02 7.57E-02 7.57E-02 7.57E-02 8.99E-02 1135 4.58E-01 4.58E-01 4.58E-01 4.58E-01 4.58E-01 4.58E-01 4.58E-01 5.35E-01 CS134 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.46E+03 CS136 2.76E+01 2.76E+01 2.76E+01 2.76E+01 2.76E+01 2.76E+01 2.76E+01 3.13E+01 CS137 1.89E+03 1.89E+03 1.89E+03 1.89E+03 1.89E+03 1.89E+03 1.89E+03 2.21E+03 CS138 5.81E-02 5.81 E-02 5.81E-02 5.81 E-02 5.81E-02 5.81E-02 5.81E-02 6.64E-02 BA139 1.84E-02 1.84E-02 1.84E-02 1.84E-02 1.84E-02 1.84E-02 1.84E-02 2.0?E-02 BA140 3.77E+OO 3.77E+OO 3.77E+OO 3.77E+OO 3.77E+OO 3.77E+OO 3.77E+OO 4.31E+OO BA141 6.11E-03 6.11E-03 6.11E-03 6.11E-03 6.11 E-03 6.11E-03 6.11E-03 6.96E-03 BA142 5.59E-03 5.59E-03 5.59E-03 5.59E-03 5.59E-03 5.59E-03 5.59E-03 6.37E-03 LA140 3.53E+OO 3.53E+OO 3.53E+OO 3.53E+OO 3.53E+OO 3.53E+OO 3.53E+OO 4.00E+OO LA142 1.29E-01 1.29E-01 1.29E-01 1.29E-01 1.29E-01 1.29E-01 1.29E-01 1.55E-01 CE141 2.51E+OO 2.51E+OO 2.51E+OO 2.51E+OO 2.51E+OO 2.51E+OO 2.51E+OO 2.83E+OO CE143 4.26E-01 4.26E-01 4.26E-01 4.26E-01 4.26E-01 4.26E-01 4.26E-01 4.84E-01 CE144 1.28E+01 1.28E+01 1.28E+01 1.28E+01 1.28E+01 1.28E+01 1.28E+01 1.48E+01 PR143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 2.65E-04 2.65E-04 2.65E-04 2.65E-04 2.65E-04 2.65E-04 2.65E-04 3.04E-04 ND147 1.56E+OO 1.56E+OO 1.56E+OO 1.56E+OO 1.56E+OO 1.56E+OO 1.56E+OO 1.87E+OO W187 4.33E-01 4.33E-01 4.33E-01 4.33E-01 4.33E-01 4.33E-01 4.33E-01 5.02E-01 NP239 3.15E-01 3.15E-01 3.15E-01 3.15E-01 3.15E-01 3.15E-01 3.15E-01 3.64E-01 DAEC DODAM Page 180of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
SWIMMING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 1.09E+02 1.09E+02 1.09E+02 1.09E+02 1.09E+02 1.09E+02 1.09E+02 O.OOE-01 p 32 8.99E-02 8.99E-02 8.99E-02 8.99E-02 8.99E-02 8.99E-02 8.99E-02 O.OOE-01 CR51 7.30E-01 7.30E-01 7.30E-01 7.30E-01 7.30E-01 7.30E-01 7.30E-01 O.OOE-01 MN 54 2.11E+01 2.11E+01 2.11E+01 2.11 E+01 2.11E+01 2.11E+01 2.11E+01 O.OOE-01 MN 56 4.38E+01 4.38E+01 4.38E+01 4.38E+01 4.38E+01 4.38E+01 4.38E+01 O.OOE-01 FE55 8.99E-04 8.99E-04 8.99E-04 8.99E-04 8.99E-04
~.99E-04 8.99E-04 O.OOE-01 FE 59 3.09E+01 3.09E+01 3.09E+01 3.09E+01 3.09E+01 3.09E+01 3.09E+01 O.OOE-01 C058 2.53E+01 2.53E+01 2.53E+01 2.53E+01 2.53E+01 2.53E+01 2.53E+01 O.OOE-01 C060 6.46E+01 6.46E+01 6.46E+01 6.46E+01 6.46E+01 6.46E+01 6.46E+01 O.OOE-01 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 1.37E+01 1.37E+01 1.37E+01 1.37E+01 1.37E+01 1.37E+01 1.37E+01 O.OOE-01 cu 64 5.17E+OO 5.17E+OO 5.17E+OO 5.17E+OO 5.17E+OO 5.17E+OO 5.17E+OO O.OOE-01 ZN 65 1.55E+01 1.55E+01 1.55E+01 1.55E+01 1.55E+01 1.55E+01 1.55E+01 O.OOE-01 ZN 69 2.09E-02 2.09E-02 2.09E-02 2.09E-02 2.09E-02 2.09E-02 2.09E-02 O.OOE-01 BR83 2.32E-01 2.32E-01 2.32E-01 2.32E-01 2.32E-01 2.32E-01 2.32E-01 O.OOE-01 BR84 4.32E+01 4.32E+01 4.32E+01 4.32E+01 4.32E+01 4.32E+01 4.32E+01 O.OOE-01 BR85 4.61E-02 4.61E-02 4.61E-02 4.61E-02 4.61E-02 4.61E-02 4.61 E-02 O.OOE-01 RB 86 2.39E+OO 2.39E+OO 2.39E+OO 2.39E+OO 2.39E+OO 2.39E+OO 2.39E+OO O.OOE-01 RB 88 1.34E+01 1.34E+01 1.34E+01 1.34E+01 1.34E+01 1.34E+01 1.34E+01 O.OOE-01 RB 89 4.81 E+01 4.81E+01 4.81E+01 4.81E+01 4.81E+01 4.81E+01 4.81E+01 O.OOE-01 SR89 6.46E-02 6.46E-02 6.46E-02 6.46E-02 6.46E-02 6.46E-02 6.46E-02 O.OOE-01 SR 90 7.59E-03 7.59E-03 7.59E-03 7.59E-03 7.59E-03 7.59E-03 7.59E-03 O.OOE-01 SR 91 2.65E+01 2.65E+01 2.65E+01 2.65E+01 2.65E+01 2.65E+01 2.65E+01 O.OOE-01 SR 92 3.56E+01 3.56E+01 3.56E+01 3.56E+01 3.56E+01 3.56E+01 3.56E+01 O.OOE-01 y 90 1.83E-01 1.83E-01 1.83E-01 1.83E-01 1.83E-01 1.83E-01 1.83E-01 O.OOE-01 Y 91M 1.29E+01 1.29E+01 1.29E+01 1.29E+01 1.29E+01 1.29E+01 1.29E+01 O.OOE-01 y 91 9.41E-02 9.41E-02 9.41E-02 9.41E-02 9.41E-02 9.41E-02 9.41E-02 O.OOE-01 y 92 6.34E+OO 6.34E+OO 6.34E+OO 6.34E+OO 6.34E+OO 6.34E+OO 6.34E+OO O.OOE-01 y 93 2.65E+OO 2.65E+OO 2.65E+OO 2.65E+OO 2.65E+OO 2.65E+OO 2.65E+OO O.OOE-01 ZR95 2.11E+01 2.11E+01 2.11E+01 2.11E+01 2.11E+01 2.11E+01 2.11E+01 O.OOE-01 ZR97 2.10E+01 2.10E+01 2.10E+01 2.10E+01 2.10E+01 2.10E+01 2.10E+01 O.OOE-01 NB 95 1.97E+01 1.97E+01 1.97E+01 1.97E+01 1.97E+01 1.97E+01 1.97E+01 O.OOE-01 M099 6.60E+OO 6.60E+OO 6.60E+OO 6.60E+OO 6.60E+OO 6.60E+OO 6.60E+OO O.OOE-01 TC99M 3.33E+OO 3.33E+OO 3.33E+OO 3.33E+OO 3.33E+OO 3.33E+OO 3.33E+OO O.OOE-01 TC101 7.13E+OO 7.13E+OO 7.13E+OO 7.13E+OO 7.13E+OO 7.13E+OO 7.13E+OO O.OOE-01 DAEC DODAM Page 181 of 196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
SWIMMING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 O.OOE-01 RU105 1.66E+01 1.66E+01 1.66E+01 1.66E+01 1.66E+01 1.66E+01 1.66E+01 O.OOE-01 RU106 5.34E+OO 5.34E+OO 5.34E+OO 5.34E+OO 5.34E+OO 5.34E+OO 5.34E+OO O.OOE-01 AG110M 6.88E+01 6.88E+01 6.88E+01 6.88E+01 6.88E+01 6.88E+01 6.88E+01 O.OOE-01 TE125M 5.18E-02 5.18E-02 5.18E-02 5.18E-02 5.18E-02 5.18E-02 5.18E-02 O.OOE-01 TE127M 3.65E-03 3.65E-03 3.65E-03 3.65E-03 3.65E-03 3.65E-03 3.65E-03 O.OOE-01 TE127 3.91E-02 3.91E-02 3.91E-02 3.91E-02 3.91E-02 3.91E-02 3.91E-02 O.OOE-01 TE129M 2.95E+OO 2.95E+OO 2.95E+OO 2.95E+OO 2.95E+OO 2.95E+OO 2.95E+OO O.OOE-01 TE129 2.52E+OO 2.52E+OO 2.52E+OO 2.52E+OO 2.52E+OO 2.52E+OO 2.52E+OO O.OOE-01 TE131M 3.08E+01 3.08E+01 3.08E+01 3.08E+01 3.08E+01 3.08E+01 3.08E+01 O.OOE-01 TE131 8.81 E+OO 8.81 E+OO 8.81E+OO 8.81E+OO 8.81E+OO 8.81E+OO 8.81E+OO O.OOE-01 TE132 5.61E+OO 5.61E+OO 5.61E+OO 5.61E+OO 5.61E+OO 5.61E+OO 5.61E+OO O.OOE-01 I 130 5.45E+01 5.45E+01 5.45E+01 5.45E+01 5.45E+01 5.45E+01 5.45E+01 O.OOE-01 1131 1.10E+01 1.10E+01 1.10E+01 1.10E+01 1.10E+01 1.10E+01 1.10E+01 O.OOE-01 1132 6.00E+01 6.00E+01 6.00E+01 6.00E+01 6.00E+01 6.00E+01 6.00E+01 O.OOE-01 I 133 1.34E+01 1.34E+01 1.34E+01 1.34E+01 1.34E+01 1.34E+01 1.34E+01 O.OOE-01 I 134 5.45E+01 5.45E+01 5.45E+01 5.45E+01 5.45E+01 5.45E+01 5.45E+01 O.OOE-01 I 135 4.59E+01 4.59E+01 4.59E+01 4.59E+01 4.59E+01 4.59E+01 4.59E+01 O.OOE-01 CS134 4.07E+01 4.07E+01 4.07E+01 4.07E+01 4.07E+01 4.07E+01 4.07E+01 O.OOE-01 CS136 5.76E+01 5.76E+01 5.76E+01 5.76E+01 5.76E+01 5.76E+01 5.76E+01 O.OOE-01 CS137 1.41E+01 1.41E+01 1.41E+01 1.41 E+01 1.41 E+01 1.41E+01 1.41E+01 O.OOE-01 CS138 4.94E+01 4.94E+01 4.94E+01 4.94E+01 4.94E+01 4.94E+01 4.94E+01 O.OOE-01 BA139 1.03E+OO 1.03E+OO 1.03E+OO 1.03E+OO 1.03E+OO 1.03E+OO 1.03E+OO O.OOE-01 BA140 6.88E+OO 6.88E+OO 6.88E+OO 6.88E+OO 6.88E+OO 6.88E+OO 6.88E+OO O.OOE-01 BA141 1.23E+01 1.23E+01 1.23E+01 1.23E+01 1.23E+01 1.23E+01 1.23E+01 O.OOE-01 BA142 2.10E+01 2.10E+01 2.10E+01 2.10E+01 2.10E+01 2.10E+01 2.10E+01 O.OOE-01 LA140 5.75E+01 5.75E+01 5.75E+01 5.75E+01 5.75E+01 5.75E+01 5.75E+01 O.OOE-01 LA142 6.04E+01 6.04E+01 6.04E+01 6.04E+01 6.04E+01 6.04E+01 6.04E+01 O.OOE-01 CE141 1.83E+OO 1.83E+OO 1.83E+OO 1.83E+OO 1.83E+OO 1.83E+OO 1.83E+OO O.OOE-01 CE143 7.99E+OO 7.99E+OO 7.99E+OO 7.99E+OO 7.99E+OO 7.99E+OO 7.99E+OO O.OOE-01 CE144 1.21E+OO 1.21E+OO 1.21E+OO 1.21 E+OO 1.21E+OO 1.21 E+OO 1.21E+OO O.OOE-01 PR143 2.25E-02 2.25E-02 2.25E-02 2.25E-02 2.25E-02 2.25E-02 2.25E-02 O.OOE-01 PR144 6.18E-01 6.18E-01 6.18E-01 6.18E-01 6.18E-01 6.18E-01 6.18E-01 O.OOE-01 ND147 3.93E+OO 3.93E+OO 3.93E+OO 3.93E+OO 3.93E+OO 3.93E+OO 3.93E+OO O.OOE-01 W187 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 O.OOE-01 NP239 3.37E+OO 3.37E+OO 3.37E+OO 3.37E+OO 3.37E+OO 3.37E+OO 3.37E+OO O.OOE-01 DAEC DODAM Page 182of196 Rev.000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
CHILD PATHWAY
=
BOATING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 1.01E+02 1.01E+02 1.01E+02 1.01E+02 1.01E+02 1.01E+02 1.01E+02 O.OOE-01 p 32 8.35E-02 8.35E-02 8.35E-02 8.35E-02 8.35E-02 8.35E-02 8.35E-02 O.OOE-01 CR51 6.78E-01 6.78E-01 6.78E-01 6.78E-01 6.78E-01 6.78E-01 6.78E-01 O.OOE-01 MN54 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 O.OOE-01 MN 56 4.06E+01 4.06E+01 4.06E+01 4.06E+01 4.06E+01 4.06E+01 4.06E+01 O.OOE-01 FE55 8.35E-04 8.35E-04 8.35E-04 8.35E-04 8.35E-04 8.35E-04 8.35E-04 O.OOE-01 FE59 2.87E+01 2.87E+01 2.87E+01 2.87E+01 2.87E+01 2.87E+01 2.87E+01 O.OOE-01 C058 2.35E+01 2.35E+01 2.35E+01 2.35E+01 2.35E+01 2.35E+01 2.35E+01 O.OOE-01 C060 6.00E+01 6.00E+01 6.00E+01 6.00E+01 6.00E+01 6.00E+01 6.00E+01 O.OOE-01 Nl63 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 1.27E+01 1.27E+01 1.27E+01 1.27E+01 1.27E+01 1.27E+01 1.27E+01 O.OOE-01 CU64 4.80E+OO 4.80E+OO 4.80E+OO 4.80E+OO 4.80E+OO 4.80E+OO 4.80E+OO O.OOE-01 ZN 65 1.44E+01 1.44E+01 1.44E+01 1.44E+01 1.44E+01 1.44E+01 1.44E+01 O.OOE-01 ZN 69 1.94E-02 1.94E-02 1.94E-02 1.94E-02 1.94E-02 1.94E-02 1.94E-02 O.OOE-01 BR83 2.15E-01 2.15E-01 2.15E-01 2.15E-01 2.15E-01 2.15E-01 2.15E-01 O.OOE-01 BR84 4.01E+01 4.01E+01 4.01E+01 4.01E+01 4.01 E+01 4.01E+01 4.01E+01 O.OOE-01 BR85 4.28E-02 4.28E-02 4.28E-02 4.28E-02 4.28E-02 4.28E-02 4.28E-02 O.OOE-01 RB86 2.22E+OO 2.22E+OO 2.22E+OO 2.22E+OO 2.22E+OO 2.22E+OO 2.22E+OO O.OOE-01 RB 88 1.24E+01 1.24E+01 1.24E+01 1.24E+01 1.24E+01 1.24E+01 1.24E+01 O.OOE-01 RB 89 4.47E+01 4.47E+01 4.47E+01 4.47E+01 4.47E+01 4.47E+01 4.47E+01 O.OOE-01 SR89 6.00E-02 6.00E-02 6.00E-02 6.00E-02 6.00E-02 6.00E-02 6.00E-02 O.OOE-01 SR90 7.04E-03 7.04E-03 7.04E-03 7.04E-03 7.04E-03 7.04E-03 7.04E-03 O.OOE-01 SR91 2.46E+01 2.46E+01 2.46E+01 2.46E+01 2.46E+01 2.46E+01 2.46E+01 O.OOE-01 SR92 3.31E+01 3.31E+01 3.31 E+01 3.31 E+01 3.31E+01 3.31E+01 3.31 E+01 O.OOE-01 y 90 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.69E-01 1.69E-01 O.OOE-01 Y 91M 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.20E+01 1.20E+01 O.OOE-01 y 91 8.74E-02 8.74E-02 8.74E-02 8.74E-02 8.74E-02 8.74E-02 8.74E-02 O.OOE-01 y 92 5.89E+OO 5.89E+OO 5.89E+OO 5.89E+OO 5.89E+OO 5.89E+OO 5.89E+OO O.OOE-01 y 93 2.46E+OO 2.46E+OO 2.46E+OO 2.46E+OO 2.46E+OO 2.46E+OO 2.46E+OO O.OOE-01 ZR95 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 1.96E+01 O.OOE-01 ZR97 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 O.OOE-01 NB 95 1.83E+01 1.83E+01 1.83E+01 1.83E+01 1.83E+01 1.83E+01 1.83E+01 O.OOE-01 M099 6.12E+OO 6.12E+OO 6.12E+OO 6.12E+OO 6.12E+OO 6.12E+OO 6.12E+OO O.OOE-01 TC99M 3.10E+OO 3.10E+OO 3.10E+OO 3.10E+OO 3.10E+OO 3.10E+OO 3.10E+OO O.OOE-01 TC101 6.62E+OO 6.62E+OO 6.62E+OO 6.62E+OO 6.62E+OO 6.62E+OO 6.62E+OO O.OOE-01 DAEC DODAM Page 183of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
= CHILD PATHWAY
= BOATING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 1.16E+01 O.OOE-01 RU105 1.54E+01 1.54E+01 1.54E+01 1.54E+01 1.54E+01 1.54E+01 1.54E+01 O.OOE-01 RU106 4.96E+OO 4.96E+OO 4.96E+OO 4.96E+OO 4.96E+OO 4.96E+OO 4.96E+OO O.OOE-01 AG110M 6.39E+01 6.39E+01 6.39E+01 6.39E+01 6.39E+01 6.39E+01 6.39E+01 O.OOE-01 TE125M 4.81E-02 4.81 E-02 4.81 E-02 4.81E-02 4.81 E-02 4.81 E-02 4.81E-02 O.OOE-01 TE127M 3.39E-03 3.39E-03 3.39E-03 3.39E-03 3.39E-03 3.39E-03 3.39E-03 O.OOE-01 TE127 3.63E-02 3.63E-02 3.63E-02 3.63E-02 3.63E-02 3.63E-02 3.63E-02 O.OOE-01 TE129M 2.74E+OO 2.74E+OO 2.74E+OO 2.74E+OO 2.74E+OO 2.74E+OO 2.74E+OO O.OOE-01 TE129 2.34E+OO 2.34E+OO 2.34E+OO 2.34E+OO 2.34E+OO 2.34E+OO 2.34E+OO O.OOE-01 TE131M 2.86E+01 2.86E+01 2.86E+01 2.86E+01 2.86E+01 2.86E+01 2.86E+01 O.OOE-01 TE131 8.18E+OO 8.18E+OO 8.18E+OO 8.18E+OO 8.18E+OO 8.18E+OO 8.18E+OO O.OOE-01 TE132 5.21E+OO 5.21E+OO 5.21E+OO 5.21E+OO 5.21E+OO 5.21E+OO 5.21 E+OO O.OOE-01 I 130 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 O.OOE-01 1131 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 1.02E+01 O.OOE-01 I 132 5.57E+01 5.57E+01 5.57E+01 5.57E+01 5.57E+01 5.57E+01 5.57E+01 O.OOE-01 I 133 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 1.25E+01 O.OOE-01 I 134 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 5.06E+01 O.OOE-01 I 135 4.26E+01 4.26E+01 4.26E+01 4.26E+01 4.26E+01 4.26E+01 4.26E+01 O.OOE-01 CS134 3.78E+01 3.78E+01 3.78E+01 3.78E+01 3.78E+01 3.78E+01 3.78E+01 O.OOE-01 CS136 5.35E+01 5.35E+01 5.35E+01 5.35E+01 5.35E+01 5.35E+01 5.35E+01 O.OOE-01 CS137 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 1.31E+01 O.OOE-01 CS138 4.59E+01 4.59E+01 4.59E+01 4.59E+01 4.59E+01 4.59E+01 4.59E+01 O.OOE-01 BA139 9.55E-01 9.55E-01 9.55E-01 9.55E-01 9.55E-01 9.55E-01 9.55E-01 O.OOE-01 BA140 6.39E+OO 6.39E+OO 6.39E+OO 6.39E+OO 6.39E+OO 6.39E+OO 6.39E+OO O.OOE-01 BA141 1.14E+01 1.14E+01 1.14E+01 1.14E+01 1.14E+01 1.14E+01 1.14E+01 O.OOE-01 BA142 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 1.95E+01 O.OOE-01 LA140 5.34E+01 5.34E+01 5.34E+01 5.34E+01 5.34E+01 5.34E+01 5.34E+01 O.OOE-01 LA142 5.61E+01 5.61E+01 5.61E+01 5.61E+01 5.61E+01 5.61E+01 5.61E+01 O.OOE-01 CE141 1.70E+OO 1.70E+OO 1.70E+OO 1.70E+OO 1.70E+OO 1.70E+OO 1.70E+OO O.OOE-01 CE143 7.42E+OO 7.42E+OO 7.42E+OO 7.42E+OO 7.42E+OO 7.42E+OO 7.42E+OO O.OOE-01 CE144 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO 1.12E+OO O.OOE-01 PR143 2.09E-02 2.09E-02 2.09E-02 2.09E-02 2.09E-02 2.09E-02 2.09E-02 O.OOE-01 PR144 5.74E-01 5.74E-01 5.74E-01 5.74E-01 5.74E-01 5.74E-01 5.74E-01 O.OOE-01 ND147 3.65E+OO 3.65E+OO 3.65E+OO 3.65E+OO 3.65E+OO 3.65E+OO 3.65E+OO O.OOE-01 W187 1.08E+01 1.08E+01 1.08E+01 1.08E+01 1.08E+01 1.08E+01 1.08E+01 O.OOE-01 NP239 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO 3.13E+OO O.OOE-01 DAEC DODAM Page 184of196 Rev.000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
= INFANT PATHWAY
= POTABLE WATER TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 2.91E+01 2.91E+01 O.OOE-01 2.91E+01 2.91E+01 2.91E+01 2.91E+01 O.OOE-01 c 14 8.38E+02 8.38E+02 3.92E+03 8.38E+02 8.38E+02 8.38E+02 8.38E+02 O.OOE-01 NA24 5.53E+02 5.53E+02 5.53E+02 5.53E+02 5.53E+02 5.53E+02 5.53E+02 O.OOE-01 p 32 1.04E+04 3.63E+03 2.68E+05 1.58E+04 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 2.28E+OO 6.64E+01 O.OOE-01 O.OOE-01 3.25E-01 1.49E+OO 2.89E+OO O.OOE-01 MN 54 7.45E+02 1.21E+03 O.OOE-01 3.29E+03 7.29E+02 O.OOE-01 0.00E-01 O.OOE-01 MN56 3.58E-02 1.89E+01 O.OOE-01 2.08E-01 1.79E-01 O.OOE-01 O.OOE-01 O.OOE-01 FE55 3.97E+02 1.89E+02 2.30E+03 1.49E+03 O.OOE-01 O.OOE-01 7.26E+02 O.OOE-01 FE59 3.46E+03 4.19E+03 5.02E+03 8.77E+03 O.OOE-01 O.OOE-01 2.59E+03 O.OOE-01 C058 1.47E+03 1.47E+03 O.OOE-01 5.90E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 4.22E+03 4.25E+03 O.OOE-01 1.79E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 3.64E+03 3.23E+02 1.05E+05 6.49E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 5.45E-02 9.11E+OO 1.06E+OO 1.20E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CU64 1.26E+01 5.57E+02 O.OOE-01 2.71 E+01 4.59E+01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 4.80E+03 8.80E+03 3.04E+03 1.04E+04 5.05E+03 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 5.00E-08 5.48E-05 3.73E-07 6.72E-07 2.79E-07 O.OOE-01 O.OOE-01 O.OOE-01 BR83 5.73E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 1.34E+04 6.94E+02 O.OOE-01 2.71E+04 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 1.18E+04 8.43E+03 4.10E+05 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 9.50E+04 3.82E+04 4.69E+06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 5.19E+01 1.70E+03 1.43E+03 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 2.56E-01 7.43E+01 6.89E+OO 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 2.98E-01 1.53E+04 1.11E+01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 4.93E+OO 1.33E+04 1.85E+02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 3.29E-04 2.24E+02 1.17E-02 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 2.11E-02 6.10E+03 7.73E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 5.83E+OO 4.09E+03 3.37E+01 8.22E+OO 8.86E+OO O.OOE-01 O.OOE-01 O.OOE-01 ZR97 7.17E-02 1.00E+04 9.15E-01 1.57E-01 1.58E-01 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 1.62E+OO 2.37E+03 6.82E+OO 2.81E+OO 2.01E+OO O.OOE-01 0.00E-01 O.OOE-01 M099 8.53E+02 1.44E+03 O.OOE-01 4.37E+03 6.54E+03 O.OOE-01 O.OOE-01 O.OOE-01 TC99M 5.32E-01 1.20E+01 2.00E-02 4.13E-02 4.44E-01 O.OOE-01 2.16E-02 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 185of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
INFANT PATHWAY
=
POTABLE WATER TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 8.05E+01 2.93E+03 2.41E+02 O.OOE-01 5.01E+02 O.OOE-01 O.OOE-01 O.OOE-01 RU105 1.78E-01 2.11E+02 5.30E-01 O.OOE-01 3.89E+OO O.OOE-01 O.OOE-01 O.OOE-01 RU106 4.97E+02 3.02E+04 3.98E+03 0.00E-01 4.71E+03 O.OOE-01 O.OOE-01 O.OOE-01 AG110M 7.94E+01 6.23E+03 1.64E+02 1.20E+02 1.72E+02 O.OOE-01 O.OOE-01 O.OOE-01 TE125M 5.15E+02 1.82E+03 3.81E+03 1.27E+03 O.OOE-01 1.28E+03 O.OOE-01 O.OOE-01 TE127M 1.16E+03 3.88E+03 9.63E+03 3.19E+03 2.37E+04 2.78E+03 O.OOE-01 O.OOE-01 TE127 6.01E+OO 5.86E+02 2.79E+01 9.36E+OO 6.82E+01 2.27E+01 O.OOE-01 O.OOE-01 TE129M 2.50E+03 9.68E+03 1.62E+04 5.56E+03 4.05E+04 6.23E+03 O.OOE-01 O.OOE-01 TE129 6.48E-06 2.22E-03 2.78E-05 9.57E-06 6.91E-05 2.33E-05 O.OOE-01 O.OOE-01 TE131M 4.80E+02 9.79E+03 1.44E+03 5.82E+02 4.00E+03 1.18E+03 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 1.29E+03 5.10E+03 2.78E+03 1.38E+03 8.62E+03 2.03E+03 O.OOE-01 O.OOE-01 I 130 2.28E+02 1.22E+02 2.58E+02 5.68E+02 6.24E+02 6.37E+04 O.OOE-01 O.OOE-01 1131 2.83E+03 2.29E+02 5.45E+03 6.43E+03 7.50E+03 2.11E+06 O.OOE-01 O.OOE-01 I 132 1.44E-01 3.27E-01 1.99E-01 4.04E-01 4.SOE-01 1.89E+01 O.OOE-01 O.OOE-01 I 133 3.97E+02 2.29E+02 9.31E+02 1.35E+03 1.59E+03 2.46E+05 O.OOE-01 O.OOE-01 1134 5.83E-07 1.69E-06 8.00E-07 1.64E-06 1.83E-06 3.82E-05 O.OOE-01 O.OOE-01 I 135 3.51E+01 3.48E+01 4.84E+01 9.62E+01 1.07E+02 8.62E+03 O.OOE-01 O.OOE-01 CS134 1.17E+04 3.16E+02 6.24E+04 1.16E+05 2.99E+04 O.OOE-01 1.23E+04 O.OOE-01 CS136 7.92E+03 3.22E+02 7.21E+03 2.12E+04 8.45E+03 O.OOE-01 1.73E+03 O.OOE-01 CS137 7.17E+03 3.16E+02 8.64E+04 1.01E+05 2.72E+04 O.OOE-01 1.10E+04 O.OOE-01.
CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 2.36E-05 5.16E-02 8.14E-04 5.40E-07 3.24E-07 O.OOE-01 3.27E-07 O.OOE-01 BA140 1.38E+03 6.59E+03 2.68E+04 2.68E+01 6.37E+OO O.OOE-01 1.65E+01 O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 2.35E-01 1.07E+04 2.31E+OO 9.12E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 3.27E-07 2.32E-01 3.72E-06 1.37E-06 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 9.16E-01 4.02E+03 1.28E+01 7.78E+OO 2.40E+OO O.OOE-01 O.OOE-01 O.OOE-01 CE143 1.12E-01 5.74E+03 1.48E+OO 9.84E+02 2.87E-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 2.76E+01 2.82E+04 4.92E+02 2.01E+02 8.14E+01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 6.34E-01 6.75E+03 1.28E+01 4.78E+OO 1.78E+OO O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 ND147 5.41E-01 5.60E+03 8.60E+OO 8.84E+OO 3.41E+OO O.OOE-01 O.OOE-01 O.OOE-01 W187 1.79E+01 3.05E+03 7.46E+01 5.19E+01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 6.93E-02 3.54E+03 1.37E+OO 1.23E-01 2.44E-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 186of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
INFANT PATHWAY
=
FRESH WATER FISH TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 p 32 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 56 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CU64 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 83 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR97 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 M099 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TC 99M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 187of196 Rev.000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE INFANT PATHWAY FRESH WATER FISH TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU105 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU106 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AG110M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE125M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE127M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE127 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 130 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 132 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 W187 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 188of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
= INFANT PATHWAY
= ANIMAL DRINKING WATER-MEAT TOTAL BODY Gl-LLI BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 p 32 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN56 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CU64 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 83 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR97 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 M099 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TC99M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 189of196 Rev.000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
INFANT PATHWAY
=
ANIMAL DRINKING WATER-MEAT TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU105 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU106 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AG110M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE125M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 TE127M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE127 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 130 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 132 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 1134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 W187 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 190of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
INFANT PATHWAY
=
RIVER SHORELINE DEPOSITS TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 p 32 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 56 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 Nl65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 cu 64 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 ZN 69 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR83 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR97 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 M099 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TC99M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 191 of 196 Rev.000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
INFANT PATHWAY
=
RIVER SHORELINE DEPOSITS TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU105 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU106 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AG110M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE125M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE127M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE127 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 130 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 132 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 W187 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 192of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
INFANT PATHWAY
=
SWIMMING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 p 32 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 56 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 cu 64 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR83 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 RB 86 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR 95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR97 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 M099 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TC99M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 193of196 Rev.000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
INFANT PATHWAY
=
SWIMMING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
RU103 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU105 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU106 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AG110M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE125M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE127M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE127 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 130 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 132 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 133 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 0.00E-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA140 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 W187 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 194of196 Rev. 000
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
=
INFANT PATHWAY
=
BOATING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci minl H 3 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 c 14 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NA24 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 p 32 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CR 51 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 54 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 MN 56 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 55 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 FE 59 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C058 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 C060 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl63 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Nl65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 cu 64 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 65 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZN 69 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 83 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR 84 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BR85 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 86 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB88 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RB 89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR89 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 SR 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 90 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 Y 91M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 91 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 92 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 y 93 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR 95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ZR97 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NB 95 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 M099 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TC99M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TC101 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 195of196 Rev.ODO
Appendix C DOSE TRANSFER FACTORS FOR RADIONUCLIDES IN EFFLUENT WATER AGE
= INFANT PATHWAY
= BOATING TOTAL BODY GI-LU BONE LIVER KIDNEY THYROID LUNG SKIN (mrem gal)/(Ci min)
-~
RU103 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU105 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 RU106 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 AG110M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE125M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE127M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE127 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE129 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131M O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 TE132 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 130 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 I 131 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 1132 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 133 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 I 135 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS134 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS136 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS137 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CS138 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA139 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 BA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 0.00E-01 LA140 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 LA142 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE141 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 CE144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR143 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 PR144 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 ND147 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 W187 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 NP239 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 O.OOE-01 DAEC DODAM Page 196of196 Rev.000

NG-21-0008, Attachment 3: Defueled Offsite Dose Assessment Manual (Dodam)

Contents

Text

1.0 INTRODUCTION

1.0 INTRODUCTION

Navigation menu

NG-21-0008, Attachment 3: Defueled Offsite Dose Assessment Manual (Dodam)

Text

1.0 INTRODUCTION

1.0 INTRODUCTION

Navigation menu

Search